Docstoc

Evolution Of Whole Cells And Organisms By Recursive Sequence Recombination - Patent 6287862

Document Sample
Evolution Of Whole Cells And Organisms By Recursive Sequence Recombination - Patent 6287862 Powered By Docstoc
					


United States Patent: 6287862


































 
( 1 of 1 )



	United States Patent 
	6,287,862



 delCardayre
,   et al.

 
September 11, 2001




 Evolution of whole cells and organisms by recursive sequence recombination



Abstract

The invention provides methods employing iterative cycles of recombination
     and selection/screening for evolution of whole cells and organisms toward
     acquisition of desired properties. Examples of such properties include
     enhanced recombinogenicity, genome copy number, and capacity for
     expression and/or secretion of proteins and secondary metabolites.


 
Inventors: 
 delCardayre; Stephen (Belmont, CA), Tobin; Matthew (San Jose, CA), Stemmer; Willem P. C. (Los Gatos, CA), Ness; Jon E. (Sunnyvale, CA), Minshull; Jeremy (Menlo Park, CA), Patten; Phillip (Menlo Park, CA), Subramanian; Venkiteswaran (San Diego, CA), Castle; Linda (Mountain View, CA), Krebber; Claus M. (Mountain View, CA), Bass; Steven H. (Hillsborough, CA) 
 Assignee:


Maxygen, Inc.
 (Redwood City, 
CA)





Appl. No.:
                    
 09/626,410
  
Filed:
                      
  July 26, 2000

 Related U.S. Patent Documents   
 

Application NumberFiling DatePatent NumberIssue Date
 116188Jul., 1998
 PCTUS9800852Jan., 1998
 

 



  
Current U.S. Class:
  435/440  ; 435/6; 536/23.1; 536/24.3
  
Current International Class: 
  C12P 17/16&nbsp(20060101); C12Q 1/68&nbsp(20060101); C12N 15/82&nbsp(20060101); C12N 15/10&nbsp(20060101); C07K 14/195&nbsp(20060101); C07K 14/245&nbsp(20060101); C12N 015/00&nbsp(); C12Q 001/68&nbsp(); C07H 021/02&nbsp(); C07H 021/04&nbsp()
  
Field of Search: 
  
  






 435/440,6 536/23.1,24.3 935/76,77,78
  

References Cited  [Referenced By]
U.S. Patent Documents
 
 
 
4729951
March 1988
Ferenczy et al.

4889806
December 1989
Olson et al.

4940834
July 1990
Hurley et al.

5512463
April 1996
Stemmer

5514588
May 1996
Varadaraj

5521077
May 1996
Khosla et al.

5578461
November 1996
Sherwin et al.

5605793
February 1997
Stemmer

5605820
February 1997
Timberlake et al.

5695975
December 1997
Zimmerman et al.

5721367
February 1998
Kay et al.

5763239
June 1998
Short et al.

5789228
August 1998
Lam et al.

5811238
September 1998
Stemmer et al.

5814473
September 1998
Warren et al.

5824485
October 1998
Thompson et al.

5830696
November 1998
Short

5830721
November 1998
Stemmer et al.

5834252
November 1998
Stemmer et al.

5837458
November 1998
Minushull et al.

5837470
November 1998
Carlson et al.

5869718
February 1999
Julien et al.

5876997
March 1999
Kretz

5925749
July 1999
Mathur et al.

5928905
July 1999
Stemmer et al.

5929250
August 1999
Short

5939250
August 1999
Short

5939300
August 1999
Robertson et al.

5942430
August 1999
Robertson et al.

5948666
September 1999
Callen et al.

5958672
September 1999
Short

5958751
September 1999
Murphy et al.

5962258
October 1999
Mathur et al.

5962283
October 1999
Warren et al.

5965408
October 1999
Short

5976862
November 1999
Kauffman et al.

5985646
November 1999
Murphy et al.



 Foreign Patent Documents
 
 
 
0911396A2
Apr., 1999
EP

0911396A3
May., 1999
EP

0934999A1
Aug., 1999
EP

WO9503400
Feb., 1995
WO

97/07205
Feb., 1997
WO

97/20078
Jun., 1997
WO

97/21806
Jun., 1997
WO

97/25410
Jul., 1997
WO

97/35966
Oct., 1997
WO

97/35957
Oct., 1997
WO

97/44361
Nov., 1997
WO

97/48717
Dec., 1997
WO

97/48416
Dec., 1997
WO

97/48794
Dec., 1997
WO

98/00526
Jan., 1998
WO

98/01581
Jan., 1998
WO

WO9801573
Jan., 1998
WO

98/13487
Apr., 1998
WO

98/13485
Apr., 1998
WO

98/27230
Jun., 1998
WO

98/24799
Jun., 1998
WO

98/28416
Jul., 1998
WO

98/31837
Jul., 1998
WO

98/36080
Aug., 1998
WO

98/41653
Sep., 1998
WO

98/41623
Sep., 1998
WO

98/41622
Sep., 1998
WO

98/42727
Oct., 1998
WO

98/48034
Oct., 1998
WO

98/42832
Oct., 1998
WO

98/58085
Dec., 1998
WO

99/08539
Feb., 1999
WO

99/07837
Feb., 1999
WO

99/10539
Mar., 1999
WO

99/10472
Mar., 1999
WO

99/19518
Apr., 1999
WO

99/21979
May., 1999
WO

99/23107
May., 1999
WO

99/23236
May., 1999
WO

99/41369
Aug., 1999
WO

99/41383
Aug., 1999
WO

99/41402
Aug., 1999
WO

99/45154
Sep., 1999
WO

99/57128
Nov., 1999
WO

99/65927
Dec., 1999
WO



   
 Other References 

Capecchi M., Science 244: 1288-1292 (1989).*
.
Larionov et al., PNAS 93: 491-496 (1996).*
.
Larionov et al., Nucleic Acids Research 22 (20): 4154-4162 (1994).*
.
Larionov et al., PNAS 93: 13925-13930 (1996).*
.
Ragoussis et al., Nucleic Acids Research 20(12): 3135-3138 (1992).*
.
Spencer et al., Methods 5(2): 161-175 (1993).*
.
Allard, R.W., (1960) Principles of Plant Breeding, John Wiley and Sons, Inc., New York, Chapter 23 Recurrent Selection, pp. 282-302.
.
William P.C. Stemmer, "DNA Shuffling by Random Fragmentation and Reassembly In Vitro Recombination for Molecular Evolution", Proc. natl. Acad. Sci, 91:10747-10751 (10/94).
.
William P.C. Stemmer, "Rapid Evolution of a Protein In Vitro by DNA Shuffling", Nature 370:389-391 (Aug. 4, 1994).
.
Stemmer, W.P.C. et al., (1995), Single-step assembly of a gene and entire plasmid form large numbers of oligodeoxyribonucleotides, Gene, 164:49-53.
.
Stemmer, W.P.C., (1995), Searching Sequence Space, Bio/Technology 13:549-553.
.
Stemmer, W.P.C., (1995), The Evolution of Molecular Computation, Science 270:1510.
.
Crameri, A. and Stemmer, W.P.C. (1995), Combinatorial multiple cassette mutagenesis creates all the permutations of mutant and wild-type cassettes, Biotechniques 18:194-195.
.
Stemmer, W.P.C. (1996), Sexual PCR and Assembly PCR. In: The Encyclopedia of Molecular Biology, VCH Publishers, New York. pp. 447-457.
.
Gates, C.M. et al., (1996), Affinity selective isolation of ligands from peptide libraries through display on a lac repressor `headpiece dimer`, Journal of Molecular Biology 255:373-386.
.
Crameri, A., et al., (1996), Improve green fluorescent protein by molecular evolution using DNA shuffling, Nature Biotechnology 14:315-319.
.
Crameri, A., et al., (1996), Construction and evolution of antibody-phage libraries by DNA shuffling, Nature Medicine 2:100-103.
.
Zhang, J., et al., (1997), Directed evolution of fucosidase from a galactosidase by DNA shuffling and screening, Proceedings of the National Academy of Sciences, U.S.A. 94:4504-4509.
.
Patten, P.A., et al., (1997), Applications of DNA Shuffling to Pharmaceuticals and Vaccines, Current Opinion in Biotechnology 8:724-733.
.
Crameri, A., et al., (1997), Molecular evolution of an arsenate detoxification pathway by DNA shuffling, Nature Biotechnology 15:436-438.
.
Gerritse, Gijs, et. al., (1998), The phenoltype enhancement method identifies the Xcp outer membrane secretion machinery from Pseudomonas alcaligenes as a bottleneck for lipase production. Journal of Biotechnology 24:23-38.
.
Crameri, A., et al., (1998), DNA shuffling of a family of genes from diverse species accelerates directed evolution, Nature 391:288-291.
.
Christians, F.C., et al. (1999), Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling, Nature Biotechnology 17:259-264.
.
Minshull, J., et al., (1999), Protein evolution by molecular breeding, Current Opinion in Chemical Biology 3:284-290.
.
Stemmer, W.P.C., et al., (1999) Molecular breeding of viruses for targeting and other clinical properties. Tumor Targeting 4:1-4.
.
Edited by Gardner Et Al., Principles of Genetics, 1981, pp. 9-40, Sixth Edition. John Wiley & Sons, New York, New York..  
  Primary Examiner:  Whisenant; Ethan


  Attorney, Agent or Firm: Kruse; Norman J.
Quine; Jonathan Alan
    The Law Offices of Jonathan Alan Quine



Parent Case Text



CROSS-REFERENCE TO RELATED APPLICATION


This application is a DIV of and claims the benefit of U.S. application
     Ser. No. 09/116,188 filed Jul. 15, 1998 which is a CIP of PCT/US98/00852
     filed Jan. 16, 1998 which claims priority to U.S. provisional application
     No. 60/035,054 filed Jan. 7, 1997.

Claims  

What is claimed is:

1.  A method of evolving a cell toward acquisition of a desired property, comprising:


(a) introducing a DNA fragment library cloned into an artificial chromosome into a population of cells;


(b) culturing the cells under conditions whereby sexual recombination occurs between the cells, whereby DNA fragments cloned into the artificial chromosome homologously recombine with corresponding segments of endogenous chromosomes of the
population of cells, and endogenous chromosomes recombine with each other;


(c) screening or selecting for cells that have evolved toward acquisition of the desired property.


2.  The method of claim 1, wherein the cells are yeast cells and the artificial chromosome is a YAC.


3.  The method claim 1, further comprising:


(d) culturing the cells surviving the screening or selecting step under conditions whereby sexual recombination occurs between cells, whereby further recombination occurs between endogenous chromosomes;


(e) screening or selecting for further cells that have evolved toward acquisition of the desired property;


(f) repeating steps (d) and (e) as needed until the desired property has been acquired.


4.  A method of evolving a DNA segment for acquisition of a desired property, comprising:


(a) providing a library of variants of the segment, each variant cloned into separate copies of an artificial chromosome;


(b) introducing the copies of the artificial chromosome into a population of cells;


(c) culturing the cells under conditions whereby sexual recombination occurs between cells and homologous recombination occurs between copies of the artificial chromosome bearing the variants;


(d) screening or selecting for variants that have evolved toward acquisition of the desired property.


5.  The method of claim 1, further comprising:


(d) repeating steps (a) through (c) with the same or a different library of fragments until the desired property or a further desired property has been acquired.


6.  The method of claim 1, comprising introducing two or more artificial chromosomes into at least one member of the population of cells, and culturing the cells under conditions whereby recombination occurs between fragments cloned into the two
or more artificial chromosomes.


7.  The method of claim 1, wherein the library comprises at least one fragment having sequence or structural identity with a cognate or allelic gene within the cells.


8.  The method of claim 1, wherein the library comprises fragments from a different species, cell type, organism or individual than the cells into which the library is introduced.


9.  The method of claim 1, wherein the library of fragments comprises at least one naturally occurring variant or induced variant of a cognate or allelic gene of the cells into which the library is introduced.


10.  The method of claim 9, wherein the at least one naturally occurring variant or induced variant differs from the cognate or allelic gene by at least two nucleotides.


11.  The method of claim 9, wherein the induced variants are produced by one or more of radiation, error-prone PCR, growth in a mutator organism, chemical mutagenesis or cassette mutagenesis.


12.  The method of claim 1, wherein the library comprises random fragments.


13.  The method of claim 1, wherein the library comprises fragments that are known to encode a desirable property.


14.  The method of claim 1, wherein the library comprises fragments comprising at least one operon of genes.


15.  The method of claim 1, wherein the library comprises fragments comprising a viral or bacterial genome.


16.  The method of claim 1, wherein the library comprises fragments comprising at least one gene in a biosynthetic pathway.


17.  The method of claim 1, wherein the library comprises fragments comprising at least on gene in a biosynthetic pathway for the synthesis of polyols, amino acids, polyketides, nonribosomal polypeptides, or ergosterol.


18.  The method of claim 1, wherein the library comprises a concatamer of expression cassettes.


19.  The method of claim 1, wherein the library comprises pooled genomic DNA of a population of cells having the desired characteristics.


20.  The method of claim 1, wherein the cells comprise fungal cells, yeast cells, plant cells or mammalian cells.


21.  The method of claim 1, wherein the artificial chromosome is a YAC, a BAC or a HAC.


22.  The method of claim 1, wherein the artificial chromosome comprises a positive selection marker and a negative selection marker.


23.  The method of claim 3, wherein the cells are yeast cells and the artificial chromosomes are YACs.


24.  The method of claim 23, wherein the yeast cells comprise a mutation increasing the frequency of recombination or the frequency of spontaneous mutation within the cells.


25.  The method of claim 24, wherein the mutation comprises a mutation in a gene selected from among PMS1, MLH1, MSH2, MSH6, TOP3, RAD50, MRE11, SRS2, HOP1, RED1, HPR1, HDF1, Kar-1, HOT1, CDC2 or CDC4.


26.  The method of claim 5, wherein recombination between fragments and endogenous chromosomes, and recombination between endogenous chromosomes occurs in a common nucleus or cytoplasm produced by protoplast fusion.


27.  The method of claim 26, wherein protoplast fusion occurs between cells of different vegetative compatibility groups.


28.  The method of claim 27, wherein the desired property is selected from among one or more of increased capacity to express a heterologous protein, increased capacity to secrete a heterologous protein, improved recombinogenicity, improved
stability to temperture, improved stability to solvents, increased tolerance to ethanol, capacity to grow under selected nutritional conditions, capacity to produce selected secondary matabolite, and increased flocculence.


29.  The method of claim 4, further comprising:


(d) repeating steps (a) through (c) with the same or a different library of variant segments until the desired property or a further desired property has been acquired.


30.  The method of claim 4, further comprising:


(d) culturing the cells surviving the screening or selecting of step (c) under conditions whereby recombination between cells, whereby further recombination occurs between copies of artificial chromosomes, between endogenous chromosomes or
between a copy of an artificial chromosome and an endogenous chromosome;


(e) screening or selecting for further variants that have evolved toward acquisition of the desired property;  and,


(f) repeating steps (d) and (e) as needed until the desired property has been acquired.


31.  The method of claim 4, wherein the library of variants comprises at least one segment having sequence or structural identity with a cognate or allelic gene within the cells.


32.  The method of claim 4, wherein the library of variants comprises segments from a different species, cell type, organism or individual than the cells into which the library is introduced.


33.  The method of claim 3, wherein the library of variants comprises at least one naturally occurring variant or induced variant of a cognate or allelic gene of the cells into which the library is introduced.


34.  The method of claim 3, wherein the at least on naturally occurring variant or induced variant differs from the cognate or allelic gene by at least to nucleotides.


35.  The method of claim 3, wherein the induced variants are produced by one or more of radiation, error-prone PCR, chemical mutagenesis, growth in a mutator organism or cassette mutagenesis.


36.  The method of claim 3, wherein the library of variants comprises segments comprising at least one operon of genes.


37.  The method of claim 3, wherein the library of variants comprises a concatamer of expression cassettes.


38.  The method of claim 3, wherein the library of fragments comprises at least on gene in a biosynthetic pathway.


39.  The method of claim 3, wherein the library of fragments comprises at least one gene in a biosynthetic pathway for the synthesis of taxol, polyols, amino acids, polyketides, nonribosomal polypeptides, or ergosterol.


40.  The method of claim 3, wherein the library of variants comprises pooled genomic DNA of a population of cells having the desired characteristics.


41.  The method of claim 3, wherein the cells comprises fungel cells, yeast cells, plant cells or mammalian cells.


42.  The method of claim 3, wherein the artificial chromosome is a YAC, a BAC or a HAC.


43.  The method of claim 3, wherein the artificial chromosome comprises a positive selection marker and a negative selection marker.


44.  The method of claim 3, wherein the cells are yeast cells and the artificial chromosomes are YACs.


45.  The method of claim 3, wherein the yeast cells comprise a mutation increasing the frequency of recombination or the frequency of spontaneous mutation within the cells.


46.  The method of claim 3, wherein the mutation comprises a mutation in a gene selected from among PMS1, MLH1, MSH2, MSH6, TOP3, RAD50, MRE11, SRS2, HOP1, RED1, HPR1, HDF1, kar-1, HOT1, CDC2 or CDC4.


47.  The method of claim 3, wherein recombination occurs between segments in a common nucleus or cytoplasm produced by protoplast fusion.


48.  The method of claim 3, wherein the desired property is selected from among one or more of increased capacity to express a heterologous protein, increased capacity to secrete a heterologous protein, improved recombinogenicity, improved
stability to temperature, improved stability to solvents, increased tolerance to ethanol, capacity to grow under selected nutritional conditions, capacity to produce selected secondary matabolite, and increased flocculence. 
Description  

TECHNICAL FIELD


The invention applies the technical field of molecular genetics to evolve the genomes of cells and organisms to acquire new and improved properties.


BACKGROUND


Cells have a number of well-established uses in molecular biology.  For example, cells are commonly used as hosts for manipulating DNA in processes such as transformation and recombination.  Cells are also used for expression of recombinant
proteins encoded by DNA transformed into the cells.  Some types of cells are also used as progenitors for generation of transgenic animals and plants.  Although all of these processes are now routine, in general, the genomes of the cells used in these
processes have evolved little from the genomes of natural cells, and particularly not toward acquisition of new or improved properties for use in the above processes.


The traditional approach to artificial or forced molecular evolution focuses on optimization of individual genes having discrete and selectable phenotypes.  The strategy is to clone a gene, identify a discrete function for the gene and an assay
by which it can be selected, mutate selected positions in the gene (e.g., by error-prone PCR or cassette mutagenesis) and select variants of the gene for improvement in the known function of the gene.  A variant having improved function can then be
expressed in a desired cell type.  This approach has a number of limitations.  First, it is only applicable to genes that have been isolated and functionally characterized.  Second, the approach is usually only applicable to genes that have a discrete
function.  In other words, multiple genes that cooperatively confer a single phenotype cannot usually be optimized in this manner--and many genes have cooperative functions.  Finally, this approach can only explore a very limited number of the total
number of permutations even for a single gene.  For example, varying even ten positions in a protein with every possible amino acid would generate 20.sup.10 variants, which is more than can be accommodated by existing methods of transfection and
screening.


In view of these limitations, traditional approaches are inadequate for improving cellular genomes in many useful properties.  For example, to improve a cell's capacity to express a recombinant protein might require modification in any or all of
a substantial number of genes, known and unknown, having roles in transcription, translation, posttranslational modification, secretion or proteolytic degradation, among others.  Attempting individually to optimize even all the known genes having such
functions would be a virtually impossible task, let alone optimizing hitherto unknown genes which may contribute to expression in manners not yet understood.


For example, one area where traditional methods are used extensively is in the fermentation industry.  The primary goal of current strain improvement programs (SIPs) in fermentation is typically an increase in product titre.  State-of-the-art
mutagenesis and screening is practiced by large fermentation companies, such as those in the pharmaceutical and chemical industries.  Parent strains are mutated and individual fermentations of 5,000-40,000 mutants are screened by high-throughput methods
for increases in product titre.  For a well developed strain, an increase in yield of 10% per year (i.e., one new parent strain per year) is achieved using these methods.  In general, cells are screened for titre increases significantly above that of the
parent, with the detection sensitivity of most screens being .about.5% increase due to variation in growth conditions.  Only those that "breed true" during scale up make it to production and become the single parent of the next round of random
mutagenesis.


Employing optimal mutation conditions one mutant out of 5,000-40,000 typically has a titre increase of 10%.  However, a much higher percentage has slightly lower titre increases, 4-6%.  These are generally not pursued, since experience has
demonstrated that a higher producer can be isolated and that a significant percent of the lower producers actually are no better than the parent strain.  The key to finding high producers using current strategies is to screen very large numbers of
mutants per round of mutagenesis and to have a stable and sensitive assay.  For these reasons, R&D to advance this field are in the automation and the screening capacity of the SIPs.  Unfortunately, this strategy is inherently limited by the value of
single mutations to strain improvement and the growth rate of the target organisms.


The present invention overcomes the problems noted above, providing, inter alia, novel methods for evolving the genome of whole cells and organisms.


SUMMARY OF THE INVENTION


In one aspect, the invention provides methods of evolving a cell to acquire a desired function.  Such methods entail, e.g., introducing a library of DNA fragments into a plurality of cells, whereby at least one of the fragments undergoes
recombination with a segment in the genome or an episome of the cells to produce modified cells.  The modified cells are then screened for modified cells that have evolved toward acquisition of the desired function.  DNA from the modified cells that have
evolved toward the desired function is then recombined with a further library of DNA fragments, at least one of which undergoes recombination with a segment in the genome or the episome of the modified cells to produce further modified cells.  The
further modified cells are then screened for further modified cells that have further evolved toward acquisition of the desired function.  Steps of recombination and screening/selection are repeated as required until the further modified cells have
acquired the desired function.


In some methods, the library or further library of DNA fragments is coated with recA protein to stimulate recombination with the segment of the genome.  In some methods, the library of fragments is denatured to produce single-stranded DNA, the
single-stranded DNA are annealed to produce duplexes some of which contain mismatches at points of variation in the fragments, and duplexes containing mismatches are selected by affinity chromatography to immobilized MutS.


In some methods, the desired function is secretion of a protein, and the plurality of cells further comprises a construct encoding the protein.  The protein is inactive unless secreted and further modified cells are selected for protein function. Optionally, the protein is toxic to the plurality of cells unless secreted.  In this case, the modified or further modified cells which evolve toward acquisition of the desired function are screened by propagating the cells and recovering surviving
cells.


In some methods, the desired function is enhanced recombination.  In such methods, the library of fragments sometimes comprises a cluster of genes collectively conferring recombination capacity.  Screening can be achieved using cells carrying a
gene encoding a marker whose expression is prevented by a mutation removable by recombination.  The cells are screened by their expression of the marker resulting from removal of the mutation by recombination.


In some methods, the plurality of cells are plant cells and the desired property is improved resistance to a chemical or microbe.  The modified or further modified cells (or whole plants) are exposed to the chemical or microbe and modified or
further modified cells having evolved toward the acquisition of the desired function are selected by their capacity to survive the exposure.


In some methods, the plurality of cells are embryonic cells of an animal, and the method further comprises propagating the transformed cells to transgenic animals.


The invention further provides methods for performing in vivo recombination.  At least first and second segments from at least one gene are introduced into a cell, the segments differing from each other in at least two nucleotides, whereby the
segments recombine to produce a library of chimeric genes.  A chimeric gene is selected from the library having acquired a desired function.


The invention further provides methods of predicting efficacy of a drug in treating a viral infection.  Such method entail recombining a nucleic acid segment from a virus, whose infection is inhibited by a drug, with at least a second nucleic
acid segment from the virus, the second nucleic acid segment differing from the nucleic acid segment in at least two nucleotides, to produce a library of recombinant nucleic acid segments.  Host cells are then contacted with a collection of viruses
having genomes including the recombinant nucleic acid segments in a media containing the drug, and progeny viruses resulting from infection of the host cells are collected.


A recombinant DNA segment from a first progeny virus recombines with at least a recombinant DNA segment from a second progeny virus to produce a further library of recombinant nucleic acid segments.  Host cells are contacted with a collection of
viruses having genomes including the further library or recombinant nucleic acid segments, in media containing the drug, and further progeny viruses are produced by the host cells.  The recombination and selection steps are repeated, as necessary, until
a further progeny virus has acquired a desired degree of resistance to the drug, whereby the degree of resistance acquired and the number of repetitions needed to acquire it provide a measure of the efficacy of the drug in treating the virus.  Viruses
are optionally adapted to grow on particular cell lines.


The invention further provides methods of predicting efficacy of a drug in treating an infection by a pathogenic microorganism.  These methods entail delivering a library of DNA fragments into a plurality of microorganism cells, at least some of
which undergo recombination with segments in the genome of the cells to produce modified microorganism cells.  Modified microorganisms are propagated in a media containing the drug, and surviving microorganisms are recovered.  DNA from surviving
microorganisms is recombined with a further library of DNA fragments at least some of which undergo recombination with cognate segments in the DNA from the surviving microorganisms to produce further modified microorganisms cells.  Further modified
microorganisms are propagated in media containing the drug, and further surviving microorganisms are collected.  The recombination and selection steps are repeated as needed, until a further surviving microorganism has acquired a desired degree of
resistance to the drug.  The degree of resistance acquired and the number of repetitions needed to acquire it provide a measure of the efficacy of the drug in killing the pathogenic microorganism.


The invention further provides methods of evolving a cell to acquire a desired function.  These methods entail providing a populating of different cells.  The cells are cultured under conditions whereby DNA is exchanged between cells, forming
cells with hybrid genomes.  The cells are then screened or selected for cells that have evolved toward acquisition of a desired property.  The DNA exchange and screening/selecting steps are repeated, as needed, with the screened/selected cells from one
cycle forming the population of different cells in the next cycle, until a cell has acquired the desired property.


Mechanisms of DNA exchange include conjugation, phage-mediated transduction, protoplast fusion, and sexual recombination of the cells.  Optionally, a library of DNA fragments can be transformed or electroporated into the cells.


As noted, some methods of evolving a cell to acquire a desired property are effected by protoplast-mediated exchange of DNA between cells.  Such methods entail forming protoplasts of a population of different cells.  The protoplasts are then
fused to form hybrid protoplasts, in which genomes from the protoplasts recombine to form hybrid genomes.  The hybrid protoplasts are incubated under conditions promoting regeneration of cells.  The next step is to select or screen to isolate regenerated
cells that have evolved toward acquisition of the desired property.  DNA exchange and selection/screening steps are repeated, as needed, with regenerated cells in one cycle being used to form protoplasts in the next cycle until the regenerated cells have
acquired the desired property.  Industrial microorganisms are a preferred class of organisms for conducting the above methods.  Some methods further comprise a step of selecting or screening for fused protoplasts free from unfused protoplasts of parental
cells.  Some methods further comprise a step of selecting or screening for fused protoplasts with hybrid genomes free from cells with parental genomes.  In some methods, protoplasts are provided by treating individual cells, mycelia or spores with an
enzyme that degrades cell walls.  In some methods, the strain is a mutant that is lacking capacity for intact cell wall synthesis, and protoplasts form spontaneously.  In some methods, protoplasts are formed by treating growing cells with an inhibitor of
cell wall formation to generate protoplasts.


In some methods, the desired property is expression and/or secretion of a protein or secondary metabolite, such as an industrial enzyme, a therapeutic protein, a primary metabolite such as lactic acid or ethanol, or a secondary metabolite such as
erythromycin cyclosporin A or taxol.  In other methods it is the ability of the cell to convert compounds provided to the cell to different compounds.  In yet other methods, the desired property is capacity for meiosis.  In some methods, the desired
property is compatibility to form a heterokaryon with another strain.


The invention further provides methods of evolving a cell toward acquisition of a desired property.  These methods entail providing a population of different cells.  DNA is isolated from a first subpopulation of the different cells and
encapsulated in liposomes.  Protoplasts are formed from a second subpopulation of the different cells.  Liposomes are fused with the protoplasts, whereby DNA from the liposomes is taken up by the protoplasts and recombines with the genomes of the
protoplasts.  The protoplasts are incubated under regenerating conditions.  Regenerating or regenerated cells are then selected or screened for evolution toward the desired property.


The invention further provides methods of evolving a cell toward acquisition of a desired property using artificial chromosomes.  Such methods entail introducing a DNA fragment library cloned into an artificial chromosome into a population of
cells.  The cells are then cultured under conditions whereby sexual recombination occurs between the cells, and DNA fragments cloned into the artificial chromosome homologously recombines with corresponding segments of endogenous chromosomes of the
populations of cells, and endogenous chromosomes recombine with each other.  Cells that have evolved toward acquisition of the desired property are then selected or screened.  The method is then repeated with cells that have evolved toward the desired
property in one cycle forming the population of different cells in the next cycle.


The invention further provides methods of evolving a DNA segment cloned into an artificial chromosome for acquisition of a desired property.  These methods entail providing a library of variants of the segment, each variant cloned into separate
copies of an artificial chromosome.  The copies of the artificial chromosome are introduced into a population of cells.  The cells are cultured under conditions whereby sexual recombination occurs between cells and homologous recombination occurs between
copies of the artificial chromosome bearing the variants.  Variants are then screened or selected for evolution toward acquisition of the desired property.


The invention further provides hyperrecombinogenic recA proteins.  Examples of such proteins are from clones 2, 4, 5, 6 and 13 shown in FIG. 13. 

BRIEF DESCRIPTION OF THE DRAWING


FIG. 1, panels A-D: Scheme for in vitro shuffling of genes.


FIG. 2: Scheme for enriching for mismatched sequences using MutS.


FIG. 3: Alternative scheme for enriching for mismatched sequences using MutS.


FIG. 4: Scheme for evolving growth hormone genes to produce larger fish.


FIG. 5: Scheme for shuffling prokaryotes by protoplast fusion.


FIG. 6: Scheme for introducing a sexual cycle into fungi previously incapable of sexual reproduction.


FIG. 7: General scheme for shuffling of fungi by protoplast fusion.


FIG. 8: Shuffling fungi by protoplast fusion with protoplasts generated by use of inhibitors of enzymes responsible for cell wall formation.


FIG. 9: Shuffling fungi by protoplast fusion using fungal strains deficient in cell-wall synthesis that spontaneously form protoplasts.


FIG. 10: YAC-mediated whole genome shuffling of Saccharomyces cerevisiae and related organisms.


FIG. 11: YAC-mediated shuffling of large DNA fragments.


FIG. 12: (A, B, C and D) DNA sequences of a wildtype recA protein and five hyperrecombinogenic variants thereof.


FIG. 13: Amino acid sequences of a wildtype recA protein and five hyperrecombinogenic variants thereof.


FIG. 14: illustration of combinatoriality.


FIG. 15: Repeated pairwise recombination to access multi-mutant progeny.


FIG. 16: graph of fitness versus sequence space for three different mutation strategies.


FIG. 17: graphs of asexual sequential mutagenesis and sexual recursive recombination.


FIG. 18: Schematic for non-homologous recombination.


FIG. 19: Schematic for split and pool strategy.


FIG. 20, panel A: schematic for selectable/counterselectable marker strategy.


FIG. 20, panel B: schematic for selectable/counterselectable marker strategy for Rec A.


FIG. 21: plant regeneration strategy for regenerating salt-tolerant plants.


FIG. 22: Whole genome shuffling of parsed (subcloned) genomes.


FIG. 23: Schematic for blind cloning of gene homologs.


FIG. 24: High throughput family shuffling.


FIG. 25: Schematic and graph of poolwise recombination.


FIG. 26: Schematic of protoplast fusion.


FIG. 27: Schematic assay for poolwise recombination.


FIG. 28: Schematic of halo assay and integrated system. 

DEFINITIONS


The term cognate refers to a gene sequence that is evolutionarily and functionally related between species.  For example, in the human genome, the human CD4 gene is the cognate gene to the mouse CD4 gene, since the sequences and structures of
these two genes indicate that they are homologous and that both genes encode a protein which functions in signaling T-cell activation through MHC class II-restricted antigen recognition.


Screening is, in general, a two-step process in which one first determines which cells do and do not express a screening marker or phenotype (or a selected level of marker or phenotype), and then physically separates the cells having the desired
property.  Selection is a form of screening in which identification and physical separation are achieved simultaneously by expression of a selection marker, which, in some genetic circumstances, allows cells expressing the marker to survive while other
cells die (or vice versa).  Screening markers include luciferase, .beta.-galactosidase, and green fluorescent protein.  Selection markers include drug and toxin resistance genes.


An exogenous DNA segment is one foreign (or heterologous) to the cell or homologous to the cell but in a position within the host cell nucleic acid in which the element is not ordinarily found.  Exogenous DNA segments can be expressed to yield
exogenous polypeptides.


The term gene is used broadly to refer to any segment of DNA associated with a biological function.  Thus, genes include coding sequences and/or the regulatory sequences required for their expression.  Genes also include nonexpressed DNA segments
that, for example, form recognition sequences for other proteins.


The terms "identical" or percent "identity," in the context of two or more nucleic acids or polypeptide sequences, refer to two or more sequences or subsequences that are the same or have a specified percentage of amino acid residues or
nucleotides that are the same, when compared and aligned for maximum correspondence, as measured using one of the following sequence comparison algorithms or by visual inspection.


The phrase "substantially identical," in the context of two nucleic acids or polypeptides, refers to two or more sequences or subsequences that have at least 60%, preferably 80%, most preferably 90-95% nucleotide or amino acid residue identity,
when compared and aligned for maximum correspondence, as measured using one of the following sequence comparison algorithms or by visual inspection.  Preferably, the substantial identity exists over a region of the sequences that is at least about 50
residues in length, more preferably over a region of at least about 100 residues, and most preferably the sequences are substantially identical over at least about 150 residues.  In a most preferred embodiment, the sequences are substantially identical
over the entire length of the coding regions.


For sequence comparison, typically one sequence acts as a reference sequence, to which test sequences are compared.  When using a sequence comparison algorithm, test and reference sequences are input into a computer, subsequence coordinates are
designated, if necessary, and sequence algorithm program parameters are designated.  The sequence comparison algorithm then calculates the percent sequence identity for the test sequence(s) relative to the reference sequence, based on the designated
program parameters.


Optimal alignment of sequences for comparison can be conducted, e.g., by the local homology algorithm of Smith & Waterman, Adv.  Appl.  Math. 2:482 (1981), by the homology alignment algorithm of Needleman & Wunsch, J. Mol. Biol.  48:443 (1970),
by the search for similarity method of Pearson & Lipman, Proc.  Nat'l.  Acad.  Sci.  USA 85:2444 (1988), by computerized implementations of algorithms GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package Release 7.0, Genetics
Computer Group, 575 Science Dr., Madison, Wis.


Another example of a useful alignment algorithm is PILEUP.  PILEUP creates a multiple sequence alignment from a group of related sequences using progressive, pairwise alignments to show relationship and percent sequence identity.  It also plots a
tree or dendogram showing the clustering relationships used to create the alignment.  PILEUP uses a simplification of the progressive alignment method of Feng & Doolittle, J. Mol. Evol.  35:351-360 (1987).  The method used is similar to the method
described by Higgins & Sharp, CABIOS 5:151-153 (1989).  The program can align up to 300 sequences, each of a maximum length of 5,000 nucleotides or amino acids.  The multiple alignment procedure begins with the pairwise alignment of the two most similar
sequences, producing a cluster of two aligned sequences.  This cluster is then aligned to the next most related sequence or cluster of aligned sequences.  Two clusters of sequences are aligned by a simple extension of the pairwise alignment of two
individual sequences.  The final alignment is achieved by a series of progressive, pairwise alignments.  The program is run by designating specific sequences and their amino acid or nucleotide coordinates for regions of sequence comparison and by
designating the program parameters.  For example, a reference sequence can be compared to other test sequences to determine the percent sequence identity relationship using the following parameters: default gap weight (3.00), default gap length weight
(0.10), and weighted end gaps.


Another example of algorithm that is suitable for determining percent sequence identity and sequence similarity is the BLAST algorithm, which is described in Altschul et al., J. Mol. Biol.  215:403-410 (1990).  Software for performing BLAST
analyses is publicly available through the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/).  This algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query
sequence, which either match or satisfy some positive-valued threshold score T when aligned with a word of the same length in a database sequence.  T is referred to as the neighborhood word score threshold (Altschul et al, supra).  These initial
neighborhood word hits act as seeds for initiating searches to find longer HSPs containing them.  The word hits are then extended in both directions along each sequence for as far as the cumulative alignment score can be increased.  Cumulative scores are
calculated using, for nucleotide sequences, the parameters M (reward score for a pair of matching residues; always >0) and N (penalty score for mismatching residues; always <0).  For amino acid sequences, a scoring matrix is used to calculate the
cumulative score.  Extension of the word hits in each direction are halted when: the cumulative alignment score falls off by the quantity X from its maximum achieved value; the cumulative score goes to zero or below, due to the accumulation of one or
more negative-scoring residue alignments; or the end of either sequence is reached.  The BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment.  The BLASTN program (for nucleotide sequences) uses as defaults a
wordlength (W) of 11, an expectation (E) of 10, M=5, N=-4, and a comparison of both strands.  For amino acid sequences, the BLASTP program uses as defaults a wordlength (W) of 3, an expectation (E) of 10, and the BLOSUM62 scoring matrix (see Henikoff &
Henikoff, Proc.  Natl.  Acad.  Sci.  USA 89:10915 (1989)).


In addition to calculating percent sequence identity, the BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin & Altschul, Proc.  Nat'l.  Acad.  Sci.  USA 90:5873-5787 (1993)).  One
measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance.  For example, a nucleic
acid is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleic acid to the reference nucleic acid is less than about 0.  1, more preferably less than about 0.01, and most preferably less than about
0.001.


A further indication that two nucleic acid sequences or polypeptides are substantially identical is that the polypeptide encoded by the first nucleic acid is immunologically cross reactive with the polypeptide encoded by the second nucleic acid,
as described below.  Thus, a polypeptide is typically substantially identical to a second polypeptide, for example, where the two peptides differ only by conservative substitutions.  Another indication that two nucleic acid sequences are substantially
identical is that the two molecules hybridize to each other under stringent conditions.


The term "naturally-occurring" is used to describe an object that can be found in nature.  For example, a polypeptide or polynucleotide sequence that is present in an organism (including viruses) that can be isolated from a source in nature and
which has not been intentionally modified by man in the laboratory is naturally-occurring.  Generally, the term naturally-occurring refers to an object as present in a non-pathological (undiseased) individual, such as would be typical for the species.


Asexual recombination is recombination occurring without the fusion of gametes to form a zygote.


A "mismatch repair deficient strain" can include any mutants in any organism impaired in the functions of mismatch repair.  These include mutant gene products of mutS, mutT, mutH, mutL, ovrD, dcm, vsr, umuC, umuD, sbcB, recj, etc. The impairment
is achieved by genetic mutation, allelic replacement, selective inhibition by an added reagent such as a small compound or an expressed antisense RNA, or other techniques.  Impairment can be of the genes noted, or of homologous genes in any organism.


DETAILED DESCRIPTION


I. General


A. The Basic Approach


The invention provides methods for artificially evolving cells to acquire a new or improved property by recursive sequence recombination.  Briefly, recursive sequence recombination entails successive cycles of recombination to generate molecular
diversity and screening/selection to take advantage of that molecular diversity.  That is, a family of nucleic acid molecules is created showing substantial sequence and/or structural identity but differing as to the presence of mutations.  These
sequences are then recombined in any of the described formats so as to optimize the diversity of mutant combinations represented in the resulting recombined library.  Each recombination cycle is followed by at least one cycle of screening or selection
for molecules having a desired characteristic.  The molecule(s) selected in one round form the starting materials for generating diversity in the next round.


The cells to be evolved can be bacteria, archaebacteria, or eukaryotic cells and can constitute a homogeneous cell line or mixed culture.  Suitable cells for evolution include the bacterial and eukaryotic cell lines commonly used in genetic
engineering, protein expression, or the industrial production or conversion of proteins, enzymes, primary metabolites, secondary metabolites, fine, specialty or commodity chemicals.  Suitable mammalian cells include those from, e.g., mouse, rat, hamster,
primate, and human, both cell lines and primary cultures.  Such cells include stem cells, including embryonic stem cells and hemopoietic stem cells, zygotes, fibroblasts, lymphocytes, Chinese hamster ovary (CHO), mouse fibroblasts (NIH3T3), kidney,
liver, muscle, and skin cells.  Other eukaryotic cells of interest include plant cells, such as maize, rice, wheat, cotton, soybean, sugarcane, tobacco, and arabidopsis; fish, algae, fungi (penicillium, aspergillus, podospora, neurospora, saccharomyces),
insect (e.g., baculo lepidoptera), yeast (picchia and saccharomyces, Schizosaccharomyces pombe).  Also of interest are many bacterial cell types, both gram-negative and gram-positive, such as Bacillus subtilis, B. licehniformis, B. cereus, Escherichia
coli, Streptomyces, Pseudomonas, Salmonella, Actinomycetes and Erwinia.  The complete genome sequences of E. coli and Bacillus subtilis are described by Blattner et al., Science 277, 1454-1462 (1997); Kunst et al., Nature 390, 249-256 (1997)).


Evolution commences by generating a population of variant cells.  Typically, the cells in the population are of the same type but represent variants of a progenitor cell.  In some instances, the variation is natural as when different cells are
obtained from different individuals within a species, from different species or from different genera.  In other instances, variation is induced by mutagenesis of a progenitor cell.  Mutagenesis can be effected by subjecting the cell to mutagenic agents,
or if the cell is a mutator cell (e.g., has mutations in genes involved in DNA replication, recombination and/or repair which favor introduction of mutations) simply by propagating the mutator cells.  Mutator cells can be generated from successive
selections for simple phenotypic changes (e.g., acquisition of rifampicin-resistance, then nalidixic acid resistance then lac- to lac+ (see Mao et al., J. Bacteriol.  179, 417-422 (1997)), or mutator cells can be generated by exposure to specific
inhibitors of cellular factors that result in the mutator phenotype.  These could be inhibitors of mutS, mutL, mutD, recD, mutY, mutM, dam, uvrD and the like.


More generally, mutations are induced in cell populations using any available mutation technique.  Common mechanisms for inducing mutations include, but are not limited to the use of strains comprising mutations such as those involved in mismatch
repair.  e.g. mutations in mutS, mutT, mutL and mutH; exposure to U.V.  light; Chemical mutagenesis, e.g. use of inhibitors of MMR, DNA damage inducible genes, or SOS inducers; overproduction/underproduction/mutation of any component of the homologous
recombination complex/pathway, eg.  RecA, ssb, etc.; overproduction/underproduction/mutation of genes involved in DNA synthesis/homeostasis; overproduction/underproduction/mutation of recombination-stimulating genes from bacteria, phage (eg.  Lambda Red
function), or other organisms; addition of chi sites into/flanking the donor DNA fragments; coating the DNA fragments with RecA/ssb and the like.


In other instances, variation is the result of transferring a library of DNA fragments into the cells (e.g., by conjugation, protoplast fusion, transformation, transduction or natural competence).  At least one, and usually many of the fragments
in the library, show some, but not complete, sequence or structural identity with a cognate or allelic gene within the cells sufficient to allow homologous recombination to occur.  For example, in one embodiment, homologous integration of a plasmid
carrying a shuffled gene or metabolic pathway leads to insertion of the plasmid-borne sequences adjacent to the genomic copy.  Optionally, a counterselectable marker strategy is used to select for recombinants in which recombination occurred between the
homologous sequences, leading to elimination of the counterselectable marker.  This strategy is illustrated in FIG. 20A.  A variety of selectable and counter selectable markers are amply illustrated in the art.  For a list of useful markers, see, Berg
and Berg (1996), Transposable element tools for microbial genetics.  Escherichia coli and Salmonella Neidhardt.  Washington, D.C., ASM Press.  2:2588-2612; La Rossa, ibid., 2527-2587.


The library of fragments can derive from one or more sources.  One source of fragments is a genomic library of fragments from a different species, cell type, organism or individual from the cells being transfected.  In this situation, many of the
fragments in the library have a cognate or allelic gene in the cells being transformed but differ from that gene due to the presence of naturally occurring species variation, polymorphisms, mutations, and the presence of multiple copies of some
homologous genes in the genome.  Alternatively, the library can be derived from DNA from the same cell type as is being transformed after that DNA has been subject to induced mutation, by conventional methods, such as radiation, error-prone PCR, growth
in a mutator organism or cassette mutagenesis.  Alternatively, the library can derive from a genomic library of fragments generated from the pooled genomic DNA of a population of cells having the desired characteristics.  Alternatively, the library can
derive from a genomic library of fragments generated from the pooled genomic DNA of a population of cells having desired characteristics.


In any of these situations, the genomic library can be a complete genomic library or subgenomic library deriving, for example, from a selected chromosome, or part of a chromosome or an episomal element within a cell.  As well as, or instead of
these sources of DNA fragments, the library can contain fragments representing natural or selected variants of selected genes of known function (i.e., focused libraries).


The number of fragments in a library can vary from a single fragment to about 10.sup.10, with libraries having from 10.sup.3 to 10.sup.8 fragments being common.  The fragments should be sufficiently long that they can undergo homologous
recombination and sufficiently short that they can be introduced into a cell, and if necessary, manipulated before introduction.  Fragment sizes can range from about 10 b to about 20 mb.  Fragments can be double- or single-stranded.


The fragments can be introduced into cells as whole genomes or as components of viruses, plasmids, YACS, HACs or BACs or can be introduced as they are, in which case all or most of the fragments lack an origin of replication.  Use of viral
fragments with single-stranded genomes offer the advantage of delivering fragments in single stranded form, which promotes recombination.  The fragments can also be joined to a selective marker before introduction.  Inclusion of fragments in a vector
having an origin of replication affords a longer period of time after introduction into the cell in which fragments can undergo recombination with a cognate gene before being degraded or selected against and lost from the cell, thereby increasing the
proportion of cells with recombinant genomes.  Optionally, the vector is a suicide vector capable of a longer existence than an isolated DNA fragment but not capable of permanent retention in the cell line.  Such a vector can transiently express a marker
for a sufficient time to screen for or select a cell bearing the vector (e.g., because cells transduced by the vector are the target cell type to be screened in subsequent selection assays), but is then degraded or otherwise rendered incapable of
expressing the marker.  The use of such vectors can be advantageous in performing optional subsequent rounds of recombination to be discussed below.  For example, some suicide vectors express a long-lived toxin which is neutralized by a short-lived
molecule expressed from the same vector.  Expression of the toxin alone will not allow vector to be established.  Jense & Gerdes, Mol. Microbiol., 17, 205-210 (1995); Bernard et al., Gene 162, 159-160.  Alternatively, a vector can be rendered suicidal by
incorporation of a defective origin of replication (e.g. a temperature-sensitive origin of replication) or by omission of an origin of replication.  Vectors can also be rendered suicidal by inclusion of negative selection markers, such as ura3 in yeast
or sacB in many bacteria.  These genes become toxic only in the presence of specific compounds.  Such vectors can be selected to have a wide range of stabilities.  A list of conditional replication defects for vectors which can be used, e.g., to render
the vector replication defective is found, e.g., in Berg and Berg (1996), "Transposable element tools for microbial genetics" Escherichia coli and Salmonella Neidhardt.  Washington, D.C., ASM Press.  2:2588-2612.  Similarly, a list of counterselectable
markers, generally applicable to vector selection is also found in Berg and Berg, id.  See also, LaRossa (1996) "Mutant selections linking physiology, inhibitors, and genotypes" Escherichia coli and Salmonella F. C. Neidhardt.  Washington, D.C., ASM
Press.  2:2527-2587.


After introduction into cells, the fragments can recombine with DNA present in the genome, or episomes of the cells by homologous, nonhomologous or site-specific recombination.  For present purposes, homologous recombination makes the most
significant contribution to evolution of the cells because this form of recombination amplifies the existing diversity between the DNA of the cells being transfected and the DNA fragments.  For example, if a DNA fragment being transfected differs from a
cognate or allelic gene at two positions, there are four possible recombination products, and each of these recombination products can be formed in different cells in the transformed population.  Thus, homologous recombination of the fragment doubles the
initial diversity in this gene.  When many fragments recombine with corresponding cognate or allelic genes, the diversity of recombination products with respect to starting products increases exponentially with the number of mutations.  Recombination
results in modified cells having modified genomes and/or episomes.


The variant cells, whether the result of natural variation, mutagenesis, or recombination are screened or selected to identify a subset of cells that have evolved toward acquisition of a new or improved property.  The nature of the screen, of
course, depends on the property and several examples will be discussed below.  Optionally, the screening is repeated before performing subsequent cycles of recombination.  Stringency can be increased in repeated cycles of screening.


The subpopulation of cells surviving screening are optionally subjected to a further round of recombination.  In some instances, the further round of recombination is effected by propagating the cells under conditions allowing exchange of DNA
between cells.  For example, protoplasts can be formed from the cells, allowed to fuse, and regenerated.  Cells with recombinant genomes are propagated from the fused protoplasts.  Alternatively, exchange of DNA can be promoted by propagation of cells or
protoplasts in an electric field.  For cells having a conjugative transfer apparatus, exchange of DNA can be promoted simply by propagating the cells.


In other methods, the further round of recombination is performed by a split and pool approach.  That is, the surviving cells are divided into two pools.  DNA is isolated from one pool, and if necessary amplified, and then transformed into the
other pool.  Accordingly, DNA fragments from the first pool constitute a further library of fragments and recombine with cognate fragments in the second pool resulting in further diversity.  An example of this strategy is illustrated in FIG. 19.  As
shown, a pool of mutant bacteria with improvements in a desired phenotype is obtained and split.  Genes are obtained from one half, e.g., by PCR or by cloning of random genomic fragments.  These are then shuffled, or simply cloned into an allele
replacement vector (e.g., one carrying selectable and counter-selectable markers).  The gene pool is then transformed into the other half of the original mutant pool and recombinants are selected and screened for further improvements in phenotype.  These
best variants are used as the starting point for then next cycle.


In other methods, some or all of the cells surviving screening are transfected with a fresh library of DNA fragments, which can be the same or different from the library used in the first round of recombination: In this situation, the genes in
the fresh library undergo recombination with cognate genes in the surviving cells.  If genes are introduced as components of a vector, compatibility of this vector with any vector used in a previous round of transfection should be considered.  If the
vector used in a previous round was a suicide vector, there is no problem of incompatibility.  If, however, the vector used in a previous round was not a suicide vector, a vector having a different incompatibility origin should be used in the subsequent
round.  In all of these formats, further recombination generates additional diversity in the DNA component of the cells resulting in further modified cells.


The further modified cells are subjected to another round of screening/selection according to the same principles as the first round.  Screening/selection identifies a subpopulation of further modified cells that have further evolved toward
acquisition of the property.  This subpopulation of cells can be subjected to further rounds of recombination and screening according to the same principles, optionally with the stringency of screening being increased at each round.  Eventually, cells
are identified that have acquired the desired property.


B. Variations


1.  Coating Fragments with recA Protein


The frequency of homologous recombination between library fragments and cognate endogenous genes can be increased by coating the fragments with a recombinogenic protein before introduction into cells.  See Pati et al., Molecular Biology of Cancer
1, 1 (1996); Sena & Zarling, Nature Genetics 3, 365 (1996); Revet et al., J. Mol. Biol.  232, 779-791 (1993); Kowalczkowski & Zarling in Gene Targeting (CRC 1995), Ch.  7.  The recombinogenic protein promotes homologous pairing and/or strand exchange. 
The best characterized recA protein is from E. coli and is available from Pharmacia (Piscataway, N.J.).  In addition to the wild-type protein, a number of mutant recA-like proteins have been identified (e.g., recA803).  Further, many organisms have
recA-like recombinases with strand-transfer activities (e.g., Ogawa et al., Cold Spring Harbor Symposium on Quantitative Biology 18, 567-576 (1993); Johnson & Symington, Mol. Cell.  Biol.  15, 4843-4850 (1995); Fugisawa et al., Nucl.  Acids Res.  13,
7473 (1985); Hsieh et al., Cell 44, 885 (1986); Hsieh et al., J. Biol.  Chem. 264, 5089 (1989); Fishel et al., Proc.  Natl.  Acad.  Sci.  USA 85, 3683 (1988); Cassuto et al., Mol. Gen.  Genet.  208, 10 (1987); Ganea et al., Mol. Cell Biol.  7, 3124
(1987); Moore et al., J. Biol.  Chem. 19, 11108 (1990); Keene et al., Nucl.  Acids Res.  12, 3057 (1984); Kimiec, Cold Spring Harbor Symp.  48, 675 (1984); Kimeic, Cell 44, 545 (1986); Kolodner et al., Proc.  Natl.  Acad.  Sci.  USA 84, 5560 (1987);
Sugino et al., Proc.  Natl.  Acad.  Sci.  USA 85, 3683 (1985); Halbrook et al., J. Biol.  Chem. 264, 21403 (1989); Eisen et al., Proc.  Natl.  Acad.  Sci.  USA 85, 7481 (1988); McCarthy et al., Proc.  Natl.  Acad.  Sci.  USA 85, 5854 (1988); Lowenhaupt
et al., J. Biol.  Chem. 264, 20568 (1989).  Examples of such recombinase proteins include recA, recA803, uvsX, (Roca, A. I., Crit. Rev.  Biochem.  Molec.  Biol.  25, 415 (1990)), sep1 (Kolodner et al., Proc.  Natl.  Acad.  Sci.  (U.S.A.) 84, 5560 (1987);
Tishlkoff et al., Molec.  Cell.  Biol.  11, 2593), RuvC (Dunderdale et al., Nature 354, 506 (1991)), DST2, KEM1, XRN1 (Dykstra et al., Molec.  Cell.  Biol.  11, 2583 (1991)), STP.alpha./DST1 (Clark et al., Molec.  Cell.  Biol.  11, 2576 (1991)), HPP-1
(Moore et al., Proc.  Natl.  Acad.  Sci.  (U.S.A.) 88, 9067 (1991)), other eukaryotic recombinases (Bishop et al., Cell 69, 439 (1992); Shinohara et al., Cell 69, 457.


RecA protein forms a nucleoprotein filament when it coats a single-stranded DNA.  In this nucleoprotein filament, one monomer of recA protein is bound to about 3 nucleotides.  This property of recA to coat single-stranded DNA is essentially
sequence independent, although particular sequences favor initial loading of recA onto a polynucleotide (e.g., nucleation sequences).  The nucleoprotein filament(s) can be formed on essentially any DNA to be shuffled and can form complexes with both
single-stranded and double-stranded DNA in procaryotic and eukaryotic cells.


Before contacting with recA or other recombinase, fragments are often denatured, e.g., by heat-treatment.  RecA protein is then added at a concentration of about 1-10 .mu.M.  After incubation, the recA-coated single-stranded DNA is introduced
into recipient cells by conventional methods, such as chemical transformation or electroporation.  The fragments undergo homologous recombination with cognate endogenous genes.  Because of the increased frequency of recombination due to recombinase
coating, the fragments need not be introduced as components of vectors.


Fragments are sometimes coated with other nucleic acid binding proteins that promote recombination, protect nucleic acids from degradation, or target nucleic acids to the nucleus.  Examples of such proteins includes Agrobacterium virE2
(Durrenberger et al., Proc.  Natl.  Acad.  Sci.  USA 86, 9154-9158 (1989)).  Alternatively, the recipient strains are deficient in RecD activity.  Single stranded ends can also be generated by 3'-5' exonuclease activity or restriction enzymes producing
5' overhangs.


2.  MutS Selection


The E. coli mismatch repair protein MutS can be used in affinity chromatography to enrich for fragments of double-stranded DNA containing at least one base of mismatch.  The MutS protein recognizes the bubble formed by the individual strands
about the point of the mismatch.  See, e.g., Hsu & Chang, WO 9320233.  The strategy of affinity enriching for partially mismatched duplexes can be incorporated into the present methods to increase the diversity between an incoming library of fragments
and corresponding cognate or allelic genes in recipient cells.


FIG. 2 shows one scheme in which MutS is used to increase diversity.  The DNA substrates for enrichment are substantially similar to each other but differ at a few sites.  For example, the DNA substrates can represent complete or partial genomes
(e.g., a chromosome library) from different individuals with the differences being due to polymorphisms.  The substrates can also represent induced mutants of a wildtype sequence.  The DNA substrates are pooled, restriction digested, and denatured to
produce fragments of single-stranded DNA.  The single-stranded DNA is then allowed to reanneal.  Some single-stranded fragments reanneal with a perfectly matched complementary strand to generate perfectly matched duplexes.  Other single-stranded
fragments anneal to generate mismatched duplexes.  The mismatched duplexes are enriched from perfectly matched duplexes by MutS chromatography (e.g., with MutS immobilized to beads).  The mismatched duplexes recovered by chromatography are introduced
into recipient cells for recombination with cognate endogenous genes as described above.  MutS affinity chromatography increases the proportion of fragments differing from each other and the cognate endogenous gene.  Thus, recombination between the
incoming fragments and endogenous genes results in greater diversity.


FIG. 3 shows a second strategy for MutS enrichment.  In this strategy, the substrates for MutS enrichment represent variants of a relatively short segment, for example, a gene or cluster of genes, in which most of the different variants differ at
no more than a single nucleotide.  The goal of MutS enrichment is to produce substrates for recombination that contain more variations than sequences occurring in nature.  This is achieved by fragmenting the substrates at random to produce overlapping
fragments.  The fragments are denatured and reannealed as in the first strategy.  Reannealing generates some mismatched duplexes which can be separated from perfectly matched duplexes by MutS affinity chromatography.  As before, MutS chromatography
enriches for duplexes bearing at least a single mismatch.  The mismatched duplexes are then reassembled into longer fragments.  This is accomplished by cycles of denaturation, reannealing, and chain extension of partially annealed duplexes (see Section
V).  After several such cycles, fragments of the same length as the original substrates are achieved, except that these fragments differ from each other at multiple sites.  These fragments are then introduced into cells where they undergo recombination
with cognate endogenous genes.


3.  Positive Selection For Allelic Exchange


The invention further provides methods of enriching for cells bearing modified genes relative to the starting cells.  This can be achieved by introducing a DNA fragment library (e.g., a single specific segment or a whole or partial genomic
library) in a suicide vector (i.e., lacking a functional replication origin in the recipient cell type) containing both positive and negative selection markers.  Optionally, multiple fragment libraries from different sources (e.g., B. subtilis, B.
lichenifornis and B. cereus) can be cloned into different vectors bearing different selection markers.  Suitable positive selection markers include neo.sup.R, kanamycin.sup.R, hyg, hisD, gpt, ble, tet.sup.R, hprt SacB and ura3.  Suitable negative
selection markers include hsv-tk, hprt, gpt, and cytosine deaminase.  A variety of examples of conditional replication vectors, mutations affecting vector replication, limited host range vectors, and counterselectable markers are found in Berg and Berg,
supra, and LaRossa, ibid.  and the references therein.


In one example, a plasmid with R6K and f1 origins of replication, a positively selectable marker (beta-lactamase), and a counterselectable marker (B. subtilis sacB) was used.  M13 transduction of plasmids containing cloned genes were efficiently
recombined into the chromosomal copy of that gene in a rep mutant E. coli strain.


Another strategy for applying negative selection is to include a wildtype rpsL gene (encoding ribosomal protein S12) in a vector for use in cells having a mutant rpsL gene conferring streptomycin resistance.  The mutant form of rpsL is recessive
in cells having wildtype rpsL.  Thus, selection for Sm resistance selects against cells having a wildtype copy of rpsL.  See Skorupski & Taylor, Gene 169, 47-52 (1996).  Alternatively, vectors bearing only a positive selection marker can be used with one
round of selection for cells expressing the marker, and a subsequent round of screening for cells that have lost the marker (e.g., screening for drug sensitivity).  The screen for cells that have lost the positive selection marker is equivalent to
screening against expression of a negative selection marker.  For example, Bacillus can be transformed with a vector bearing a CAT gene and a sequence to be integrated.  See Harwood & Cutting, Molecular Biological Methods for Bacillus, at pp.  31-33. 
Selection for chloramphenicol resistance isolates cells that have taken up vector.  After a suitable period to allow recombination, selection for CAT sensititivity isolates cells which have lost the CAT gene.  About 50% of such cells will have undergone
recombination with the sequence to be integrated.


Suicide vectors bearing a positive selection marker and optionally, a negative selection marker and a DNA fragment can integrate into host chromosomal DNA by a single crossover at a site in chromosomal DNA homologous to the fragment. 
Recombination generates an integrated vector flanked by direct repeats of the homologous sequence.  In some cells, subsequent recombination between the repeats results in excision of the vector and either acquisition of a desired mutation from the vector
by the genome or restoration of the genome to wildtype.


In the present methods, after transfer of the gene library cloned in a suitable vector, positive selection is applied for expression of the positive selection marker.  Because nonintegrated copies of the suicide vector are rapidly eliminated from
cells, this selection enriches for cells that have integrated the vector into the host chromosome.  The cells surviving positive selection can then be propagated and subjected to negative selection, or screened for loss of the positive selection marker. 
Negative selection selects against cells expressing the negative selection marker.  Thus, cells that have retained the integrated vector express the negative marker and are selectively eliminated.  The cells surviving both rounds of selection are those
that initially integrated and then eliminated the vector.  These cells are enriched for cells having genes modified by homologous recombination with the vector.


4.  Individualized Optimization of Genes


In general, the above methods do not require knowledge of the number of genes to be optimized, their map location or their function.  However, in some instances, where this information is available for one or more gene, it can be exploited.  For
example, if the property to be acquired by evolution is enhanced recombination of cells, one gene likely to be important is recA, even though many other genes, known and unknown, may make additional contributions.  In this situation, the recA gene can be
evolved, at least in part, separately from other candidate genes.  The recA gene can be evolved by any of the methods of recursive recombination described in Section V. Briefly, this approach entails obtaining diverse forms of a recA gene, allowing the
forms to recombine, selecting recombinants having improved properties, and subjecting the recombinants to further cycles of recombination and selection.  At any point in the individualized improvement of recA, the diverse forms of recA can be pooled with
fragments encoding other genes in a library to be used in the general methods described herein.  In this way, the library is seeded to contain a higher proportion of variants in a gene known to be important to the property sought to be acquired than
would otherwise be the case.


In one example (illustrated in FIG. 20B), a plasmid is constructed carrying a non-functional (mutated) version of a chromosomal gene such as URA3, where the wild-type gene confers sensitivity to a drug (in this case 5-fluoroorotic acid).  The
plasmid also carries a selectable marker (resistance to another drug such as kanamycin), and a library of recA variants.  Transformation of the plasmid into the cell results in expression of the recA variants, some of which will catalyze homologous
recombination at an increased rate.  Those cells in which homologous recombination occurred are resistant to the selectable drug on the plasmid, and to 5-fluoroorotic acid because of the disruption of the chromosomal copy of this gene.  The recA variants
which give the highest rates of homologous recombination are the most highly represented in a pool of homologous recombinants.  The mutant recA genes can be isolated from this pool by PCR, re-shuffled, cloned back into the plasmid and the process
repeated.  Other sequences can be inserted in place of recA to evolve other components of the homologous recombination system.


5.  Harvesting DNA Substrates for Shuffling


In some shuffling methods, DNA substrates are isolated from natural sources and are not easily manipulated by DNA modifying or polymerizing enzymes due to recalcitrant impurities, which poison enzymatic reactions.  Such difficulties can be
avoided by processing DNA substrates through a harvesting strain.  The harvesting strain is typically a cell type with natural competence and a capacity for homologous recombination between sequences with substantial diversity (e.g., sequences exhibiting
only 75% sequence identity).  The harvesting strain bears a vector encoding a negative selection marker flanked by two segments respectively complementary to two segments flanking a gene or other region of interest in the DNA from a target organism.  The
harvesting strain is contacted with fragments of DNA from the target organism.  Fragments are taken up by natural competence, or other methods described herein, and a fragment of interest from the target organism recombines with the vector of the
harvesting strain causing loss of the negative selection marker.  Selection against the negative marker allows isolation of cells that have taken up the fragment of interest.  Shuffling can be carried out in the harvester strain or vector can be isolated
from the harvester strain for in vitro shuffling or transfer to a different cell type for in vivo shuffling.  Alternatively, the vector can be transferred to a different cell type by conjugation, protoplast fusion or electrofusion.  An example of a
suitable harvester strain is Acinetobacter calcoaceticus mutS.  Young et al., 97th ASM Meeting Abstracts.  This strain is naturally competent and takes up DNA in a nonsequence-specific manner.  Also, because of the mutS mutation, this strain is capable
of homologous recombinatin of sequences showing only 75% sequence identity.


III.  Applications


A. Recombinogenicity


One goal of whole cell evolution is to generate cells having improved capacity for recombination.  Such cells are useful for a variety of purposes in molecular genetics including the in vivo formats of recursive sequence recombination described
in Section V. Almost thirty genes (e.g., recA, recB, recC, recD, recE, recF, recG, recO, recQ, recR, recT, ruvA, ruvB, ruvC, sbcB, ssb, topA, gyrA and B, lig, polA, uvrD, E, recL, mutD, mutH, mutL, mutT, mutU, helD) and DNA sites (e.g., chi, recN, sbcC)
involved in genetic recombination have been identified in E. coli, and cognate forms of several of these genes have been found in other organisms (e.g., rad5l, rad55-rad57, Dmc1 in yeast (see Kowalczykowski et al., Microbiol.  Rev.  58, 401-465 (1994);
Kowalczkowski & Zarling, supra) and human homologs of Rad51 and Dmc1 have been identified (see Sandler et al., Nucl.  Acids Res.  24, 2125-2132 (1996)).  At least some of the E. coli genes, including recA are functional in mammalian cells, and can be
targeted to the nucleus as a fusion with SV40 large T antigen nuclear targeting sequence (Reiss et al., Proc.  Natl.  Acad.  Sci.  USA, 93, 3094-3098 (1996)).  Further, mutations in mismatch repair genes, such as mutL, mutS, mutH, mutT relax homology
requirements and allow recombination between more diverged sequences (Rayssiguier et al., Nature 342, 396-401 (1989)).  The extent of recombination between divergent strains can be enhanced by impairing mismatch repair genes and stimulating SOS genes. 
Such can be achieved by use of appropriate mutant strains and/or growth under conditions of metabolic stress, which have been found to stimulate SOS and inhibit mismatch repair genes.  Vulic et al., Proc.  Natl.  Acad.  Sci.  USA 94 (1997).  In addition,
this can be achieved by impairing the products of mismatch repair genes by exposure to selective inhibitors.


Starting substrates for recombination are selected according to the general principles described above.  That is, the substrates can be whole genomes or fractions thereof containing recombination genes or sites.  Large libraries of essentially
random fragments can be seeded with collections of fragments constituting variants of one or more known recombination genes, such as recA.  Alternatively, libraries can be formed by mixing variant forms of the various known recombination genes and sites.


The library of fragments is introduced into the recipient cells to be improved and recombination occurs, generating modified cells.  The recipient cells preferably contain a marker gene whose expression has been disabled in a manner that can be
corrected by recombination.  For example, the cells can contain two copies of a marker gene bearing mutations at different sites, which copies can recombine to generate the wildtype gene.  A suitable marker gene is green fluorescent protein.  A vector
can be constructed encoding one copy of GFP having stopcodons near the N-terminus, and another copy of GFP having stopcodons near the C-terminus of the protein.  The distance between the stop codons at the respective ends of the molecule is 500 bp and
about 25% of recombination events result in active GFP.  Expression of GFP in a cell signals that a cell is capable of homologous recombination to recombine in between the stop codons to generate a contiguous coding sequence.  By screening for cells
expressing GFP, one enriches for cells having the highest capacity for recombination.  The same type of screen can be used following subsequent rounds of recombination.  However, unless the selection marker used in previous round(s) was present on a
suicide vector, subsequent round(s) should employ a second disabled screening marker within a second vector bearing a different origin of replication or a different positive selection marker to vectors used in the previous rounds.


B. Multigenomic Copy Number--Gene Redundancy


The majority of bacterial cells in stationary phase cultures grown in rich media contain two, four or eight genomes.  In minimal medium the cells contain one or two genomes.  The number of genomes per bacterial cell thus depends on the growth
rate of the cell as it enters stationary phase.  This is because rapidly growing cells contain multiple replication forks, resulting in several genomes in the cells after termination.  The number of genomes is strain dependent, although all strains
tested have more than one chromosome in stationary phase.  The number of genomes in stationary phase cells decreases with time.  This appears to be due to fragmentation and degradation of entire chromosomes, similar to apoptosis in mammalian cells.  This
fragmentation of genomes in cells containing multiple genome copies results in massive recombination and mutagenesis.  Useful mutants may find ways to use energy sources that will allow them to continue growing.  Multigenome or gene-redundant cells are
much more resistant to mutagenesis and can be improved for a selected trait faster.


Some cell types, such as Deinococcus radians (Daly and Minton J. Bacteriol.  177, 5495-5505 (1995)) exhibit polyploidy throughout the cell cycle.  This cell type is highly radiation resistant due to the presence of many copies of the genome. 
High frequency recombination between the genomes allows rapid removal of mutations induced by a variety of DNA damaging agents.


A goal of the present methods is to evolve other cell types to have increased genome copy number akin to that of Deinoccocus radians.  Preferably, the increased copy number is maintained through all or most of its cell cycle in all or most growth
conditions.  The presence of multiple genome copies in such cells results in a higher frequency of homologous recombination in these cells, both between copies of a gene in different genomes within the cell, and between a genome within the cell and a
transfected fragment.  The increased frequency of recombination allows the cells to be evolved more quickly to acquire other useful characteristics.


Starting substrates for recombination can be a diverse library of genes only a few of which are relevant to genomic copy number, a focused library formed from variants of gene(s) known or suspected to have a role in genomic copy number or a
combination of the two.  As a general rule one would expect increased copy number would be achieved by evolution of genes involved in replication and cell septation such that cell septation is inhibited without impairing replication.  Genes involved in
replication include tus, xerC, xerD, dif, gyrA, gyrB, parE, parC, dif, TerA, TerB, TerC, TerD, TerE, TerF, and genes influencing chromosome partitioning and gene copy number include minD, mukA (tolC), mukB, mukC, mukD, spoOJ, spoIIIE (Wake & Errington,
Annu.  Rev.  Genet.  29, 41-67 (1995)).  A useful source of substrates is the genome of a cell type such as Deinoccocus radians known to have the desired phenotype of multigenomic copy number.  As well as, or instead of, the above substrates, fragments
encoding protein or antisense RNA inhibitors to genes known to be involved in cell septation can also be used.


In nature, the existence of multiple genomic copies in a cell type would usually not be advantageous due to the greater nutritional requirements needed to maintain this copy number.  However, artificial conditions can be devised to select for
high copy number.  Modified cells having recombinant genomes are grown in rich media (in which conditions, multicopy number should not be a disadvantage) and exposed to a mutagen, such as ultraviolet or gamma irradiation or a chemical mutagen, e.g.,
mitomycin, nitrous acid, photoactivated psoralens, alone or in combination, which induces DNA breaks amenable to repair by recombination.  These conditions select for cells having multicopy number due to the greater efficiency with which mutations can be
excised.  Modified cells surviving exposure to mutagen are enriched for cells with multiple genome copies.  If desired, selected cells can be individually analyzed for genome copy number (e.g., by quantitative hybridization with appropriate controls). 
Some or all of the collection of cells surviving selection provide the substrates for the next round of recombination.  In addition, individual cells can be sorted using a cell sorter for those cells containing more DNA, e.g., using DNA specific
fluorescent compounds or sorting for increased size using light dispersion.  Eventually cells are evolved that have at least 2, 4, 6, 8 or 10 copies of the genome throughout the cell cycle.


C. Secretion


The protein (or metabolite) secretion pathways of bacterial and eukaryotic cells can be evolved to export desired molecules more efficiently, such as for the manufacturing of protein pharmaceuticals, small molecule drugs or specialty chemicals. 
Improvements in efficiency are particularly desirable for proteins requiring multisubunit assembly (such as antibodies) or extensive posttranslational modification before secretion.


The efficiency of secretion may depend on a number of genetic sequences including a signal peptide coding sequence, sequences encoding protein(s) that cleave or otherwise recognize the coding sequence, and the coding sequence of the protein being
secreted.  The latter may affect folding of the protein and the ease with which it can integrate into and traverse membranes.  The bacterial secretion pathway in E. coli include the SecA, SecB, SecE, SecD and SecF genes.  In Bacillus subtilis, the major
genes are secA, secD, secE, secF, secY, ffh, ftsY together with five signal peptidase genes (sipS, sipT, sipU, sipV and sipW) (Kunst et al, supra).  For proteins requiring posttranslational modification, evolution of genes effecting such modification may
contribute to improved secretion.  Likewise genes with expression products having a role in assembly of multisubunit proteins (e.g., chaperonins) may also contribute to improved secretion.


Selection of substrates for recombination follows the general principles discussed above.  In this case, the focused libraries referred to above comprise variants of the known secretion genes.  For evolution of procaryotic cells to express
eukaryotic proteins, the initial substrates for recombination are often obtained at least in part from eukaryotic sources.  Incoming fragments can undergo recombination both with chromosomal DNA in recipient cells and with the screening marker construct
present in such cells (see below).  The latter form of recombination is important for evolution of the signal coding sequence incorporated in the screening marker construct.  Improved secretion can be screened by the inclusion of marker construct in the
cells being evolved.  The marker construct encodes a marker gene, operably linked to expression sequences, and usually operably linked to a signal peptide coding sequence.  The marker gene is sometimes expressed as a fusion protein with a recombinant
protein of interest.  This approach is useful when one wants to evolve the recombinant protein coding sequence together with secretion genes.


In one variation, the marker gene encodes a product that is toxic to the cell containing the construct unless the product is secreted.  Suitable toxin proteins include diphtheria toxin and ricin toxin.  Propagation of modified cells bearing such
a construct selects for cells that have evolved to improve secretion of the toxin.  Alternatively, the marker gene can encode a ligand to a known receptor, and cells bearing the ligand can be detected by FACS using labelled receptor.  Optionally, such a
ligand can be operably linked to a phospholipid anchoring sequence that binds the ligand to the cell membrane surface following secretion.  (See commonly owned, copending Ser.  No. 08/309,345).  In a further variation, secreted marker protein can be
maintained in proximity with the cell secreting it by distributing individual cells into agar drops.  This is done, e.g., by droplet formation of a cell suspension.  Secreted protein is confined within the agar matrix and can be detected by e.g., FACS. 
In another variation, a protein of interest is expressed as a fusion protein together with b-lactamase or alkaline phosphatase.  These enzymes metabolize commercially available chromogenic substrates (e.g., X-gal), but do so only after secretion into the
periplasm.  Appearance of colored substrate in a colony of cells therefore indicates capacity to secrete the fusion protein and the intensity of color is related to the efficiency of secretion.


The cells identified by these screening and selection methods have the capacity to secrete increased amounts of protein.  This capacity may be attributable to increased secretion and increased expression, or from increased secretion alone.


D. Expression


Cells can also be evolved to acquire increased expression of a recombinant protein.  The level of expression is, of course, highly dependent on the construct from which the recombinant protein is expressed and the regulatory sequences, such as
the promoter, enhancer(s) and transcription termination site contained therein.  Expression can also be affected by a large number of host genes having roles in transcription, posttranslational modification and translation.  In addition, host genes
involved in synthesis of ribonucleotide and amino acid monomers for transcription and translation may have indirect effects on efficiency of expression.  Selection of substrates for recombination follows the general principles discussed above.  In this
case, focused libraries comprise variants of genes known to have roles in expression.  For evolution of procaryotic cells to express eukaryotic proteins, the initial substrates for recombination are often obtained, at least in part, from eukaryotic
sources; that is eukaryotic genes encoding proteins such as chaperonins involved in secretion and/assembly of proteins.  Incoming fragments can undergo recombination both with chromosomal DNA in recipient cells and with the screening marker construct
present in such cells (see below).


Screening for improved expression can be effected by including a reporter construct in the cells being evolved.  The reporter construct expresses (and usually secretes) a reporter protein, such as GFP, which is easily detected and nontoxic.  The
reporter protein can be expressed alone or together with a protein of interest as a fusion protein.  If the reporter gene is secreted, the screening effectively selects for cells having either improved secretion or improved expression, or both.


E. Plant Cells


A further application of recursive sequence recombination is the evolution of plant cells, and transgenic plants derived from the same, to acquire resistance to pathogenic diseases (fungi, viruses and bacteria), insects, chemicals (such as salt,
selenium, pollutants, pesticides, herbicides, or the like), including, e.g., atrazine or glyphosate, or to modify chemical composition, yield or the like.  The substrates for recombination can again be whole genomic libraries, fractions thereof or
focused libraries containing variants of gene(s) known or suspected to confer resistance to one of the above agents.  Frequently, library fragments are obtained from a different species to the plant being evolved.


The DNA fragments are introduced into plant tissues, cultured plant cells or plant protoplasts by standard methods including electroporation (From et al., Proc.  Natl.  Acad.  Sci.  USA 82, 5824 (1985), infection by viral vectors such as
cauliflower mosaic virus (CaMV) (Hohn et al., Molecular Biology of Plant Tumors, (Academic Press, N.Y., 1982) pp.  549-560; Howell, U.S.  Pat.  No. 4,407,956), high velocity ballistic penetration by small particles with the nucleic acid either within the
matrix of small beads or particles, or on the surface (Klein et al., Nature 327, 70-73 (1987)), use of pollen as vector (WO 85/01856), or use of Agrobacterium tumefaciens or A. rhizogenes carrying a T-DNA plasmid in which DNA fragments are cloned.  The
T-DNA plasmid is transmitted to plant cells upon infection by Agrobacterium tumefaciens, and a portion is stably integrated into the plant genome (Horsch et al., Science 233, 496-498 (1984); Fraley et al., Proc.  Natl.  Acad.  Sci.  USA 80, 4803 (1983)).


Diversity can also be generated by genetic exchange between plant protoplasts according to the same principles described below for fungal protoplasts.  Procedures for formation and fusion of plant protoplasts are described by Takahashi et al.,
U.S.  Pat.  No. 4,677,066; Akagi et al., U.S.  Pat.  No. 5,360,725; Shimamoto et al., U.S.  Pat.  No. 5,250,433; Cheney et al., U.S.  Pat.  No. 5,426,040.


After a suitable period of incubation to allow recombination to occur and for expression of recombinant genes, the plant cells are contacted with the agent to which resistance is to be acquired, and surviving plant cells are collected.  Some or
all of these plant cells can be subject to a further round of recombination and screening.  Eventually, plant cells having the required degree of resistance are obtained.


These cells can then be cultured into transgenic plants.  Plant regeneration from cultured protoplasts is described in Evans et al., "Protoplast Isolation and Culture," Handbook of Plant Cell Cultures 1, 124-176 (MacMillan Publishing Co., N.Y.,
1983); Davey, "Recent Developments in the Culture and Regeneration of Plant Ptotoplasts," Protoplasts, (1983) pp.  12-29, (Birkhauser, Basal 1983); Dale, "Protoplast Culture and Plant Regeneration of Cereals and Other Recalcitrant Crops," Protoplasts
(1983) pp.  31-41, (Birkhauser, Basel 1983); Binding, "Regeneration of Plants," Plant Protoplasts, pp.  21-73, (CRC Press, Boca Raton, 1985).


In a variation of the above method, one or more preliminary rounds of recombination and screening can be performed in bacterial cells according to the same general strategy as described for plant cells.  More rapid evolution can be achieved in
bacterial cells due to their greater growth rate and the greater efficiency with which DNA can be introduced into such cells.  After one or more rounds of recombination/screening, a DNA fragment library is recovered from bacteria and transformed into the
plants.  The library can either be a complete library or a focused library.  A focused library can be produced by amplification from primers specific for plant sequences, particularly plant sequences known or suspected to have a role in conferring
resistance.


EXAMPLE


Concatemeric Assembly of Atrazine-Catabolizing Plasmid


Pseudomonas atrazine catabolizing genes AtzA and AtzB were subcloned from pMD1 (deSouza et al., Appl.  Environ.  Microbiol.  61, 3373-3378 (1995); de Souza et al., J. Bacteriol.  178, 4894-4900 (1996)) into pUC18.  A 1.9 kb Aval fragment
containing AtzA was end-filled and inserted into an Aval site of pUC18.  A 3.9 kb ClaI fragment containing AtzB was end-filled and cloned into the HincII site of pUC18.  AtzA was then excised from pUC18 with EcoRI and BamHI, AzB with BamHI and HindIII,
and the two inserts were co-ligated into pUC18 digested with EcoRI and HindIII.  The result was a 5.8 kb insert containing AtzA and AtzB in pUC18 (total plasmid size 8.4 kb).


Recursive sequence recombination was performed as follows.  The entire 8.4 kb plasmid was treated with DNaseI in 50 mM Tris-Cl pH 7.5, 10 mM MnCl.sub.2 and fragments between 500 and 2000 bp were gel purified.  The fragments were assembled in a
PCR reaction using Tth-XL enzyme and buffer from Perkin Elmer, 2.5 mM MgOAc, 400 .mu.M dNTPs and serial dilutions of DNA fragments.  The assembly reaction was performed in an MJ Research "DNA Engine" programmed with the following cycles: 1) 94.degree. 
C., 20 seconds; 2) 94.degree.  C., 15 seconds; 3) 40.degree.  C., 30 seconds; 4).  72.degree.  C., 30 seconds+2 seconds per cycle; 5) go to step 2, 39 more times; 6) 4.degree.  C.


We were unable to amplify the AtzA and AtzB genes from the assembly reaction using the polymerase chain reaction, so instead we purified DNA from the reaction by phenol extraction and ethanol precipitation, then digested the assembled DNA with a
restriction enzyme that linearized the plasmid (KpnI: the KpnI site in pUC18 was lost during subcloning, leaving only the KpnI site in AtzA).  Linearized plasmid was gel-purified, self-ligated overnight and transformed into E. coli strain NM522.  (The
choice of host strain was important: very little plasmid of poor quality was obtained from a number of other commercially available strains including TG1, DH10B, DH12S.)


Serial dilutions of the transformation reaction were plated onto LB plates containing 50 .mu.g/ml ampicillin, the remainder of the transformation was made 25% in glycerol and frozen at -80.degree.  C. Once the transformed cells were titered, the
frozen cells were plated at a density of between 200 and 500 on 150 mm diameter plates containing 500 .mu.g/ml atrazine and grown at 37.degree.  C.


Atrazine at 500 .mu.g/ml forms an insoluble precipitate.  The products of the AtzA and AtzB genes transform atrazine into a soluble product.  Cells containing the wild type AtzA and AtzB genes in pUC18 will thus be surrounded by a clear halo
where the atrazine has been degraded.  The more active the AtzA and AtzB enzymes, the more rapidly a clear halo will form and grow on atrazine-containing plates.  Positives were picked as those colonies that most rapidly formed the largest clear zones. 
The (approximately) 40 best colonies were picked, pooled, grown in the presence of 50 .mu.g/ml ampicillin and plasmid prepared from them.  The entire process (from DNase-treatment to plating on atrazine plates) was repeated 4 times with 2000-4000
colonies/cycle.


A modification was made in the fourth round.  Cells were plated on both 500 .mu.g/ml atrazine, and 500 .mu.g/ml of the atrazine analogue terbutylazine, which was undegradable by the wild type AtzA and AtzB genes.  Positives were obtained that
degraded both compounds.  The atrazine chlorohydrolase (product of AtzA gene) was 10-100 fold higher than that produced by the wildtype gene.


F. Plant Genome Shuffling


Plant genome shuffling allows recursive cycles to be used for the introduction and recombination of genes or pathways that confer improved properties to desired plant species.  Any plant species, including weeds and wild cultivars, showing a
desired trait, such as herbicide resistance, salt tolerance, pest resistance, or temperature tolerance, can be used as the source of DNA that is introduced into the crop or horticultural host plant species.


Genomic DNA prepared from the source plant is fragmented (e.g. by DNaseI, restriction enzymes, or mechanically) and cloned into a vector suitable for making plant genomic libraries, such as pGA482 (An.  G., 1995, Methods Mol. Biol.  44:47-58). 
This vector contains the A. tumefaciens left and right borders needed for gene transfer to plant cells and antibiotic markers for selection in E. coli, Agrobacterium, and plant cells.  A multicloning site is provided for insertion of the genomic
fragments.  A cos sequence is present for the efficient packaging of DNA into bacteriophage lambda heads for transfection of the primary library into E. coli.  The vector accepts DNA fragments of 25-40 kb.


The primary library can also be directly electroporated into an A. tumefaciens or A. rhizogenes strain that is used to infect and transform host plant cells (Main, G. D. et al., 1995, Methods Mol. Biol.  44:405-412).  Alternatively, DNA can be
introduced by electroporation or PEG-mediated uptake into protoplasts of the recipient plant species (Bilang et al. (1994) Plant Mol. Biol Manual, Kluwer Academic Publishers, A1:1-16) or by particle bombardment of cells or tissues (Christou, ibid,
A2:1-15).  If necessary, antibiotic markers in the T-DNA region can be eliminated, as long as selection for the trait is possible, so that the final plant products contain no antibiotic genes.


Stably transformed whole cells acquiring the trait are selected on solid or liquid media containing the agent to which the introduced DNA confers resistance or tolerance.  If the trait in question cannot be selected for directly, transformed
cells can be selected with antibiotics and allowed to form callus or regenerated to whole plants and then screened for the desired property.


The second and further cycles consist of isolating genomic DNA from each transgenic line and introducing it into one or more of the other transgenic lines.  In each round, transformed cells are selected or screened for incremental improvement. 
To speed the process of using multiple cycles of transformation, plant regeneration can be eliminated until the last round.  Callus tissue generated from the protoplasts or transformed tissues can serve as a source of genomic DNA and new host cells. 
After the final round, fertile plants are regenerated and the progeny are selected for homozygosity of the inserted DNAs.  Ultimately, a new plant is created that carries multiple inserts which additively or synergistically combine to confer high levels
of the desired trait.


In addition, the introduced DNA that confers the desired trait can be traced because it is flanked by known sequences in the vector.  Either PCR or plasmid rescue is used to isolate the sequences and characterize them in more detail.  Long PCR
(Foord, O. S. and Rose, E. A., 1995, PCR Primer: A Laboratory Manual, CSHL Press, pp 63-77) of the full 25-40 kb insert is achieved with the proper reagents and techniques using as primers the T-DNA border sequences.  If the vector is modified to contain
the E. coli origin of replication and an antibiotic marker between the T-DNA borders, a rare cutting restriction enzyme, such as NotI or SfiI, that cuts only at the ends of the inserted DNA is used to create fragments containing the source plant DNA that
are then self-ligated and transformed into E. coli where they replicate as plasmids.  The total DNA or subfragment of it that is responsible for the transferred trait can be subjected to in vitro evolution by DNA shuffling.  The shuffled library is then
introduced into host plant cells and screened for improvement of the trait.  In this way, single and multigene traits can be transferred from one species to another and optimized for higher expression or activity leading to whole organism improvement.


EXAMPLE


Acquisition of Salt Tolerance


As depicted in FIG. 21, DNA from a salt tolerant plant is isolated and used to create a genomic library.  Protoplasts made from the recipient species are electroporated with the genomic library.  Cells are selected on media with a normally
inhibitory level of NaCl.  Only the cells with newly acquired salt tolerance will grow into callus tissue.  The best lines are chosen and genomic libraries are made from their pooled DNA.  These libraries are electroporated into protoplasts made from the
first round transformed calli.  Again, cells are selected on increased salt concentrations.  After the desired level of salt tolerance is achieved, the callus tissue can be induced to regenerate whole plants.  Progeny of these plants are typically
analyzed for homozygosity of the inserts to ensure stability of the acquired trait.  At the indicated steps, plant regeneration or isolation and shuffling of the introduced genes can be added to the overall protocol.


G. Transgenic Animals


1.  Transgene Optimization


One goal of transgenesis is to produce transgenic animals, such as mice, rabbits, sheep, pigs, goats, and cattle, secreting a recombinant protein in the milk.  A transgene for this purpose typically comprises in operable linkage a promoter and an
enhancer from a milk-protein gene (e.g., .alpha., .beta., or .gamma.  casein, .beta.-lactoglobulin, acid whey protein or .alpha.-lactalbumin), a signal sequence, a recombinant protein coding sequence and a transcription termination site.  Optionally, a
transgene can encode multiple chains of a multichain protein, such as an immunoglobulin, in which case, the two chains are usually individually operably linked to sets of regulatory sequences.  Transgenes can be optimized for expression and secretion by
recursive sequence recombination.  Suitable substrates for recombination include regulatory sequences such as promoters and enhancers from milk-protein genes from different species or individual animals.  Cycles of recombination can be performed in vitro
or in vivo by any of the formats discussed in Section V. Screening is performed in vivo on cultures of mammary-gland derived cells, such as HC11 or MacT, transfected with transgenes and reporter constructs such as those discussed above.  After several
cycles of recombination and screening, transgenes resulting in the highest levels of expression and secretion are extracted from the mammary gland tissue culture cells and used to transfect embryonic cells, such as zygotes and embryonic stem cells, which
are matured into transgenic animals.


2.  Whole Animal Optimization


In this approach, libraries of incoming fragments are transformed into embryonic cells, such as ES cells or zygotes.  The fragments can be variants of a gene known to confer a desired property, such as growth hormone.  Alternatively, the
fragments can be partial or complete genomic libraries including many genes.


Fragments are usually introduced into zygotes by microinjection as described by Gordon et al., Methods Enzymol.  101, 414 (1984); Hogan et al., Manipulation of the Mouse Embryo: A Laboratory Manual (C.S.H.L.  N.Y., 1986) (mouse embryo); and
Hammer et al., Nature 315, 680 (1985) (rabbit and porcine embryos); Gandolfi et al., J. Reprod.  Fert.  81, 23-28 (1987); Rexroad et al., J. Anim.  Sci.  66, 947-953 (1988) (ovine embryos) and Eyestone et al., J. Reprod.  Fert.  85, 715-720 (1989);
Camous et al., J. Reprod.  Fert.  72, 779-785 (1984); and Heyman et al., Theriogenology 27, 5968 (1987) (bovine embryos) by reference in their entirety for all purposes).  Zygotes are then matured and introduced into recipient female animals which
gestate the embryo and give birth to a transgenic offspring.


Alternatively, transgenes can be introduced into embryonic stem cells (ES).  These cells are obtained from preimplantation embryos cultured in vitro.  Bradley et al., Nature 309, 255-258 (1984).  Transgenes can be introduced into such cells by
electroporation or microinjection.  Transformed ES cells are combined with blastocysts from a nonhuman animal.  The ES cells colonize the embryo and in some embryos form the germ line of the resulting chimeric animal.  See Jaenisch, Science, 240,
1468-1474 (1988).


Regardless whether zygotes or ES are used, screening is performed on whole animals for a desired property, such as increased size and/or growth rate, DNA is extracted from animals having evolved toward acquisition of the desired property.  This
DNA is then used to transfect further embryonic cells.  These cells can also be obtained from animals that have acquired toward the desired property in a split and pool approach.  That is, DNA from one subset of such animals is transformed into embryonic
cells prepared from another subset of the animals.  Alternatively, the DNA from animals that have evolved toward acquisition of the desired property can be transfected into fresh embryonic cells.  In either alternative, transfected cells are matured into
transgenic animals, and the animals subjected to a further round of screening for the desired property.


FIG. 4 shows the application of this approach for evolving fish toward a larger size.  Initially, a library is prepared of variants of a growth hormone gene.  The variants can be natural or induced.  The library is coated with recA protein and
transfected into fertilized fish eggs.  The fish eggs then mature into fish of different sizes.  The growth hormone gene fragment of genomic DNA from large fish is then amplified by PCR and used in the next round of recombination.  Alternatively, fish
.alpha.-IFN is evolved to enhance resistance to viral infections as described below.


3.  Evolution of Improved Hormones for Expression in Transgenic Animals (e.g., Fish) to Create Animals with Improved Traits.


Hormones and cytokines are key regulators of size, body weight, viral resistance and many other commercially important traits.  DNA shuffling is used to rapidly evolve the genes for these proteins using in vitro assays.  This was demonstrated
with the evolution of the human alpha interferon genes to have potent antiviral activity on murine cells.  Large improvements in activity were achieved in two cycles of family shuffling of the human IFN genes.


In general, a method of increasing resistance to virus infection in cells can be performed by first introducing a shuffled library comprising at least one shuffled interferon gene into animal cells to create an initial library of animal cells or
animals.  The initial library is then challenged with the virus.  Animal cells or animals are selected from the initial library which are resistant to the virus and a plurality of transgenes from a plurality of animal cells or animals which are resistant
to the virus are recovered.  The plurality of transgenes is recovered to produce an evolved library of animal cells or animals which is again challenged with the virus.  Cells or animals are selected from the evolved library the which are resistant to
the virus.


For example, genes evolved with in vitro assays are introduced into the germplasm of animals or plants to create improved strains.  One limitation of this procedure is that in vitro assays are often only crude predictors of in vivo activity. 
However, with improving methods for the production of transgenic plants and animals, one can now marry whole organism breeding with molecular breeding.  The approach is to introduce shuffled libraries of hormone genes into the species of interest.  This
can be done with a single gene per transgenic or with pools of genes per transgenic.  Progeny are then screened for the phenotype of interest.  In this case, shuffled libraries of interferon genes (alpha IFN for example) are introduced into transgenic
fish.  The library of transgenic fish are challenged with a virus.  The most resistant fish are identified (i.e. either survivors of a lethal challenge; or those that are deemed most `healthy` after the challenge).  The IFN transgenes are recovered by
PCR and shuffled in either a poolwise or a pairwise fashion.  This generates an evolved library of IFN genes.  A second library of transgenic fish is created and the process is repeated.  In this way, IFN is evolved for improved antiviral activity in a
whole organism assay.


This procedure is general and can be applied to any trait that is affected by a gene or gene family of interest and which can be quantitatively measured.


Fish interferon sequence data is available for the Japanese flatfish (Paralichthys olivaceus) as mRNA sequence (Tamai et al. (1993) "Cloning and expression of flatfish (Paralichthys olivaceus) interferon cDNA." Biochem.  Biophys.  Acta 1174,
182-186; see also, Tami et al. (1993) "Purification and characterization of interferon-like antiviral protein derived from flatfish (Paralichthys olivaceus) lymphocytes immortalized by oncogenes." Cytotechnology 1993; 11 (2):121-131).  This sequence can
be used to clone out IFN genes from this species.  This sequence can also be used as a probe to clone homologous interferons from additional species of fish.  As well, additional sequence information can be utilized to clone out more species of fish
interferons.  Once a library of interferons has been cloned, these can be family shuffled to generate a library of variants.


A Protein sequence of flatfish interferon is:


MIRSTNSNKS DILMNCHHLIIR YDDNSAPSGGSL FRKMIMLLKL LKLITFGQLRVV ELFVKSNTSKTS TVLSIDGSNLISL LDAPKDILDKPSCNSF QLDLLLASSAWTLLT ARLLNYPYPA VLLSAGVASVVLVQVP.


In one embodiment, BHK-21 (A fibroblast cell line from hamster) can be transfected with the shuffled IFN-expression plasmids.  Active recombinant IFN is produced and then purified by WGA agarose affinity chromatography (Tamai, et al. 1993 Biochim
Ciophys Acta.  supra).  The antiviral activity of IFN can be measured on fish cells challenged by rhabdoviurs.  Tami et al. (1993) "Purification and characterization of interferon-like antiviral protein derived from flatfish (Paralichthys olivaceus)
lymphocytes immortalized by oncogenes." Cytotechnology 1993; 11 (2):121-131).


H. Rapid Evolution as a Predictive Tool


Recursive sequence recombination can be used to simulate natural evolution of pathogenic microorganisms in response to exposure to a drug under test.  Using recursive sequence recombination, evolution proceeds at a faster rate than in natural
evolution.  One measure of the rate of evolution is the number of cycles of recombination and screening required until the microorganism acquires a defined level of resistance to the drug.  The information from this analysis is of value in comparing the
relative merits of different drugs and in particular, in predicting their long term efficacy on repeated administration.


The pathogenic microorganisms used in this analysis include the bacteria that are a common source of human infections, such as chlamydia, rickettsial bacteria, mycobacteria, staphylococci, streptocci, pneumonococci, meningococci and conococci,
klebsiella, proteus, serratia, pseudomonas, legionella, diphtheria, salmonella, bacilli, cholera, tetanus, botulism, anthrax, plague, leptospirosis, and Lymes disease bacteria.  Evolution is effected by transforming an isolate of bacteria that is
sensitive to a drug under test with a library of DNA fragments.  The fragments can be a mutated version of the genome of the bacteria being evolved.  If the target of the drug is a known protein or nucleic acid, a focused library containing variants of
the corresponding gene can be used.  Alternatively, the library can come from other kinds of bacteria, especially bacteria typically found inhabiting human tissues, thereby simulating the source material available for recombination in vivo.  The library
can also come from bacteria known to be resistant to the drug.  After transformation and propagation of bacteria for an appropriate period to allow for recombination to occur and recombinant genes to be expressed, the bacteria are screened by exposing
them to the drug under test and then collecting survivors.  Surviving bacteria are subject to further rounds of recombination.  The subsequent round can be effected by a split and pool approach in which DNA from one subset of surviving bacteria is
introduced into a second subset of bacteria.  Alternatively, a fresh library of DNA fragments can be introduced into surviving bacteria.  Subsequent round(s) of selection can be performed at increasing concentrations of drug, thereby increasing the
stringency of selection.


A similar strategy can be used to simulate viral acquisition of drug resistance.  The object is to identify drugs for which resistance can be acquired only slowly, if at all.  The viruses to be evolved are those that cause infections in humans
for which at least modestly effective drugs are available.  Substrates for recombination can come from induced mutants, natural variants of the same viral strain or different viruses.  If the target of the drug is known (e.g., nucleotide analogs which
inhibit the reverse transcriptase gene of HIV), focused libraries containing variants of the target gene can be produced.  Recombination of a viral genome with a library of fragments is usually performed in vitro.  However, in situations in which the
library of fragments constitutes variants of viral genomes or fragments that can be encompassed in such genomes, recombination can also be performed in vivo, e.g., by transfecting cells with multiple substrate copies (see Section V).  For screening,
recombinant viral genomes are introduced into host cells susceptible to infection by the virus and the cells are exposed to a drug effective against the virus (initially at low concentration).  The cells can be spun to remove any noninfected virus. 
After a period of infection, progeny viruses can be collected from the culture medium, the progeny viruses being enriched for viruses that have acquired at least partial resistance to the drug.  Alternatively, virally infected cells can be plated in a
soft agar lawn and resistant viruses isolated from plaques.  Plaque size provides some indication of the degree of viral resistance.


Progeny viruses surviving screening are subject to additional rounds of recombination and screening at increased stringency until a predetermined level of drug resistance has been acquired.  The predetermined level of drug resistance may reflect
the maximum dosage of a drug practical to administer to a patient without intolerable side effects.  The analysis is particularly valuable for investigating acquisition of resistance to various combination of drugs, such as the growing list of approved
anti-HIV drugs (e.g., AZT, ddI, ddC, d4T, TIBO 82150, nevaripine, 3TC, crixivan and ritonavir).


I. Fermentation


The fermentation of microorganisms for the production of natural products is the oldest and most sophisticated application of biocatalysis.  Industrial microorganisms effect the multistep conversion of renewable feedstocks to high value chemical
products in a single reactor and in so doing catalyze a multi-billion dollar industry.  Fermentation products range from fine and commodity chemicals such as ethanol, lactic acid, amino acids and vitamins, to high value small molecule pharmaceuticals,
protein pharmaceuticals, and industrial enzymes.  See, e.g., McCoy (1998) C&EN 13-19) for an introduction to biocatalysis.


Success in bringing these products to market and success in competing in the market depends on continuous improvement of the whole cell biocatalysts.  Improvements include increased yield of desired products, removal of unwanted co-metabolites,
improved utilization of inexpensive carbon and nitrogen sources, and adaptation to fermenter conditions, increased production of a primary metabolite, increased production of a secondary metabolite, increased tolerance to acidic conditions, increased
tolerance to basic conditions, increased tolerance to organic solvents, increased tolerance to high salt conditions and increased tolerance to high or low temperatures.  Shortcomings in any of these areas can result in high manufacturing costs, inability
to capture or maintain market share, and failure of bringing promising products to market.  For this reason, the fermentation industry invests significant financial and personnel resources in the improvement of production strains.


Current strategies for strain improvement rely on the empirical and iterative modification of fermenter conditions and genetic manipulation of the producing organism.  While advances in the molecular biology of established industrial organisms
have been made, rational metabolic engineering is information intensive and is not broadly applicable to less characterized industrial strains.  The most widely practiced strategy for strain improvement employs random mutagenesis of the producing strain
and screening for mutants having improved properties.  For mature strains, those subjected to many rounds of improvement, these efforts routinely provide a 10% increase in product titre per year.  Although effective, this classic strategy is slow,
laborious, and expensive.  Technological advances in this area are aimed at automation and increasing sample screening throughput in hopes of reducing the cost of strain improvement.  However, the real technical barrier resides in the intrinsic
limitation of single mutations to effect significant strain improvement.  The methods herein overcome this limitation and provide access to multiple useful mutations per cycle which can be used to complement automation technologies and catalyze strain
improvement processes.


The methods herein allow biocatalysts to be improved at a faster pace than conventional methods.  Whole genome shuffling can at least double the rate of strain improvement for microorganisms used in fermentation as compared to traditional
methods.  This provides for a relative decrease in the cost of fermentation processes.  New products can enter the market sooner, producers can increase profits as well as market share, and consumers gain access to more products of higher quality and at
lower prices.  Further, increased efficiency of production processes translates to less waste production and more frugal use of resources.  Whole genome shuffling provides a means of accumulating multiple useful mutation per cycle and thus eliminate the
inherent limitation of current strain improvement programs (SIPs).


DNA shuffling provides recursive mutagenesis, recombination, and selection of DNA sequences.  A key difference between DNA shufing-mediated recombination and natural sexual recombination is that DNA shuffling effects both the pairwise (two
parents) and the poolwise (multiple parents) recombination of parent molecules, as described supra.  Natural recombination is more conservative and is limited to pairwise recombination.  In nature, pairwise recombination provides stability within a
population by preventing large leaps in sequences or genomic structure that can result from poolwise recombination.  However, for the purposes of directed evolution, poolwise recombination is appealing since the beneficial mutations of multiple parents
can be combined during a single cross to produce a superior offspring.  Poolwise recombination is analogous to the crossbreeding of inbred strains in classic strain improvement, except that the crosses occur between many strains at once.  In essence,
poolwise recombination is a sequence of events that effects the recombination of a population of nucleic acid sequences that results in the generation of new nucleic acids that contains genetic information from more than two of the original nucleic
acids.


There are a few general methods for effecting efficient recombination in prokaryotes.  Bacteria have no known sexual cycle per se, but there are natural mechanisms by which the genomes of these organisms undergo recombination.  These mechanisms
include natural competence, phage-mediated transduction, and cell-cell conjugation.  Bacteria that are naturally competent are capable of efficiently taking up naked DNA from the environment.  If homologous, this DNA undergoes recombination with the
genome of the cell, resulting in genetic exchange.  Bacillus subtilis, the primary production organism of the enzyme industry, is known for the efficiency with which it carries out this process.


In generalized transduction, a bacteriophage mediates genetic exchange.  A transducing phage will often package headfulls of the host genome.  These phage can infect a new host and deliver a fragment of the former host genome which is frequently
integrated via homologous recombination.  Cells can also transfer DNA between themselves by conjugation.  Cells containing the appropriate mating factors transfer episomes as well as entire chromosomes to an appropriate acceptor cell where it can
recombine with the acceptor genome.  Conjugation resembles sexual recombination for microbes and can be intraspecific, interspecific, and intergeneric.  For example, an efficient means of transforming Streptomyces sp., a genera responsible for producing
many commercial antibiotics, is by the conjugal transfer of plasmids from Echerichia coli.


For many industrial microorganisms, knowledge of competence, transducing phage, or fertility factors is lacking.  Protoplast fusion has been developed as a versatile and general alternative to these natural methods of recombination.  Protoplasts
are prepared by removing the cell wall by treating cells with lytic enzymes in the presence of osmotic stabilizers.  In the presence of a fusogenic agent, such as polyethylene glycol (PEG), protoplasts are induced to fuse and form transient hybrids or
"fusants." During this hybrid state, genetic recombination occurs at high frequency allowing the genomes to reassort.  The final crucial step is the successful segregation and regeneration of viable cells from the fused protoplasts.  Protoplast fusion
can be intraspecific, interspecific, and intergeneric and has been applied to both prokaryotes and eukaryotes.  In addition, it is possible to fuse more than two cells, thus providing a mechanism for effecting poolwise recombination.  While no fertility
factors, transducing phages or competency development is needed for protoplast fusion, a method for the formation, fusing, and regeneration of protoplasts is typically optimized for each organism.  Protoplast fusion as applied to poolwise recombination
is described in more detail, supra.


One key to SIP is having an assay that can be dependably used to identify a few mutants out of thousands that have subtle increases in product yield.  The limiting factor in many assay formats is the uniformity of cell growth.  This variation is
the source of baseline variability in subsequent assays.  Inoculum size and culture environment (temperature/humidity) are sources of cell growth variation.  Automation of all aspects of establishing initial cultures and state-of-the-art temperature and
humidity controlled incubators are useful in reducing variability.


Mutant cells or spores are separated on solid media to produce individual sporulating colonies.  Using an automated colony picker (Q-bot, Genetix, U.K.), colonies are identified, picked, and 10,000 different mutants inoculated into 96 well
microtitre dishes containing two 3 mm glass balls/well.  The Q-bot does not pick an entire colony but rather inserts a pin through the center of the colony and exits with a small sampling of cells (or mycelia) and spores.  The time the pin is in the
colony, the number of dips to inoculate the culture medium, and the time the pin is in that medium each effect inoculum size, and each can be controlled and optimized.  The uniform process of the Q-bot decreases human handling error and increases the
rate of establishing cultures (roughly 10,000/4 hours).  These cultures are then shaken in a temperature and humidity controlled incubator.  The glass balls act to promote uniform aeration of cells and the dispersal of mycelial fragments similar to the
blades of a fermenter.  An embodiment of this procedure is further illustrated in FIG. 28, including an integrated system for the assay.


(a.) Prescreen


The ability to detect a subtle increase in the performance of a mutant over that of a parent strain relies on the sensitivity of the assay.  The chance of finding the organisms having an improvement is increased by the number of individual
mutants that can be screened by the assay.  To increase the chances of identifying a pool of sufficient size a prescreen that increases the number of mutants processed by 10-fold can be used.  The goal of the primary screen will be to quickly identify
mutants having equal or better product titres than the parent strain(s) and to move only these mutants forward to liquid cell culture.


The primary screen is an agar plate screen is analyzed by the Q-bot colony picker.  Although assays can be fundamentally different, many result, e.g., in the production of colony halos.  For example, antibiotic production is assayed on plates
using an overlay of a sensitive indicator strain, such as B. subtilis.  Antibiotic production is typically assayed as a zone of clearing (inhibited growth of the indicator organism) around the producing organism.  Similarly, enzyme production can be
assayed on plates containing the enzyme substrate, with activity being detected as a zone of substrate modification around the producing colony.  Product titre is correlated with the ratio of halo area to colony area.


The Q-bot or other automated system is instructed to only pick colonies having a halo ratio in the top 10% of the population i.e. 10,000 mutants from the 100,000 entering the plate prescreen.  This increases the number of improved clones in the
secondary assay and eliminates the wasted effort of screening knock-out and low producers.  This improves the "hit rate" of the secondary assay.


IV.  Promotion of Genetic Exchange


(1) General


Some methods of the invention effect recombination of cellular DNA by propagating cells under conditions inducing exchange of DNA between cells.  DNA exchange can be promoted by generally applicable methods such as electroporation, biolistics,
cell fusion, or in some instances, by conjugation, transduction, or agrobacterium mediated transfer and meiosis.  For example, Agrobacterium can transform S. cerevisiae with T-DNA, which is incorporated into the yeast genome by both homologous
recombination and a gap repair mechanism.  (Piers et al., Proc.  Natl.  Acad.  Sci.  USA 93(4), 1613-8 (1996)).


In some methods, initial diversity between cells (i.e., before genome exchange) is induced by chemical or radiation-induced mutagenesis of a progenitor cell type, optionally followed by screening for a desired phenotype.  In other methods,
diversity is natural as where cells are obtained from different individuals, strains or species.


In some shuffling methods, induced exchange of DNA is used as the sole means of effecting recombination in each cycle of recombination.  In other methods, induced exchange is used in combination with natural sexual recombination of an organism. 
In other methods, induced exchange and/or natural sexual recombination are used in combination with the introduction of a fragment library.  Such a fragment library can be a whole genome, a whole chromosome, a group of functionally or genetically linked
genes, a plasmid, a cosmid, a mitochondrial genome, a viral genome (replicative and nonreplicative) or specific or random fragments of any of these.  The DNA can be linked to a vector or can be in free form.  Some vectors contain sequences promoting
homologous or nonhomologous recombination with the host genome.  Some fragments contain double stranded breaks such as caused by shearing with glass beads, sonication, or chemical or enzymatic fragmentation, to stimulate recombination.


In each case, DNA can be exchanged between cells after which it can undergo recombination to form hybrid genomes.  Cells bearing hybrid genomes are screened for a desired phenotype, and cells having this phenotype are isolated.  These cells form
the starting materials for the next cycle of recombination in a recursive recombination/selection scheme.


One means of promoting exchange of DNA between cells is by fusion of cells, such as by protoplast fusion.  A protoplast results from the removal from a cell of its cell wall, leaving a membrane-bound cell that depends on an isotonic or hypertonic
medium for maintaining its integrity.  If the cell wall is partially removed, the resulting cell is strictly referred to as a spheroplast and if it is completely removed, as a protoplast.  However, here the term protoplast includes spheroplasts unless
otherwise indicated.


Protoplast fusion is described by Shaffner et al., Proc.  Natl.  Acad.  Sci.  USA 77, 2163 (1980) and other exemplary procedures are described by Yoakum et al., U.S.  Pat.  No. 4,608,339, Takahashi et al., U.S.  Pat.  No. 4,677,066 and Sambrooke
et al., at Ch.  16.  Protoplast fusion has been reported between strains, species, and genera (e.g., yeast and chicken erythrocyte).


Protoplasts can be prepared for both bacterial and eukaryotic cells, including mammalian cells and plant cells, by several means including chemical treatment to strip cell walls.  For example, cell walls can be stripped by digestion with a cell
wall degrading enzyme such as lysozyme in a 10-20% sucrose, 50 mM EDTA buffer.  Conversion of cells to spherical protoplasts can be monitored by phase-contrast microscopy.  Protoplasts can also be prepared by propagation of cells in media supplemented
with an inhibitor of cell wall synthesis, or use of mutant strains lacking capacity for cell wall formation.  Preferably, eukaryotic cells are synchronized in G1 phase by arrest with inhibitors such as .alpha.-factor, K. lactis killer toxin, leflonamide
and adenylate cyclase inhibitors.  Optionally, some but not all, protoplasts to be fused can be killed and/or have their DNA fragmented by treatment with ultraviolet irradiation, hydroxylamine or cupferon (Reeves et al., FEMS Microbiol.  Lett.  99,
193-198 (1992)).  In this situation, killed protoplasts are referred to as donors, and viable protoplasts as acceptors.  Using dead donors cells can be advantageous in subsequently recognizing fused cells with hybrid genomes, as described below. 
Further, breaking up DNA in donor cells is advantageous for stimulating recombination with acceptor DNA.  Optionally, acceptor and/or fused cells can also be briefly, but nonlethally, exposed to uv irradiation further to stimulate recombination.


Once formed, protoplasts can be stabilized in a variety of osmolytes and compounds such as sodium chloride, potassium chloride, sodium phosphate, potassium phosphate, sucrose, sorbitol in the presence of DTT.  The combination of buffer, pH,
reducing agent, and osmotic stabilizer can be optimized for different cell types.  Protoplasts can be induced to fuse by treatment with a chemical such as PEG, calcium chloride or calcium propionate or electrofusion (Tsoneva, Acta Microbiologica Bulgaria
24, 53-59 (1989)).  A method of cell fusion employing electric fields has also been described.  See Chang U.S.  Pat.  No. 4,970,154.  Conditions can be optimized for different strains.


The fused cells are heterokaryons containing genomes from two component protoplasts.  Fused cells can be enriched from unfused parental cells by sucrose gradient sedimentation or cell sorting.  The two nuclei in the heterokaryons can fuse
(karyogamy) and homologous recombination can occur between the genomes.  The chromosomes can also segregate asymmetrically resulting in regenerated protoplasts that have lost or gained whole chromosomes.  The frequency of recombination can be increased
by treatment with ultraviolet irradiation or by use of strains overexpressing recA or other recombination genes, or the yeast rad genes, and cognate variants thereof in other species, or by the inhibition of gene products of MutS, MutL, or MutD. 
Overexpression can be either the result of introduction of exogenous recombination genes or the result of selecting strains, which as a result of natural variation or induced mutation, overexpress endogenous recombination genes.  The fused protoplasts
are propagated under conditions allowing regeneration of cell walls, recombination and segregation of recombinant genomes into progeny cells from the heterokaryon and expression of recombinant genes.  After, or occasionally before or during, recovery of
fused cells, the cells are screened or selected for evolution toward a desired property.


Thereafter a subsequent round of recombination can be performed by preparing protoplasts from the cells surviving selection/screening in a previous round.  The protoplasts are fused, recombination occurs in fused protoplasts, and cells are
regenerated from the fused protoplasts.  Protoplasts, regenerated or regenerating cells are subject to further selection or screening.


Alternatively, a subsequent round of recombination can be performed on a split pool basis as described above.  That is, a first subpopulation of cells surviving selection/screening from a previous round are used for protoplast formation.  A
second subpopulation of cells surviving selection/screening from a previous round are used as a source for DNA library preparation.  The DNA library from the second subpopulation of cells is then transformed into the protoplasts from the first
subpopulation.  The library undergoes recombination with the genomes of the protoplasts to form recombinant genomes.  Cells are regenerated from protoplasts, and selection/screening is applied to regenerating or regenerated cells.  In a further
variation, a fresh library of nucleic acid fragments is introduced into protoplasts surviving selection/screening from a previous round.


An exemplary format for shuffling using protoplast fusion is shown in FIG. 5.  The figure shows the following steps: protoplast formation of donor and recipient strains, heterokaryon formation, karyogamy, recombination, and segregation of
recombinant genomes into separate cells.  Optionally, the recombinant genomes, if having a sexual cycle, can undergo further recombination with each other as a result of meiosis and mating.  Cells are then screened or selected for a desired property. 
Cells surviving selection/screening are then used as the starting materials in a further cycle of protoplasting.


2.  Selection For Hybrid Strains


The invention provides selection strategies to identify cells formed by fusion of components from parental cells from two or more distinct subpopulations.  Selection for hybrid cells is usually performed before selecting or screening for cells
that have evolved (as a result of genetic exchange) to acquisition of a desired property.  A basic premise of most such selection schemes is that two initial subpopulations have two distinct markers.  Cells with hybrid genomes can thus be identified by
selection for both markers.


In one such scheme, at least one subpopulation of cells bears a selective marker attached to its cell membrane.  Examples of suitable membrane markers include biotin, fluorescein and rhodamine.  The markers can be linked to amide or thiol groups
or through more specific derivatization chemistries, such as iodo-acetates, iodoacetamides, maleimides.  For example, a marker can be attached as follows.  Cells or protoplasts are washed with a buffer (e.g., PBS), which does not interfere with the
chemical coupling of a chemically active ligand which reacts with amino groups of lysines or N-terminal aminogroups of membrane proteins.  The ligand is either amine reactive itself (e.g., isothiocyanates, succinimidyl esters, sulfonyl chlorides) or is
activated by a heterobifunctional linker (e.g. EMCS, SIAB, SPDP, SMB) to become amine reactive.  The ligand is a molecule which is easily bound by protein derivatized magnetic beads or other capturing solid supports.  For example, the ligand can be
succinimidyl activated biotin (Molecular probes: B-1606, B-2603, S-1515, S-1582).  This linker is reacted with aminogroups of proteins residing in and on the surface of a cell.  The cells are then washed to remove excess labelling agent before contacting
with cells from the second subpopulation bearing a second selective marker.


The second subpopulation of cells can also bear a membrane marker, albeit a different membrane marker from the first subpopulation.  Alternatively, the second subpopulation can bear a genetic marker.  The genetic marker can confer a selective
property such as drug resistance or a screenable property, such as expression of green fluorescent protein.


After fusion of first and second subpopulations of cells and recovery, cells are screened or selected for the presence of markers on both parental subpopulations.  For example, fusants are enriched for one population by adsorbtion to specific
beads and these are then sorted by FACS for those expressing a marker.  Cells surviving both screens for both markers are those having undergone protoplast fusion, and are therefore more likely to have recombined genomes.  Usually, the markers are
screened or selected separately.  Membrane-bound markers, such as biotin, can be screened by affinity enrichment for the cell membrane marker (e.g., by panning fused cells on an affinity matrix).  For example, for a biotin membrane label, cells can be
affinity purified using streptavidin-coated magnetic beads (Dynal).  These beads are washed several times to remove the non-fused host cells.  Alternatively, cells can be panned against an antibody to the membrane marker.  In a further variation, if the
membrane marker is fluorescent, cells bearing the marker can be identified by FACS.  Screens for genetic markers depend on the nature of the markers, and include capacity to grow on drug-treated media or FACS selection for green fluorescent protein.  If
first and second cell populations have fluorescent markers of different wavelengths, both markers can be screened simultaneously by FACS sorting.


In a further selection scheme for hybrid cells, first and second populations of cells to be fused express different subunits of a heteromultimeric enzyme.  Usually, the heteromultimeric enzyme has two different subunits, but heteromultimeric
enzymes having three, four or more different subunits can be used.  If an enzyme has more than two different subunits, each subunit can be expressed in a different subpopulation of cells (e.g., three subunits in three subpopulations), or more than one
subunit can be expressed in the same subpopulation of cells (e.g., one subunit in one subpopulation, two subunits in a second subpopulation).  In the case where more than two subunits are used, selection for the poolwise recombination of more than two
protoplasts can be achieved.


Hybrid cells representing a combination of genomes of first, second or more subpopulation component cells can then be recognized by an assay for intact enzyme.  Such an assay can be a binding assay, but is more typically a functional assay (e.g.,
capacity to metabolize a substrate of the enzyme).  Enzymatic activity can be detected for example by processing of a substrate to a product with a fluorescent or otherwise easily detectable emission spectrum.  The individual subunits of a
heteromultimeric enzyme used in such an assay preferably have no enzymic activity in dissociated form, or at least have significantly less activity in dissociated form than associated form.  Preferably, the cells used for fusion lack an endogenous form
of the heteromultimeric enzyme, or at least have significantly less endogenous activity than results from heteromultimeric enzyme formed by fusion of cells.


Penicillin acylase enzymes, cephalosporin acylase and penicillin acyltransferase are examples of suitable heteromultimeric enzymes.  These enzymes are encoded by a single gene, which is translated as a proenzyme and cleaved by posttranslational
autocatalytic proteolysis to remove a spacer endopeptide and generate two subunits, which associate to form the active heterodimeric enzyme.  Neither subunit is active in the absence of the other subunit.  However, activity can be reconstituted if these
separated gene portions are expressed in the same cell by co-transformation.  Other enzymes that can be used have subunits that are encoded by distinct genes (e.g., faoA and faoB genes encode 3-oxoacyl-CoA thiolase of Pseudonmonas fragi (Biochem.  J 328,
815-820 (1997)).


An exemplary enzyme is penicillin G acylase from Escherichia coli, which has two subunits encoded by a single gene.  Fragments of the gene encoding the two subunits operably linked to appropriate expression regulation sequences are transfected
into first and second subpopulations of cells, which lack endogenous penicillin acylase activity.  A cell formed by fusion of component cells from the first and second subpopulations expresses the two subunits, which assemble to form functional enzyme,
e.g., penicillin acylase.  Fused cells can then be selected on agar plates containing penicillin G, which is degraded by penicillin acylase.


In another variation, fused cells are identified by complementation of auxotrophic mutants.  Parental subpopulations of cells can be selected for known auxotrophic mutations.  Alternatively, auxotrophic mutations in a starting population of cells
can be generated spontaneously by exposure to a mutagenic agent.  Cells with auxotrophic mutations are selected by replica plating on minimal and complete media.  Lesions resulting in auxotrophy are expected to be scattered throughout the genome, in
genes for amino acid, nucleotide, and vitamin biosynthetic pathways.  After fusion of parental cells, cells resulting from fusion can be identified by their capacity to grow on minimal media.  These cells can then be screened or selected for evolution
toward a desired property.  Further steps of mutagenesis generating fresh auxotrophic mutations can be incorporated in subsequent cycles of recombination and screening/selection.


In variations of the above method, de novo generation of auxotrophic mutations in each round of shuffling can be avoided by reusing the same auxotrophs.  For example, auxotrophs can be generated by transposon mutagenesis using a transposon
bearing selective marker.  Auxotrophs are identified by a screen such as replica plating.  Auxotrophs are pooled, and a generalized transducing phage lysate is prepared by growth of phage on a population of auxotrophic cells.  A separate population of
auxtrophic cells is subjected to genetic exchange, and complementation is used to selected cells that have undergone genetic exchange and recombination.  These cells are then screened or selected for acquisition of a desired property.  Cells surviving
screening or selection then have auxotrophic markers regenerated by introduction of the transducing transposon library.  The newly generated auxotrophic cells can then be subject to further genetic exchange and screening/selection.


In a further variation, auxotrophic mutations are generated by homologous recombination with a targeting vector comprising a selective marker flanked by regions of homology with a biosynthetic region of the genome of cells to be evolved. 
Recombination between the vector and the genome inserts the positive selection marker into the genome causing an auxotrophic mutation.  The vector is in linear form before introduction of cells.  Optionally, the frequency of introduction of the vector
can be increased by capping its ends with self-complementarity oligonucleotides annealed in a hair pin formation.  Genetic exchange and screening/selection proceed as described above.  In each round, targeting vectors are reintroduced regenerating the
same population of auxotrophic markers.


In another variation, fused cells are identified by screening for a genomic marker present on one subpopulation of parental cells and an episomal marker present on a second subpopulation of cells.  For example, a first subpopulation of yeast
containing mitochondria can be used to complement a second subpopulation of yeast having a petite phenotype (i.e., lacking mitochondria).


In a further variation, genetic exchange is performed between two subpopulations of cells, one of which is dead.  Cells are preferably killed by brief exposure to DNA fragmenting agents such as hydroxylamine, cupferon, or irradiation.  Viable
cells are then screened for a marker present on the dead parental subpopulation.


3.  Liposome-Mediated Transfers


In the methods noted above, in which nucleic acid fragment libraries are introduced into protoplasts, the nucleic acids are sometimes encapsulated in liposomes to facilitate uptake by protoplasts.  Lipsome-mediated uptake of DNA by protoplasts is
described in Redford et al., Mol. Gen.  Genet.  184, 567-569 (1981).  Liposomes can efficiently deliver large volumes of DNA to protoplasts (see Deshayes et al., EMBO J. 4, 2731-2737 (1985)).  See also, Philippot and Schuber (eds) (1995) Liposomes as
Tools in Basic Research and Industry CRC press, Boca Raton, e.g., Chapter 9, Remy et al. "Gene Transfer with Cationic Amphiphiles." Further, the DNA can be delivered as linear fragments, which are often more recombinogenic that whole genomes.  In some
methods, fragments are mutated prior to encapsulation in liposomes.  In some methods, fragments are combined with RecA and homologs, or nucleases (e.g., restriction endonucleases) before encapsulation in liposomes to promote recombination.


4.  Shuffling Filamentous Fungi


Filamentous fungi are particularly suited to performing the shuffling methods described above.  Filamentous fungi are divided into four main classifications based on their structures for sexual reproduction: Phycomycetes, Ascomycetes,
Basidiomycetes and the Fungi Imperfecti.  Phycomycetes (e.g., Rhizopus, Mucor) form sexual spores in sporangium.  The spores can be uni or multinucleate and often lack septated hyphae (coenocytic).  Ascomycetes (e.g., Aspergillus, Neurospora, Penicillum)
produce sexual spores in an ascus as a result of meiotic division.  Asci typically contain 4 meiotic products, but some contain 8 as a result of additional mitotic division.  Basidiomycetes include mushrooms, and smuts and form sexual spores on the
surface of a basidium.  In holobasidiomycetes, such as mushrooms, the basidium is undivided.  In hemibasidiomycetes, such as ruts (Uredinales) and smut fungi (Ustilaginales), the basidium is divided.  Fungi imperfecti, which include most human pathogens,
have no known sexual stage.


Fungi can reproduce by asexual, sexual or parasexual means.  Asexual reproduction, involves vegetative growth of mycelia, nuclear division and cell division without involvement of gametes and without nuclear fusion.  Cell division can occur by
sporulation, budding or fragmentation of hyphae.


Sexual reproduction provides a mechanism for shuffling genetic material between cells.  A sexual reproductive cycle is characterized by an alteration of a haploid phase and a diploid phase.  Diploidy occurs when two haploid gamete nuclei fuse
(karyogamy).  The gamete nuclei can come from the same parental strains (self-fertile), such as in the homothallic fungi.  In heterothallic fungi, the parental strains come from strains of different mating type.


A diploid cell converts to haploidy via meiosis, which essentially consists of two divisions of the nucleus accompanied by one division of the chromosomes.  The products of one meiosis are a tetrad (4 haploid nuclei).  In some cases, a mitotic
division occurs after meiosis, giving rise to eight product cells.  The arrangement of the resultant cells (usually enclosed in spores) resembles that of the parental strains.  The length of the haploid and diploid stages differs in various fungi: for
example, the Basidiomycetes and many of the Ascomycetes have a mostly hapolid life cycle (that is, meiosis occurs immediately after karyogamy), whereas others (e.g., Saccharomyces cerevisiae) are diploid for most of their life cycle (karyogamy occurs
soon after meiosis).  Sexual reproduction can occur between cells in the same strain (selfing) or between cells from different strains (outcrossing).


Sexual dimorphism (dioecism) is the separate production of male and female organs on different mycelia.  This is a rare phenomenon among the fungi, although a few examples are known.  Heterothallism (one locus-two alleles) allows for outcrossing
between crosscompatable strains which are self-incompatable.  The simplest form is the two allele-one locus system of mating types/factors, illustrated by the following organisms:


A and a in Neurospora


a and .alpha.  in Saccharomyces


plus and minus in Schizzosaccharomyces and Zygomycetes


a.sub.1 and a.sub.2 in Ustilago


Multiple-allelomorph heterothallism is exhibited by some of the higher Basidiomycetes (e.g. Gasteromycetes and Hymenomycetes), which are heterothallic and have several mating types determined by multiple alleles.  Heterothallism in these
organisms is either bipolar with one mating type factor, or tetrapolar with two unlinked factors, A and B. Stable, fertile heterokaryon formation depends on the presence of different A factors and, in the case of tetrapolar organisms, of different B
factors as well.  This system is effective in the promotion of outbreeding and the prevention of self-breeding.  The number of different mating factors may be very large (i.e. thousands) (Kothe, FEMS Microbiol.  Rev.  18, 65-87 (1996)), and non-parental
mating factors may arise by recombination.


Parasexual reproduction provides a further means for shuffling genetic material between cells.  This process allows recombination of parental DNA without involvement of mating types or gametes.  Parasexual fusion occurs by hyphal fusion giving
rise to a common cytoplasm containing different nuclei.  The two nuclei can divide independently in the resulting heterokaryon but occasionally fuse.  Fusion is followed by haploidization, which can involve loss of chromosomes and mitotic crossing over
between homolgous chromosomes.  Protoplast fusion is a form of parasexual reproduction.


Within the above four classes, fungi are also classified by vegetative compatibility group.  Fungi within a vegetative compatibility group can form heterokaryons with each other.  Thus, for exchange of genetic material between different strains
of fungi, the fungi are usually prepared from the same vegetative compatibility group.  However, some genetic exchange can occur between fungi from different incompatibility groups as a result of parasexual reproduction (see Timberlake et al., U.S.  Pat. No. 5,605,820).  Further, as discussed elsewhere, the natural vegetative compatibility group of fungi can be expanded as a result of shuffling.


Several isolates of Aspergillus nidulans, A. flavus, A. fumigatus, Penicillium chrysogenum, P. notatum, Cephalosporium chrysogenum, Neurospora crassa, Aureobasidium pullulans have been karyotyped.  Genome sizes generally range between 20 and 50
Mb among the Aspergilli.  Differences in karyotypes often exist between similar strains and are also caused by transformation with exogenous DNA.  Filamentous fungal genes contain introns, usually .about.50-100 bp in size, with similar consensus 5' and
3' splice sequences.  Promotion and termination signals are often cross-recognizable, enabling the expression of a gene/pathway from one fungus (e.g. A. nidulans) in another (e.g. P. chrysogenum).


The major components of the fungal cell wall are chitin (or chitosan), .beta.-glucan, and mannoproteins.  Chitin and .beta.-glucan form the scaffolding, mannoproteins are interstitial components which dictate the wall's porosity, antigenicity and
adhesion.  Chitin synthetase catalyzes the polymerization of .beta.-(1,4)-linked N-acetylglucosamine (GIcNAc) residues, forming linear strands running antiparallel; .beta.-(1,3)-glucan synthetase catalyze the homopolymerization of glucose.


One general goal of shuffling is to evolve fungi to become useful hosts for genetic engineering, in particular for the shuffling of unrelated genes.  A. nidulans is generally the fungal organism of choice to serve as a host for such manipulations
because of its sexual cycle and well-established use in classical and molecular genetics.  Another general goal is to improve the capacity of fungi to make specific compounds (e.g. antibacterials (penicillins, cephalosporins), antifungals (e.g.
echinocandins, aureobasidins), and wood-degrading enzymes).  There is some overlap between these general goals, and thus, some desired properties are useful for achieving both goals.


One desired property is the introduction of meiotic apparatus into fungi presently lacking a sexual cycle (see Sharon et al., Mol. Gen.  Genet.  251, 60-68 (1996)).  A scheme for introducing a sexual cycle into the fungi P. chrysogenum (a fungus
imperfecti) is shown in FIG. 6.  Subpopulations of protoplasts are formed from A. nidulans (which has a sexual cycle) and P. chrysogenum, which does not.  The two strains preferably bear different markers.  The A. nidulans protoplasts are killed by
treatment with uv or hydroxylamine.  The two subpopulations are fused to form heterokaryons.  In some heterokaryons, nuclei fuse, and some recombination occurs.  Fused cells are cultured under conditions to generate new cell walls and then to allow
sexual recombination to occur.  Cells with recombinant genomes are then selected (e.g., by selecting for complementation of auxotrophic markers present on the respective parent strains).  Cells with hybrid genomes are more likely to have acquired the
genes necessary for a sexual cycle.  Protoplasts of cells can then be crossed with killed protoplasts of a further population of cells known to have a sexual cycle (the same or different as the previous round) in the same manner, followed by selection
for cells with hybrid genomes.


Another desired property is the production of a mutator strain of fungi.  Such a fungus can be produced by shuffling a fungal strain containing a marker gene with one or more mutations that impair or prevent expression of a functional product. 
Shufflants are propagated under conditions that select for expression of the positive marker (while allowing a small amount of residual growth without expression).  Shufflants growing fastest are selected to form the starting materials for the next round
of shuffling.


Another desired property is to expand the host range of a fungus so it can form heterokaryons with fungi from other vegetative compatibility groups.  Incompatability between species results from the interactions of specific alleles at different
incompatability loci (such as the "het" loci).  If two strains undergo hyphal anastomosis, a lethal cytoplasmic incomparability reaction may occur if the strains differ at these loci.  Strains must carry identical loci to be entirely compatible.  Several
of these loci have been identified in various species, and the incompatibility effect is somewhat additive (hence, "partial incompatibility" can occur).  Some tolerant and het-negative mutants have been described for these organisms (e.g. Dales & Croft,
J. Gen.  Microbiol.  136, 1717-1724 (1990)).  Further, a tolerance gene (tol) has been reported, which suppresses mating-type heterokaryon incompatibility.  Shuffling is performed between protoplasts of strains from different incompatibility groups.  A
preferred format uses a live acceptor strain and a UV-irradiated dead acceptor strain.  The UV irradiation serves to introduce mutations into DNA inactivating het genes.  The two strains should bear different genetic markers.  Protoplasts of the strain
are fused, cells are regenerated and screened for complementation of markers.  Subsequent rounds of shuffling and selection can be performed in the same manner by fusing the cells surviving screening with a protoplasts of a fresh population of donor
cells.


Another desired property is the introduction of multiple-allelomorph heterothallism into Ascomycetes and Fungi imperfecti, which do not normally exhibit this property.  This mating system allows outbreeding without self-breeding.  Such a mating
system can be introduced by shuffling Ascomycetes and Fungi imperfecti with DNA from Gasteromycetes or Hymenomycetes, which have such a system.


Another desired property is spontaneous formation of protoplasts to facilitate use of a fungal strain as a shuffling host.  Here, the fungus to be evolved is typically mutagenized.  Spores of the fungus to be evolved are briefly treated with a
cell-wall degrading agent for a time insufficient for complete protoplast formation, and are mixed with protoplasts from other strain(s) of fungi.  Protoplasts formed by fusion of the two different subpopulations are identified by genetic or other
selection/or screening as described above.  These protoplasts are used to regenerate mycelia and then spores, which form the starting material for the next round of shuffling.  In the next round, at least some of the surviving spores are treated with
cell-wall removing enzyme but for a shorter time than the previous round.  After treatment, the partially stripped cells are labelled with a first label.  These cells are then mixed with protoplasts, which may derive from other cells surviving selection
in a previous round, or from a fresh strain of fungi.  These protoplasts are physically labelled with a second label.  After incubating the cells under conditions for protoplast fusion fusants with both labels are selected.  These fusants are used to
generate mycelia and spores for the next round of shuffling, and so forth.  Eventually, progeny that spontaneously form protoplasts (i.e., without addition of cell wall degrading agent) are identified.


Another desired property is the acquisition and/or improvement of genes encoding enzymes in biosynthetic pathways, genes encoding transporter proteins, and genes encoding proteins.  involved in metabolic flux control.  In this situation, genes of
the pathway can be introduced into the fungus to be evolved either by genetic exchange with another strain of fungus possessing the pathway or by introduction of a fragment library from an organism possessing the pathway.  Genetic material of these fungi
can then be subjected to further shuffling and screening/selection by the various procedures discussed in this application.  Shufflant strains of fungi are selected/screened for production of the compound produced by the metabolic pathway or precursors
thereof.


Another desired property is increasing the stability of fungi to extreme conditions such as heat.  In this situation, genes conferring stability can be acquired by exchanging DNA with or transforming DNA from a strain that already has such
properties.  Alternatively, the strain to be evolved can be subjected to random mutagenesis.  Genetic material of the fungus to be evolved can be shuffled by any of the procedures described in this application, with shufflants being selected by surviving
exposure to extreme conditions.


Another desired property is capacity of a fungus to grow under altered nutritional requirements (e.g., growth on particular carbon or nitrogen sources).  Altering nutritional requirements is particularly valuable, e.g., for natural isolates of
fungi that produce valuable commercial products but have esoteric and therefore expensive nutritional requirement.  The strain to be evolved undergoes genetic exchange and/or transformation with DNA from a strain that has the desired nutritional
requirements.  The fungus to be evolved can then optionally be subjected to further shuffling as described in this application and with recombinant strains being selected for capacity to grow in the desired nutritional circumstances.  Optionally, the
nutritional circumstances can be varied in successive rounds of shuffling starting at close to the natural requirements of the fungus to be evolved and in subsequent rounds approaching the desired nutritional requirements.


Another desired property is acquisition of natural competence in a fungus.  The procedure for acquisition of natural competence by shuffling is generally described in PCT/US97/04494.  The fungus to be evolved typically undergoes genetic exchange
or transformation with DNA from a bacterial strain or fungal strain that already has this property.  Cells with recombinant genomes are then selected by capacity to take up a plasmid bearing a selective marker.  Further rounds of recombination and
selection can be performed using any of the procedures described above.


Another desired property is reduced or increased secretion of proteases and DNase.  In this situation, the fungus to be evolved can acquire DNA by exchange or transformation from another strain known to have the desired property.  Alternatively,
the fungus to be evolved can be subject to random mutagenesis.  The fungus to be evolved is shuffled as above.  Before selection/screening isolates, pooled isolates of fungi are typically lysed to release proteases or DNase to the surrounding media.  The
presence of such enzymes, or lack thereof, can be assayed by contacting the media with a fluorescent molecule tethered to a support via a peptide or DNA linkage.  Cleavage of the linkage releases detectable fluorescence to the media.


Another desired property is producing fungi with altered transporters (e.g., MDR).  Such altered transporters are useful, for example, in fungi that have been evolved to produce new secondary metabolites, to allow entry of precursors required for
synthesis of the new secondary metabolites into a cell, or to allow efflux of the secondary metabolite from the cell.  Transporters can be evolved by introduction of a library of transporter variants into a fungal cells and allowing the cells to
recombine by sexual or parasexual recombination.  To evolve a transporter with capacity to transport a precursor into the cells, cells are propagated in the present of precursor, and cells are then screened for production of metabolite.  To evolve a
transporter with capacity to export a metabolite, cells are propagated under conditions supporting production of the metabolite, and screened for export of metabolite to culture medium.


A general method of fungal shuffling is shown in FIG. 7.  Spores from a frozen stock, a lyophilized stock, or fresh from an agar plate are used to inoculate suitable liquid medium (1).  Spores are germinated resulting in hyphal growth (2). 
Mycelia are harvested, and washed by filtration and/or centrifugation.  Optionally the sample is pretreated with DTT to enhance protoplast formation (3).  Protoplasting is performed in an osmotically stabling medium (e.g., 1 m NaCl/20 mM MgSO4, pH 5.8)
by the addition of cell wall-degrading enzyme (e.g., Novozyme 234) (4).  Cell wall degrading enzyme is removed by repeated washing with osmotically stabilizing solution (5).  Protoplasts can be separated from mycelia, debris and spores by filtration
through miracloth, and density centrifugation (6).  Protoplasts are harvested by centrifugation and resuspended to the appropriate concentration.  This step may lead to some protoplast fusion (7).  Fusion can be stimulated by addition of PEG (e.g., PEG
3350), and/or repeated centrifugation and resuspension with or without PEG.  Electrofusion can also be performed (8).  Fused protoplasts can optionally be enriched from unfused protoplasts by sucrose gradient sedimentation (or other methods of screening
described above).  Fused protoplasts can optionally be treated with ultraviolet irradiation to stimulate recombination (9).  Protoplasts are cultured on osmotically stabilized agar plates to regenerate cell walls and form mycelia (10).  The mycelia are
used to generate spores (11), which are used as the starting material in the next round of shuffling (12).  Selection for a desired property can be performed either on regenerated mycelia or spores derived therefrom.


In an alternative method, protoplasts are formed by inhibition of one or more enzymes required for cell wall synthesis (see FIG. 8).  The inhibitor should be fungistatic rather than fungicidal under the conditions of use.  Examples of inhibitors
include antifungal compounds described by (e.g., Georgopapadakou & Walsh, Antimicrob.  Ag.  Chemother.  40, 279-291 (1996); Lyman & Walsh, Drugs 44, 9-35 (1992)).  Other examples include chitin synthase inhibitors (polyoxin or nikkomycin compounds)
and/or glucan synthase inhibitors (e.g. echinocandins, papulocandins, pneumocandins).  Inhibitors should be applied in osmotically stabilized medium.  Cells stripped of their cell walls can be fused or otherwise employed as donors or hosts in genetic
transformation/strain development programs.  A possible scheme utilizing this method reiteratively is outlined in FIG. 8.


In a further variation, protoplasts are prepared using strains of fungi, which are genetically deficient or compromised in their ability to synthesize intact cell walls (see FIG. 9).  Such mutants are generally referred to as fragile,
osmotic-remedial, or cell wall-less, and are obtainable from strain depositories.  Examples of such strains include Neurospora crassa os mutants (Selitrennikoff, Antimicrob.  Agents.  Chemother.  23, 757-765 (1983)).  Some such mutations are
temperature-sensitive.  Temperature-sensitive strains can be propagated at the permissive temperature for purposes of selection and amplification and at a nonpermissive temperature for purposes of protoplast formation and fusion.  A temperature sensitive
strain Neurospora crassa os strain has been described which propagates as protoplasts when growth in osmotically stabilizing medium containing sorbose and polyoxin at nonpermissive temperature but generates whole cells on transfer to medium containing
sorbitol at a permissive temperature.  See U.S.  Pat.  No. 4,873,196.


Other suitable strains can be produced by targeted mutagenesis of genes involved in chitin synthesis, glucan synthesis and other cell wall-related processes.  Examples of such genes include CHT1, CHT2 and CALI (or CSD2) of Saccharomyces
cerevisiae and Candida spp.  (Georgopapadakou & Walsh 1996); ETGI/FKSI/CNDI/CWH53/PB RI and homologs in S. cerevisiae, Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus, ChvAINdvA Agrobacterium and Rhizobium.  Other examples are MA, orlB,
orIC, MD, tsE, and bimG of Aspergillus nidulans (Borgia, J. Bacteriol.  174, 377-389 (1992)).  Strains of A. nidulans containing OrlAI or tsel mutations lyse at restrictive temperatures.  Lysis of these strains may be prevented by osmotic stabilization,
and the mutations may be complemented by the addition of N-acetylglucosimine (GlcNac).  BimG11 mutations are ts for a type 1 protein phosphatase (germlines of strains carrying this mutation lack chitin, and condia swell and lyse).  Other suitable genes
are chsA, chsB, chsC, chsD and chsE of Aspergillus fumigatus; chs1 and chs2 of Neurospora crassa; Phycomyces blakesleeanus MM and chs1, 2 and 3 of S. cerevisiae.  Chs1 is a non-essential repair enzyme; chs2 is involved in septum formation and chs3 is
involved in cell wall maturation and bud ring formation.


Other useful strains include S. cerevisiae CLY (cell lysis) mutants such as ts strains (Paravicini et al., Mol. Cell Biol.  12, 4896-4905 (1992)), and the CLY 15 strain which harbors a PKC 1 gene deletion.  Other useful strains include strain VY
1160 containing a ts mutation in srb (encoding actin) (Schade et al. Acta Histochem.  Suppl.  41, 193-200 (1991)), and a strain with an ses mutation which results in increased sensitivity to cell-wall digesting enzymes isolated from snail gut (Metha &
Gregory, Appl.  Environ.  Microbiol.  41, 992-999 (1981)).  Useful strains of C. albicans include those with mutations in chs1, chs2, or chs3 (encoding chitin synthetases), such as osmotic remedial conditional lethal mutants described by Payton & de
Tiani, Curr.  Genet.  17, 293-296 (1990); C. utilis mutants with increased sensitivity to cell-wall digesting enzymes isolated from snail gut (Metha & Gregory, 1981, supra); and N. crassa mutants os-1, os-2, os-3, os-4, os-5, amd os-6.  See,
Selitrennikoff, Antimicrob.  Agents Chemother.  23, 757-765 (1983).  Such mutants grow and divide without a cell wall at 37.degree.  C., but at 22.degree.  C. produce a cell wall.


Targeted mutagenesis can be achieved by transforming cells with a positive-negative selection vector containing homologous regions flanking a segment to be targeted, a positive selection marker between the homologous regions and a negative
selection marker outside the homologous regions (see Capecchi, U.S.  Pat.  No. 5,627,059).  In a variation, the negative selection marker can be an antisense transcript of the positive selection marker (see U.S.  Pat.  No. 5,527,674).


Other suitable cells can be selected by random mutagenesis or shuffling procedures in combination with selection.  For example, a first subpopulation of cells are mutagenized, allowed to recover from mutagenesis, subjected to incomplete
degradation of cell walls and then contacted with protoplasts of a second subpopulation of cells.  Hybrids cells bearing markers from both subpopulations are identified (as described above) and used as the starting materials in a subsequent round of
shuffling.  This selection scheme selects both for cells with capacity for spontaneous protoplast formation and for cells with enhanced recombinogenicity.


In a further variation, cells having capacity for spontaneous protoplast formation can be crossed with cells having enhanced recombinogenicity evolved using other methods of the invention.  The hybrid cells are particularly suitable hosts for
whole genome shuffling.


Cells with mutations in enzymes involved in cell wall synthesis or maintenance can undergo fusion simply as a result of propagating the cells in osmotic-protected culture due to spontaneous protoplast formation.  If the mutation is conditional,
cells are shifted to a nonpermissive condition.  Protoplast formation and fusion can be accelerated by addition of promoting agents, such as PEG or an electric field (See Philipova & Venkov, Yeast 6, 205-212 (1990); Tsoneva et al., FEMS Microbiol.  Lett. 51, 61-65 (1989)).


5.  Shuffling Methods in Yeast


Yeasts are subspecies of fungi that grow as single cells.  Yeasts are used for the production of fermented beverages and leavening, for production of ethanol as a fuel, low molecular weight compounds, and for the heterologous production of
proteins and enzymes (see accompanying list of yeast strains and their uses).  Commonly used strains of yeast include Saccharomyces cerevisiae, Pichia sp., Canidia sp.  and Schizosaccharomyces pombe.


Several types of vectors are available for cloning in yeast including integrative plasmid (YIp), yeast replicating plasmid (YRp, such as the 21.mu.  circle based vectors), yeast episomal plasmid (YEp), yeast centromeric plasmid (YCp), or yeast
artificial chromosome (YAC).  Each vector can carry markers useful to select for the presence of the plasmid such as LUE2, URA3, and H1S3, or the absence of the plasmid such as URA3 (a gene that is toxic to cells grown in the presence of 5-fluoro orotic
acid.


Many yeasts have a sexual cycle and asexual (vegetative) cycles.  The sexual cycle involves the recombination of the whole genome of the organism each time the cell passes through meiosis.  For example, when diploid cells of S. cerevisiae are
exposed to nitrogen and carbon limiting conditions, diploid cells undergo meiosis to form asci.  Each ascus holds four haploid spores, two of mating type "a" and two of mating type ".alpha.." Upon return to rich medium, haploid spores of opposite mating
type mate to form diploid cells once again.  Asci of opposite mating type can mate within the ascus, or if the ascus is degraded, for example with zymolase, the haploid cells can mate with spores from other asci.  This sexual cycle provides a format to
shuffle endogenous genomes of yeast and/or exogenous fragment libraries inserted into yeast vectors.  This process results in swapping or accumulation of hybrid genes, and for the shuffling of homologous sequences shared by mating cells.


Yeast strains having mutations in several known genes have properties useful for shuffling.  These properties include increasing the frequency of recombination and increasing the frequency of spontaneous mutations within a cell.  These properties
can be the result of mutation of a coding sequence or altered expression (usually overexpression) of a wildtype coding sequence.  The HO nuclease effects the transposition of HMLa/.alpha.  and HMRa/.alpha.  to the MAT locus resulting in mating type
switching.  Mutants in the gene encoding this enzyme do not switch their mating type and can be employed to force crossing between strains of defined genotype, such as ones that harbor a library or have a desired phenotype and to prevent in breeding of
starter strains.  PMS1, MLH1, MSH2, MSH6 are involved in mismatch repair.  Mutations in these genes all have a mutator phenotype (Chambers et al., Mol. Cell.  Biol.  16, 6110-6120 (1996)).  Mutations in TOP3 DNA topoisomerase have a 6-fold enhancement of
interchromosomal homologous recombination (Bailis et al., Molecular and Cellular Biology 12, 4988-4993 (1992)).  The RAD50-57 genes confer resistance to radiation.  Rad3 functions in excision of pyrimidine dimers.  RAD52 functions in gene conversion. 
RAD50, MRE11, XRS2 function in both homologous recombination and illegitimate recombination.  HOP1, RED1 function in early meiotic recombination (Mao-Draayer, Genetics 144, 71-86) Mutations in either HOP1 or RED1 reduce double stranded breaks at the HIS2
recombination hotspot.  Strains deficient in these genes are useful for maintaining stability in hyper recombinogenic constructs such as tandem expression libraries carried on YACs.  Mutations in HPR 1 are hyperrecombinogenic.  HDF1 has DNA end binding
activity and is involved in double stranded break repair and V(D)J recombination.  Strains bearing this mutation are useful for transformation with random genomic fragments by either protoplast fusion or electroporation.  Kar-1 is a dominant mutation
that prevents karyogamy.  Kar-1 mutants are useful for the directed transfer of single chromosomes from a donor to a recipient strain.  This technique has been widely used in the transfer of YACs between strains, and is also useful in the transfer of
evolved genes/chromosomes to other organisms (Markie, YAC Protocols, (Humana Press, Totowa, N.J., 1996).  HOT1 is an S. cerevisiae recombination hotspot within the promoter and enhancer region of the rDNA repeat sequences.  This locus induces mitotic
recombination at adjacent sequences-presumably due to its high level transcription.  Genes and/or pathways inserted under the transcriptional control of this region undergo increased mitotic recombination.  CDC2 encodes polymerase .delta.  and is
necessary for mitotic gene conversion.  Overexpression of this gene can be used in a shuffler or mutator strain A temperature sensitive mutation in CDC4 halts the cell cycle at G1 at the restrictive temperature and could be used to synchronize
protoplasts for optimized fusion and subsequent recombination.


As with filamentous fungi, the general goals of shuffling yeast include improvement in yeast as a host organism for genetic manipulation, and as a production apparatus for various compounds.  One desired property in either case is to improve the
capacity of yeast to express and secrete a heterologous protein.  The following example describes the use of shuffling to evolve yeast to express and secrete increased amounts of RNase A.


RNase A catalyzes the cleavage of the P-0.sub.5.  bond of RNA specifically after pyrimidine nucleotides.  The enzyme is a basic 124 amino acid polypeptide that has 8 half cystine residues, each required for catalysis.  YEpWL-RNase A is a vector
that effects the expression and secretion of RNaseA from the yeast S. cerevisiae, and yeast harboring this vector secrete 1-2 mg of recombinant RNase A per liter of culture medium (delCardayre et al., Protein Engineering 8(3):26, 1-273 (1995)).  This
overall yield is poor for a protein heterologously expressed in yeast and can be improved at least 10-100 fold by shuffling.  The expression of RNaseA is easily detected by several plate and microtitre plate assays (delCardayre & Raines, Biochemistry 33,
6031-6037 1994)).  Each of the described formats for whole genome shuffling can be used to shuffle a strain of S. cerevisiae harboring YEpWL.RNase A, and the resulting cells can be screened for the increased secretion of RNase A into the medium.  The new
strains are cycled recursively through the shuffling format, until sufficiently high levels of RNase A secretion is observed.  The use of RNase A is particularly useful since it not only requires proper folding and disulfide bond formation but also
proper glycosylation.  Thus numerous components of the expression, folding, and secretion systems can be optimized.  The resulting strain is also evolved for improved secretion of other heterologous proteins.


Another goal of shuffling yeast is to increase the tolerance of yeast to ethanol.  Such is useful both for the commercial production of ethanol, and for the production of more alcoholic beers and wines.  The yeast strain to be shuffled acquires
genetic material by exchange or transformation with other strain(s) of yeast, which may or may not be know to have superior resistance to ethanol.  The strain to be evolved is shuffled and shufflants are selected for capacity to survive exposure to
ethanol.  Increasing concentrations of ethanol can be used in successive rounds of shuffling.  The same principles can be used to shuffle baking yeasts for improved osmotolerance.


Another desired property of shuffling yeast is capacity to grow under desired nutritional conditions.  For example, it is useful to yeast to grow on cheap carbon sources such as methanol, starch, molases, cellulose, cellobiose, or xylose
depending on availability.  The principles of shuffling and selection are similar to those discussed for filamentous fungi.


Another desired property is capacity to produce secondary metabolites naturally produced by filamentous fungi or bacteria, Examples of such secondary metabolites are cyclosporin A, taxol, and cephalosporins.  The yeast to be evolved undergoes
genetic exchange or is transformed with DNA from organism(s) that produce the secondary metabolite.  For example, fungi producing taxol include Taxomyces andreanae and Pestalotopis microspora (Stierle et al., Science 260, 214-216 (1993); Strobel et al.,
Microbiol.  142, 435-440 (1996)).  DNA can also be obtained from trees that naturally produce taxol, such as Taxus brevifolia.  DNA encoding one enzyme in the taxol pathway, taxadiene synthase, which it is believed catalyzes the commited step in taxol
biosynthesis and may be rate limiting in overal taxol production, has been cloned (Wildung & Croteau, J. Biol.  Chem. 271, 9201-4 (1996).  The DNA is then shuffled, and shufflants are screened/selected for production of the secondary metabolite.  For
example, taxol production can be monitored using antibodies to taxol, by mass spectroscopy or uv spectrophotometry.  Alternatively, production of intermediates in taxol synthesis or enzymes in the taxol synthetic pathway can be monitored.  Concetti &
Ripani, Biol.  Chem. Hoppe Seyler 375, 419-23 (1994).  Other examples of secondary metabolites are polyols, amino acids, polyketides, non-ribosomal polypeptides, ergosterol, and the like.


Another desired property is to increase the flocculence of yeast to facilitate separation in preparation of ethanol.  Yeast can be shuffled by any of the procedures noted above with selection for shuffled yeast forming the largest clumps.


Exemplary Procedure for Yeast Protoplasting


Protoplast preparation in yeast is reviewed by Morgan, in Protoplasts (Birkhauser Verlag, Basel, 1983).  Fresh cells (108) are washed with buffer, for example 0.1 M potassium phosphate, then resuspended in this same buffer containing a reducing
agent, such as 50 mM DTT, incubated for 1 h at 30.degree.  C. with gentle agitation, and then washed again with buffer to remove the reducing agent.  These cells are then resuspended in buffer containing a cell wall degrading enzyme, such as Novozyme 234
(1 mg/mL), and any of a variety of osmotic stabilizers, such as sucrose, sorbitol, NaCl, KCl, MgSO.sub.4, MgCl.sub.2, or NH.sub.4 Cl at any of a variety of concentrations.  These suspensions are then incubated at 30.degree.  C. with gentle shaking
(.about.60 rpm) until protoplasts are released.  To generate protoplasts that are more likely to produce productive fusants several strategies are possible.


Protoplast formation can be increased if the cell cycle of the protoplasts have been synchronized to be halted at G1.  In the case of S. cerevisiae this can be accomplished by the addition of mating factors, either a or .alpha.  (Curran & Carter,
J. Gen.  Microbiol.  129, 1589-1591 (1983)).  These peptides act as adenylate cyclase inhibitors which by decreasing the cellular level of cAMP arrest the cell cycle at G1.  In addition, sex factors have been shown to induce the weakening of the cell
wall in preparation for the sexual fusion of a and a cells (Crandall & Brock, Bacteriol.  Rev.  32, 139-163 (1968); Osumi et al., Arch.  Microbiol.  97, 27-38 (1974)).  Thus in the preparation of protoplasts, cells can be treated with mating factors or
other known inhibitors of adenylate cyclase, such as leflunomide or the killer toxin from K. lactis, to arrest them at G1 (Sugisaki et al., Nature 304, 464-466 (1983)).  Then after fusing of the protoplasts (step 2), cAMP can be added to the regeneration
medium to induce S-phase and DNA synthesis.  Alternatively, yeast strains having a temperature sensitive mutation in the CDC4 gene can be used, such that cells could be synchronized and arrested at G1.  After fusion cells are returned to the permissive
temperature so that DNA synthesis and growth resumes.


Once suitable protoplasts have been prepared, it is necessary to induce fusion by physical or chemical means.  An equal number of protoplasts of each cell type is mixed in phosphate buffer (0.2 M, pH 5.8, 2.times.10.sup.8 cells/mL) containing an
osmotic stabilizer, for example 0.8 M NaCl, and PEG 6000 (33% w/v) and then incubated at 30.degree.  C. for 5 mm while fusion occurs.  Polyols, or other compounds that bind water, can be employed.  The fusants are then washed and resuspended in the
osmotically stabilized buffer lacking PEG, and transferred to osmotically stabilized regeneration medium on/in which the cells can be selected or screened for a desired property.


6.  Shuffling Methods Using Artificial Chromosomes


Yeast artificial chromosomes (Yacs) are yeast vectors into which very large DNA fragments (e.g., 50-2000 kb) can be cloned (see, e.g., Monaco & Larin, Trends.  Biotech.  12(7), 280-286 (1994); Ramsay, Mol. Biotechnol.  1(2), 181-201 1994; Huxley,
Genet.  Eng.  16, 65-91 (1994); Jakobovits, Curr.  Biol.  4(8), 761-3 (1994); Lamb & Gearhart, Curr.  Opin.  Genet.  Dev.  5(3), 342-8 (1995); Montoliu et al., Reprod.  Fertil.  Dev.  6, 577-84 (1994)).  These vectors have telomeres (Tel), a centromere
(Cen), an autonomously replicating sequence (ARS), and can have genes for positive (e.g., TRP1) and negative (e.g., URA3) selection.  YACs are maintained, replicated, and segregate as other yeast chromosomes through both meiosis and mitosis thereby
providing a means to expose cloned DNA to true meiotic recombination.


YACs provide a vehicle for the shuffling of libraries of large DNA fragments in vivo.  The substrates for shuffling are typically large fragments from 20 kb to 2 Mb.  The fragments can be random fragments or can be fragments known to encode a
desirable property.  For example, a fragment might include an operon of genes involved in production of antibiotics.  Libraries can also include whole genomes or chromosomes.  Viral genomes and some bacterial genomes can be cloned intact into a single
YAC.  In some libraries, fragments are obtained from a single organism.  Other libraries include fragment variants, as where some libraries are obtained from different individuals or species.  Fragment variants can also be generated by induced mutation. 
Typically, genes within fragments are expressed from naturally associated regulatory sequences within yeast.  However, alternatively, individual genes can be linked to yeast regulatory elements to form an expression cassette, and a concatemer of such
cassettes, each containing a different gene, can be inserted into a YAC.


In some instances, fragments are incorporated into the yeast genome, and shuffling is used to evolve improved yeast strains.  In other instances, fragments remain as components of YACs throughout the shuffling process, and after acquisition of a
desired property, the YACs are transferred to a desired recipient cell.


a. Methods of Evolving Yeast Strains


Fragments are cloned into a YAC vector, and the resulting YAC library is transformed into competent yeast cells.  Transformants containing a YAC are identified by selecting for a positive selection marker present on the YAC.  The cells are
allowed to recover and are then pooled.  Thereafter, the cells are induced to sporulate by transferring the cells from rich medium, to nitrogen and carbon limiting medium.  In the course of sporulation, cells undergo meiosis.  Spores are then induced to
mate by return to rich media.  Optionally, asci are lysed o liberate spores, so that the spores can mate with other spores originating from other asci.  Mating results in recombination between YACs bearing different inserts, and between YACs and natural
yeast chromosomes.  The latter can be promoted by irradiating spores with ultra violet light.  Recombination can give rise to new phenotypes either as a result of genes expressed by fragments on the YACs or as a result of recombination with host genes,
or both.


After induction of recombination between YACs and natural yeast chromosomes, YACs are often eliminated by selecting against a negative selection marker on the YACs.  For example, YACs containing the marker URA3 can be selected against by
propagation on media containing 5-fluro-orotic acid.  Any exogenous or altered genetic material that remains is contained within natural yeast chromosomes.  Optionally, further rounds of recombination between natural yeast chromosomes can be performed
after elimination of YACs.  Optionally, the same or different library of YACs can be transformed into the cells, and the above steps repeated.


After elimination of YACs, yeast are then screened or selected for a desired property.  The property can be a new property conferred by transferred fragments, such as production of an antibiotic.  The property can also be an improved property of
the yeast such as improved capacity to express or secrete an exogenous gene, improved recombinogenicity, improved stability to temperature or solvents, or other property required of commercial or research strains of yeast.


Yeast strains surviving selection/screening are then subject to a further round of recombination.  Recombination can be exclusively between the chromosomes of yeast surviving selection/screening.  Alternatively, a library of fragments can be
introduced into the yeast cells and recombined with endogenous yeast chromosomes as before.  This library of fragments can be the same or different from the library used in the previous round of transformation.  YACs are eliminated as before, followed by
additional rounds of recombination and/or transformation with further YAC libraries.  Recombination is followed by another round of selection/screening, as above.  Further rounds of recombination/screening can be performed as needed until a yeast strain
has evolved to acquire the desired property.


An exemplary scheme for evolving yeast by introduction of a YAC library is shown in FIG. 10.  The first part of the figure shows yeast containing an endogenous diploid genome and a YAC library of fragments representing variants of a sequence. 
The library is transformed into the cells to yield 100-1000 colonies per .mu.gDNA.  Most transformed yeast cells now harbor a single YAC as well as endogenous chromosomes.  Meiosis is induced by growth on nitrogen and carbon limiting medium.  In the
course of meiosis the YACs recombine with other chromosomes in the same cell.  Haploid spores resulting from meiosis mate and regenerated diploid forms.  The diploid forms now harbor recombinant chromosomes, parts of which come from endogenous
chromosomes and parts from YACs.  Optionally, the YACs can now be cured from the cells by selecting against a negative selection marker present on the YACS.  Irrespective whether YACS are selected against, cells are then screened or selected for a
desired property.  Cells surviving selection/screening are transformed with another YAC library to start another shuffling cycle.


b. Method of Evolving YACs for Transfer to Recipient Strain


These methods are based in part on the fact that multiple YACs can be harbored in the same yeast cell, and YAC-YAC recombination is known to occur (Green & Olson, Science 250, 94-98 1990)).  Inter-YAC recombination provides a format for which
families of homologous genes harbored on fragments of >20 kb can be shuffled in vivo.


The starting population of DNA fragments show sequence similarity with each other but differ as a result of for example, induced, allelic or species diversity.  Often DNA fragments are known or suspected to encode multiple genes that function in
a common pathway.


The fragments are cloned into a Yac and transformed into yeast, typically with positive selection for transformants.  The transformants are induced to sporulate, as a result of which chromosomes undergo meiosis.  The cells are then mated.  Most
of the resulting diploid cells now carry two YACs each having a different insert.  These are again induced to sporulate and mated.  The resulting cells harbor YACs of recombined sequence.  The cells can then be screened or selected for a desired
property.  Typically, such selection occurs in the yeast strain used for shuffling.  However, if fragments being shuffled are not expressed in yeast, YACs can be isolated and transferred to an appropriate cell type in which they are expressed for
screening.  Examples of such properties include the synthesis or degradation of a desired compound, increased secretion of a desired gene product, or other detectable phenotype.


Cells surviving selection/screening are subjected to successive cycles of pooling, sporulation, mating and selection/screening until the desired phenotype has been observed.  Recombination can be achieved simply by transferring cells from rich
medium to carbon and nitrogen limited medium to induce sporulation, and then returning the spores to rich media to induce mating.  Asci can be lysed to stimulate mating of spores originating from different asci.


After YACs have been evolved to encode a desired property they can be transferred to other cell types.  Transfer can be by protoplast fusion, or retransformation with isolated DNA.  For example, transfer of YACs from yeast to mammalian cells is
discussed by Monaco & Larin, Trends in Biotechnology 12, 280-286 (1994); Montoliu et al., Reprod.  Fertil.  Dev.  6, 577-84 (1994); Lamb et al., Curr.  Opin.  Genet.  Dev.  5, 342-8 (1995).


An exemplary scheme for shuffling a YAC fragment library in yeast is shown in FIG. 11.  A library of YAC fragments representing genetic variants are transformed into yeast that have diploid endogenous chromosomes.  The transformed yeast continue
to have diploid endogenous chromosomes, plus a single YAC.  The yeast are induced to undergo meiosis and sporulate.  The spores contain haploid genomes, some of which contain only endogenous yeast chromosomes, and some of which contain yeast chromosomes
plus a YAC.  The spores are induced to mate generating diploid cells.  Some of the diploid cells now contain two YAC bearing different inserts as well as diploid endogenous chromosomes.  The cells are again induced to undergo meiosis and sporulate.  In
cells bearing two YACs, recombination occurs between the inserts, and recombinant YACs are segregated to ascoytes.  Some ascoytes thus contain haploid endogenous chromosomes plus a YAC chromosome with a recombinant insert.  The ascoytes mature to spores,
which can mate again generating diploid cells.  Some diploid cells now possess a diploid complement of endogenous chromosomes plus two recombinant YACs.  These cells can then be taken through further cycles of meiosis, sporulation and mating.  In each
cycle, further recombination occurs between YAC inserts and further recombinant forms of inserts are generated.  After one or several cycles of recombination has occurred, cells can be tested for acquisition of a desired property.  Further cycles of
recombination, followed by selection, can then be performed in similar fashion.


c. Use of YACs to Clone Unlinked Genes


Shuffling of YACs is particularly amenable to transfer of unlinked but functionally related genes from one species to another, particularly where such genes have not been identified.  Such is the case for several commercially important natural
products, such as taxol.  Transfer of the genes in the metabolic pathway to a different organism is often desirable because organisms naturally producing such compounds are not well suited for mass culturing.


Clusters of such genes can be isolated by cloning a total genomic library of DNA from an organisms producing a useful compound into a YAC library.  The YAC library is then transformed into yeast.  The yeast is sporulated and mated such that
recombination occurs between YACs and/or between YACs and natural yeast chromosomes.  Selection/screening is then performed for expression of the desired collection of genes.  If the genes encode a biosynthetic pathway, expression can be detected from
the appearance of product of the pathway.  Production of individual enzymes in the pathway, or intermediates of the final expression product or capacity of cells to metabolize such intermediates indicates partial acquisition of the synthetic pathway. 
The original library or a different library can be introduced into cells surviving/selection screening, and further rounds of recombination and selection/screening can be performed until the end product of the desired metabolic pathway is produced.


7.  Conjugation-Mediated Genetic Exchange


Conjugation can be employed in the evolution of cell genomes in several ways.  Conjugative transfer of DNA occurs during contact between cells.  See Guiney (1993) in: Bacterial Conjugation (Clewell, ed., Plenum Press, New York), pp.  75-104;
Reimmann & Haas in Bacterial Conjugation (Clewell, ed., Plenum Press, N.Y.  1993), at pp.137-188 (incorporated by reference in their entirety for all purposes).  Conjugation occurs between many types of gram negative bacteria, and some types of gram
positive bacteria.  Conjugative transfer is also known between bacteria and plant cells (Agrobacterium tumefaciens) or yeast.  As discussed in copending application attorney docket no. 16528J-014612, the genes responsible for conjugative transfer can
themselves be evolved to expand the range of cell types (e.g., from bacteria to mammals) between which such transfer can occur.


Conjugative transfer is effected by an origin of transfer (oriT) and flanking genes (MOB A, B and C), and 15-25 genes, termed tra, encoding the structures and enzymes necessary for conjugation to occur.  The transfer origin is defined as the site
required in cis for DNA transfer.  Tra genes include tra A, B, C, D, E, F, G, H, I, J, K, L, M, N, P, Q, R, S, T, U, V, W, X, Y, Z, vir AB (alleles 1-11), C, D, E, G, IHF, and FinOP.  Tra genes can be expressed in cis or trans to oriT.  Other cellular
enzymes, including those of the RecBCD pathway, RecA, SSB protein, DNA gyrase, DNA poll, and DNA ligase, are also involved in conjugative transfer.  RecE or recF pathways can substitute for RecBCD.


One structural protein encoded by a tra gene is the sex pilus, a filament constructed of an aggregate of a single polypeptide protruding from the cell surface.  The sex pilus binds to a polysaccharide on recipient cells and forms a conjugative
bridge through which DNA can transfer.  This process activates a site-specific nuclease encoded by a MOB gene, which specifically cleaves DNA to be transferred at oriT.  The cleaved DNA is then threaded through the conjugation bridge by the action of
other tra enzymes.


Mobilizable vectors can exist in episomal form or integrated into the chromosome.  Episomal mobilizable vectors can be used to exchange fragments inserted into the vectors between cells.  Integrated mobilizable vectors can be used to mobilize
adjacent genes from the chromosome.


a. Use of Integrated Mobilizable Vectors to Promote Exchange of Genomic DNA


The F plasmid of E. coli integrates into the chromosome at high frequency and mobilizes genes unidirectional from the site of integration (Clewell, 1993, supra; Firth et al., in Escherichia coli and Salmonella Cellular and Molecular Biology 2,
2377-2401 (1996); Frost et al., Microbiol.  Rev.  58, 162-210 (1994)).  Other mobilizable vectors do not spontaneously integrate into a host chromosome at high efficiency but can be induced to do by growth under particular conditions (e.g., treatment
with a mutagenic agent, growth at a nonpermissive temperature for plasmid replication).  See Reimann & Haas in Bacterial Conjugation (ed.  Clewell, Plenum Press, N.Y.  1993), Ch.  6.  Of particular interest is the IncP group of conjugal plasmids which
are typified by their broad host range (Clewell, 1993, supra.


Donor "male" bacteria which bear a chromosomal insertion of a conjugal plasmid, such as the E. coli F factor can efficiently donate chromosomal DNA to recipient "female" enteric bacteria which lack F (F-).  Conjugal transfer from donor to
recipient is initiated at oriT.  Transfer of the nicked single strand to the recipient occurs in a 5' to 3' direction by a rolling circle mechanisms which allows mobilization of tandem chromosomal copies.  Upon entering the recipient, the donor strand is
discontinuously replicated.  The linear, single-stranded donor DNA strand is a potent substrate for initiation of recA-mediated homologous recombination within the recipient.  Recombination between the donor strand and recipient chromosomes can result in
the inheritance of donor traits.  Accordingly, strains which bear a chromosomal copy of F are designated Hfr (for high frequency of recombination) (Low, 1996 in Escherichia coli and Salmonella Cellular and Molecular Biology Vol. 2, pp.  2402-2405;
Sanderson, in Escherichia coli and Salmonella Cellular and Molecular Biology 2, 2406-2412 (1996)).


The ability of strains with integrated mobilizable vector to transfer chromosomal DNA provides a rapid and efficient means of exchanging genetic material between a population of bacteria thereby allowing combination of positive mutations and
dilution of negative mutations.  Such shuffling methods typically start with a population of strains with an integrated mobilizable vector encompassing at least some genetic diversity.  The genetic diversity can be the result of natural variation,
exposure to a mutagenic agent or introduction of a fragment library.  The population of cells is cultured without selection to allow genetic exchange, recombination and expression of recombinant genes.  The cells are then screened or selected for a
evolution toward a desired property.  The population surviving selection/screening can then be subject to a further round of shuffling by HFR-mediated genetic exchange or otherwise.


The natural efficiency of Hfr and other strains with integrated mob vectors as recipients of conjugal transfer can be improved by several means.  The relatively low recipient efficiency of natural HFR strains is attributable to the products of
traS and traT genes of F (Clewell, 1993, supra; Firth et al., 1996, supra; Frost et al., 1994, supra; Achtman et al., J. Mol. Biol.  138, 779-795 (1980).  These products are localized to the inner and outer membranes of F+ strains, respectively, where
they serve to inhibit redundant matings between two strains which are both capable of donating DNA.  The effects of traS and traT, and cognate genes in other conjugal plasmids, can be eliminated by use of knockout cells incapable of expressing these
enzymes or reduced by propagating cells on a carbon-limited source.  (Peters et al., J. Bacteriol., 178, 3037-3043 (1996)).


In some methods, the starting population of cells has a mobilizable vector integrated at different genomic sites.  Directional transfer from oriT typically results in more frequent inheritance of traits proximal to oriT.  This is because mating
pairs are fragile and tend to dissociate (particularly when in liquid medium) resulting in the interruption of transfer.  In a population of cells having a mobilizable vector integrated at different sites chromosomal exchange occurs in a more random
fashion.  Kits of Hfr strains are available from the E. coli.  Genetic Stock Center and the Salmonella Genetic Stock Centre (Frost et al., 1994, supra).  Alternatively, a library of strains with oriT at random sites and orientations can be produced by
insertion mutagenesis using a transposon which bears oriT.  The use of a transposon bearing an oriT [e.g., the Tn5-oriT described by Yakobson E. A., et al. J. Bacteriol.  1984 Oct; 160(1): 451-453] provides a quick method of generating such a library. 
Transfer functions for mobilization from the transposon-borne oriT sites are provided by a helper vector.  It is possible to generate similar genetic constructs using other sequences known to one of skill as well.


In one aspect, a recursive scheme for genomic shuffling using Tn-oriT elements is provided.  A prototrophic bacterial strain or set of related strains bearing a conjugal plasmid, such as the F fertility factor or a member of the IncP group of
broad host range plasmids is mutagenized and screened for the desired properties.  Individuals with the desired properties are mutagenized with a Tn-oriT element and screened for acquisition of an auxotrophy (e.g., by replica-plating to a minimal and
complete media) resulting from insertion of the Tn-oriT element in any one of many biosynthetic gene scattered across the genome.  The resulting auxotrophs are pooled and allowed to mate under conditions promoting male-to-male matings, e.g., during
growth in close proximity on a filter membrane.  Note that transfer functions are provided by the helper conjugal plasmid present in the original strain set.  Recombinant transconjugants are selected on minimal medium and screened for further
improvement.


Optionally, strains bearing integrated mobilizable vectors are defective in mismatch repair gene(s).  Inheritance of donor traits which arise from sequence heterologies increases in strains lacking the methyl-directed mismatch repair system. 
Optionally, the gene products which decrease recombination efficiency can be inhibited by small molecules.


Intergenic congual transfer between species such as E. coli and Salmonella typhimurium, which are 20% divergent at the DNA level, is also possible if the recipient strain is mutH, mutL or mutS (see Rayssiguier et al., Nature 342, 396-401 (1989)). Such transfer can be used to obtain recombination at several points as shown by the following example.


The example uses an S. typhimurium Hfr donor strain having markers thr557 at map position 0, pyrF2690 at 33 min, serA13 at 62 min and hfrK5 at 43 min. MutS +/-, F- E. coli recipient strains had markers pyrD68 at 21 min aroC355 at 51 min, ilv3164
at 85 min and mutS215 at 59 min. The triauxotrophic S. typhimurium Hfr donor and isogenic mutS +/- triauxotrophic E. coli recipient were inoculated into 3 ml of Lb broth and shaken at 37.degree.  C. until fully grown.  100 .mu.l of the donor and each
recipient were mixed in 10 ml fresh LB broth, and then deposited to a sterile Millipore 0.45 .mu.M HA filter using a Nalgene 250 ml reusable filtration device.  The donor and recipients alone were similarly diluted and deposited to check for reversion. 
The filters with cells were placed cell-side-up on the surface of an LB agar plate which was incubated overnight at 37.degree.  C. The filters were removed with the aid of a sterile forceps and placed in a sterile 50 ml tube containing 5 ml of minimal
salts broth.  Vigorous vortexing was used to wash the cells from the filters.  100 .mu.l of mating mixtures, as well as donor and recipient controls were spread to LB for viable cell counts and minimal glucose supplemented with either two of the three
recipient requirements for single recombinant counts, one of the three requirements for double recombinant counts, or none of the three requirements for triple recombinant counts.  The plates were incubated for 48 hr at 37.degree.  after which colones
were counted.


 Medium Recombinant Recombinant CFUs/Total CFUs  Supplements Genotype mutS.sup.+ mutS.sup.- mutS.sup.- /mutS.sup.+  Aro + Iiv pyr.sup.+ aro.sup.- ilv.sup.- -- -- --  Aro + Ura pyr.sup.- aro.sup.- ilv.sup.+ 1.2 .times. 10.sup.-8 2.5  .times.
10.sup.-6 208  Ilv + Ura pyr.sup.- aro.sup.+ ilv.sup.- 2.7 .times. 10.sup.-8 3.0  .times. 10.sup.-6 111  Aro pyr.sup.+ aro.sup.- ilv.sup.+ -- -- --  Ilv pyr.sup.+ aro.sup.+ ilv.sup.- -- -- --  Ura pyr.sup.- aro.sup.+ ilv.sup.+ <10.sup.-9 <10.sup.-9 nothing pyr.sup.+ aro.sup.+ ilv.sup.+  Aro = aromatic amino acids and vitamins  Ilv = branched chain amino acids  Ura = uracil


The data indicate that recombinants can be generated at reasonable frequenceis using Hfr matings.  Intergeneric recombination is enhanced 100-200 fold in a recipient that is defective methyl-directed mismatch repair.


b. Introduction of Fragments by Conjugation


Mobilizable vectors can also be used to transfer fragment libraries into cells to be evolved.  This approach is particularly useful in situations in which the cells to be evolved cannot be efficiently transformed directly with the fragment
library but can undergo conjugation with primary cells that can be transformed with the fragment library.


DNA fragments to be introduced into host cells encompasses diversity relative to the host cell genome.  The diversity can be the result of natural diversity or mutagenesis.  The DNA fragment library is cloned into a mobilizable vector having an
origin of transfer.  Some such vectors also contain mob genes although alternatively these functions can also be provided in trans.  The vector should be capable of efficient conjugal transfer between primary cells and the intended host cells.  The
vector should also confer a selectable phenotype.  This phenotype can be the same as the phenotype being evolved or can be conferred by a marker, such as a drug resistance marker.  The vector should preferably allow self-elimination in the intended host
cells thereby allowing selection for cells in which a cloned fragment has undergone genetic exchange with a host homologous host segment rather than duplication.  Such can be achieved by use of vector lacking an origin of replication functional in the
intended host type or inclusion of a negative selection marker in the vector.


One suitable vector is the broad host range conjugation plasmid described by Simon et al., Bio/Technology 1, 784-791 (1983); TrieuCuot et al., Gene 102, 99-104 (1991); Bierman et al., Gene 116, 43-49 (1992).  These plasmids can be transformed
into E. coli and then force-mated into bacteria that are difficult or impossible to transform by chemical or electrical induction of competence.  These plasmids contain the origin of the IncP plasmid, oriT.  Mobilization functions are supplied in trans
by chromosomally-integrated copies of the necessary genes.  Conjugal transfer of DNA can in some cases be assisted by treatment of the recipient (if gram-positive) with sub-inhibitory concentrations of penicillins (TrieuCuot et al., 1993 FEMS Microbiol. 
Lett.  109, 19-23).


Cells that have undergone allelic exchange with library fragments can be screened or selected for evolution toward a desired phenotype.  Subsequent rounds of recombination can be performed by repeating the conjugal transfer step.  the library of
fragments can be fresh or can be obtained from some (but not all) of the cells surviving a previous round of selection/screening.  Conjugation-mediated shuffling can be combined with other methods of shuffling.


8.  Genetic Exchange Promoted by Transducing Phage


Transduction is the transfer, from one cell to another, of nonviral genetic material within a viral coat (Masters, in Escherichia coli and Salmonella Cellular and Molecular Biology 2, 2421-2442 (1996).  Perhaps the two best examples of
generalized transducing phage are bacteriophages P1 and P22 of E. coli and S. typhimurium, respectively.  Generalized transducing bacteriophage particles are formed at a low frequency during lytic infection when viral-genome-sized, doubled-stranded
fragments of host (which serves as donor) chromosomal DNA are packaged into phage heads.  Promiscuous high transducing (HT) mutants of bacteriophage P22 which efficiently package DNA with little sequence specificity have been isolated.  Infection of a
susceptible host results in a lysate in which up to 50% of the phage are transducing particles.  Adsorption of the generalized transducing particle to a susceptible recipient cell results in the injection of the donor chromosomal fragment.  RecA-mediated
homologous recombination following injection of the donor fragment can result in the inheritance of donor traits.  Another type of phage which achieves quasi random insertion of DNA into the host chromosome is Mu.  For an overview of Mu biology, see,
Groisman (1991) in Methods in Enzymology v. 204.  Mu can generate a variety of chromosomal rearrangements including deletions, inversions, duplications and transpositions.  In addition, elements which combine the features of P22 and Mu are available,
including Mud-P22, which contains the ends of the Mu genome in place of the P22 att site and int gene.  See, Berg, supra.


Generalized transducing phage can be used to exchange genetic material between a population of cells encompassing genetic diversity and susceptible to infection by the phage.  Genetic diversity can be the result of natural variation between
cells, induced mutation of cells or the introduction of fragment libraries into cells.  DNA is then exchanged between cells by generalized transduction.  If the phage does not cause lysis of cells, the entire population of cells can be propagated in the
presence of phage.  If the phage results in lytic infection, transduction is performed on a split pool basis.  That is, the starting population of cells is divided into two.  One subpopulation is used to prepare transducing phage.  The transducing phage
are then infected into the other subpopulation.  Preferably, infection is performed at high multiplicity of phage per cell so that few cells remain uninfected.  Cells surviving infection are propagated and screened or selected for evolution toward a
desired property.  The pool of cells surviving screening/selection can then be shuffled by a further round of generalized transduction or by other shuffling methods.


The efficiency of the above methods can be increased by reducing infection of cells by infectious (nontransducing phage) and by reducing lysogen formation.  The former can be achieved by inclusion of chelators of divalent cations, such as citrate
and EGTA in culture media.  Tail defective transducing phages can be used to allow only a single round of infection.  Divalent cations are required for phage absorption and the inclusion of chelating agents therefore provides a means of preventing
unwanted infection.  Integration defective (int.sup.-) derivatives of generalized transducing phage can be used to prevent lysogen formation.  In a further variation, host cells with defects in mismatch repair gene(s) can be used to increase
recombination between transduced DNA and genomic DNA.


9.  Use of Locked in Prophages to Facilitate DNA Shuffling


The use of a hybrid, mobile genetic element (locked-in prophages) as a means to facilitate whole genome shuffling of organisms using phage transduction as a means to transfer DNA from donor to recipient is a preferred embodiment.  One such
element (Mud-P22) based on the temperate Salmonella phage P22 has been described for use in genetic and physical mapping of mutations.  See, Youderian et al. (1988) Genetics 118:581-592, and Benson and Goldman (1992) J. Bacteriol.  174(5): 1673-1681. 
Individual Mud-P22 insertions package specific regions of the Salmonella chromosome into phage P22 particles.  Libraries of random Mud-P22 insertions can be readily isolated and induced to create pools of phage particles packaging random chromosomal DNA
fragments.  These phage particles can be used to infect new cells and transfer the DNA from the host into the recipient in the process of transduction.  Alternatively, the packaged chromosomal DNA can be isolated and manipulated further by techniques
such as DNA shuffling or any other mutagenesis technique prior to being reintroduced into cells (especially recD cells for linear DNA) by transformation or electroporation, where they integrate into the chromosome.


Either the intact transducing phage particles or isolated DNA can be subjected to a variety of mutagens prior to reintroduction into cells to enhance the mutation rate.  Mutator cell lines such as mutD can also be used for phage growth.  Either
method can be used recursively in a process to create genes or strains with desired properties.  E. coli cells carrying a cosmid clone of Salmonella LPS genes are infectable by P22 phage.  It is possible to develop similar genetic elements using other
combinations of transposable elements and bacteriophages or viruses as well.


P22 is a lambdoid phage that packages its DNA into preassembled phage particles (heads) by a "headful" mechanism.  Packaging of phage DNA is initiated at a specific site (pac) and proceeds unidirectionally along a linear, double stranded normally
concatameric molecule.  When the phage head is full (.about.43 kb), the DNA strand is cleaved, and packaging of the next phage head is initiated.  Locked-in or excision-defective P22 prophages, however, initiate packaging at their pac site, and then
proceed unidirectionally along the chromosome, packaging successive headfuls of chromosomal DNA (rather than phage DNA).  When these transducing phages infect new Salmonella cells they inject the chromosomal DNA from the original host into the recipient
cell, where it can recombine into the chromosome by homologous recombination creating a chimeric chromosome.  Upon infection of recipient cells at a high multiplicity of infection, recombination can also occur between incoming transducing fragments prior
to recombination into the chromosome.


Integration of such locked-in P22 prophages at various sites in the chromosome allows flanking regions to be amplified and packaged into phage particles.  The Mud-P22 mobile genetic element contains an excision-defective P22 prophage flanked by
the ends of phage/transposon Mu.  The entire Mud-P22 element can transpose to virtually any location in the chromosome or other episome (eg.  F', BAC clone) when the Mu A and B proteins are provided in trans.


A number of embodiments for this type of genetic element are available.  In one example, the locked in prophage are used as generalized transducing phage to transfer random fragments of a donor chromosome into a recipient.  The Mud-P22 element
acts as a transposon when Mu A and B transposase proteins are provided in trans and integrate copies of itself at random locations in the chromosome.  In this way, a library of random chromosomal Mud-P22 insertions can be generated in a suitable host. 
When the Mud-P22 prophages in this library are induced, random fragments of chromosomal DNA will be packaged into phage particles.  When these phages infect recipient cells, the chromosomal DNA is injected and can recombine into the chromosome of the
recipient.  These recipient cells are screened for a desired property and cells showing improvement are then propagated.  The process can be repeated, since the Mud-P22 genetic element is not transferred to the recipient in this process.  Infection at a
high multiplicity allows for multiple chromosomal fragments to be injected and recombined into the recipient chromosome.


Locked-in prophages can also be used as specialized transducing phage.  Individual insertions near a gene of interest can be isolated from a random insertion library by a variety of methods.  Induction of these specific prophages results in
packaging of flanking chromosomal DNA including the gene(s) of interest into phage particles.  Infection of recipient cells with these phages and recombination of the packaged DNA into the chromosome creates chimeric genes that can be screened for
desired properties.  Infection at a high multiplicity of infection can allow recombination between incoming transducing fragments prior to recombination into the chromosome.


These specialized transducing phage can also be used to isolate large quantities of high quality DNA containing specific genes of interest without any prior knowledge of the DNA sequence.  Cloning of specific genes is not required.  Insertion of
such an element nearby a biosynthetic operon for example allows for large amounts of DNA from that operon to be isolated for use in DNA shuffling (in vitro and/or in vivo), cloning, sequencing, or other uses as set forth herein.  DNA isolated from
similar insertions in other organisms containing homologous operons are optionally mixed for use in family shuffling formats as described herein, in which homologous genes from different organsims (or different chromosomal locations within a single
species, or both).


Phage isolated from insertions in a variety of strains or organisms containing homologous operons are optionally mixed and used to coinfect cells at a high MOI allowing for recombination between incoming transducing fragments prior to
recombination into the chromosome.


Locked in prophage are useful for mapping of genes, operons, and/or specific mutations with either desirable or undesirable phenotypes.  Locked-in prophages can also provide a means to separate and map multiple mutations in a given host.  If one
is looking for beneficial mutations outside a gene or operon of interest, then an unmodified gene or operon can be transduced into a mutagenized or shuffled host then screened for the presence of desired secondary mutations.  Alternatively, the
gene/operon of interest can be readily moved from a mutagenized/shuffled host into a different background to screen/select for modifications in the gene/operon itself.


It is also possible to develop similar genetic elements using other combinations of transposable elements and bacteriophages or viruses as well.  Similar systems are set up in other organisms, e.g., that do not allow replication of P22 or P1. 
Broad host range phages and transposable elements are especially useful.  Similar genetic elements are derived from other temperate phages that also package by a headful mechanism.  In general, these are the phages that are capable of generalized
transduction.  Viruses infecting eukaryotic cells may be adapted for similar purposes.  Examples of generalized transducing phages that are useful are described in: Green et al., "Isolation and preliminary characterization of lytic and lysogenic phages
with wide host range within the streptomycetes", J. Gen Microbiol 131(9):2459-2465 (1985); Studdard et al., "Genome structure in Streptomyces spp.: adjacent genes on the S. coelicolor A3(2) linkage map have cotransducible analogs in S. venezuelae", J.
Bacteriol 169(8):3814-3816 (1987); Wang et al., "High frequency generalized transduction by miniMu plasmid phage", Genetics 116(2):201-206, (1987); Welker, N. E., "Transduction in Bacillus stearothermophilus", J. Bacteriol, 176(11):3354-3359, (1988);
Darzins et al., "Mini-D3112 bacteriophage transposable elements for genetic analysis of Pseudomonas aeruginosa, J. Bacteriol 171(7):3909-3916 (1989); Hugouvieux-Cotte-Pattat et al., "Expanded linkage map of Erwinia chrysanthemi strain 3937", Mol
Microbiol 3(5):573-581, (1989); Ichige et al., "Establishment of gene transfer systems for and construction of the genetic map of a marine Vibrio strain", J. Bacteriol 171(4): 1825-1834 (1989); Muramatsu et al., "Two generalized transducing phages in
Vibrio parahaemolyticus and Vibrio alginolyticus", Microbiol Immunol 35(12):1073-1084 (1991); Regue et al., "A generalized transducing bacteriophage for Serratia marcescens", Res Microbiol 42(1):23-27, (1991); Kiesel et al., "Phage Acm1-mediated
transduction in the facultatively methanol-utilizing Acetobacter methanolicus MB 58/4", J. Gen Virol 74(9):1741-1745 (1993); Blahova et al., "Transduction of imipenem resistance by the phage F-116 from a nosocomial strain of Pseudomonas aeruginosa
isolated in Slovakia", Acta Virol 38(5):247-250 (1994); Kidambi et al., "Evidence for phage-mediated gene transfer among Pseudomonas aeruginosa strains on the phylloplane", Appl Environ Microbiol 60:(2)496-500 (1994); Weiss et al., "Isolation and
characterization of a generalized transducing phage for Xanthomonas campestris pv.  campestris", J. Bacteriol 176(11):3354-3359 (1994); Matsumoto et al., "Clustering of the trp genes in Burkholderia (formerly Pseudomonas) cepacia", FEMS Microbiol Lett
134(2-3):265-271 (1995); Schicklmaier et al., "Frequency of generalized transducing phages in natura isolates of the Salmonella typhimurium complex", Appl Environ Microbiol 61(4): 61(4): 1637-1640 (1995); Humphrey et al., "Purification and
characterization of VSH-1, a generalized transducing bacteriophase of Serpulina hyodysenteriae", J Bacteriol 179(2):323-329 (1997); Willi et al., "Transduction of antibiotic resistance markers among Actinobacillus actinomycetemcomitans strains by
temperate bacteripphages Aa phi 23", Cell Mol Life Sci 53(11-12):904-910 (1997); Jensen et al., "Prevalence of broad-host-range lytic bacteriophages of Sphaerotilus natans, Escherichia coli, and Pseudomonas aeruginosa", Appl Environ Microbiol
64(2):575-580 (1998), and Nedelmann et al., "Generalized transduction for genetic linkage analysis and transfer of transposon insertions in different Staphylococcus epidermidis strains", Zentiviralalbl Bakteriol 287(1-2):85-92 (1998).


A Mud-P1/Tn-P1 system comparable to Mud-P22 is developed using phage P1.  Phage P1 has an advantage of packaging much larger (.about.110 kb) fragments per headful.  Phage P1 is currently used to create bacterial artificial chromosomes or BAC's. 
PI-based BAC vectors are designed along these principles so that cloned DNA is packaged into phage particles, rather than the current system, which requires DNA preparation from single-copy episomes.  This combines the advantages of both systems in
having the genes cloned in a stable single-copy format, whilst allowing for amplification and specific packaging of cloned DNA upon induction of the prophage.


10.  Random Placement of Genes or Improved Genes Throughout the Genome for Optimization of Gene Context


The placement and orientation of genes in a host chromosome (the "context" of the gene in a chromosome) or episome has large effects on gene expression and activity.  Random integration of plasmid or other episomal sequences into a host
chromosome by non-homologous recombination, followed by selection or screening for the desired phenotype, is a preferred way of identifing optimal chromosomal positions for expression of a target.  This strategy is illustrated in FIG. 18.


A variety of transposon mediated delivery systems can be employed to deliver genes of interest, either individual genes, genomic libraries, or a library of shuffled gene(s) randomly throughout the genome of a host.  Thus, in one preferred
embodiment, the improvement of a cellular function is achieved by cloning a gene of interest, for example a gene encoding a desired metabolic pathway, within a transposon delivery vehicle.


Such transposon vehicles are available for both Gram-negative and Gram-positive bacteria.  De Lorenzo and Timis (1994) Methods in Enzymology 235:385-404 describe the analysis and construction of stable phenotypes in gram-negative Bacteria with
Tn5- and Tn 10-derived minitransposons.  Kleckner et al. (1991) Methods in Enzymology 204, chapter 7 describe uses of transposons such as Tn10, including for use in gram positive bacteria.  Petit et al. (1990) Journal of Bacteriology 172(12):6736-6740
describe Tn10 derived transposons active in Bacillus Subtilis.  The transposon delivery vehicle is introduced into a cell population, which is then selected for recombinant cells that have incorporated the transposon into the genome.


The selection is typically by any of a variety of drug resistant markers also carried within the transposon.  The selected subpopulation is screened for cells having improved expression of the gene(s) of interest.  Once cells harboring the genes
of interest in the optimal location are isolated, the genes are amplified from within the genome using PCR, shuffled, and cloned back into a similar transposon delivery vehicle which contains a different selection marker within the transposon and lacks
the transposon integrase gene.


This shuffled library is then transformed back into the strain harboring the original transposon, and the cells are selected for the presence of the new resistance marker and the loss of the previous selection marker.  Selected cells are enriched
for those that have exchanged by homologous recombination the original transposon for the new transposon carrying members of the shuffled library.  The surviving cells are then screened for further improvements in the expression of the desired phenotype. The genes from the improved cells are then amplified by the PCR and shuffled again.  This process is carried out recursively, oscillating each cycle between the different selection markers.  Once the gene(s) of interest are optimized to a desired level,
the fragment can be amplified and again randomly distributed throughout the genome as described above to identify the optimal location of the improved genes.


Alternatively, the gene(s) conferring a desired property may not be known.  In this case the DNA fragments cloned within the transposon delivery vehicle could be a library of genomic fragments originating from a population of cells derived from
one or more strains having the desired property(ies).  The library is delivered to a population of cells derived from one or more strains having or lacking the desired property(ies) and cells incorporating the transposon are selected.  The surviving
cells are then screened for acquisition or improvement of the desired property.  The fragments contained within the surviving cells are amplified by PCR and then cloned as a pool into a similar transposon delivery vector harboring a different selection
marker from the first delivery vector.  This library is then delivered to the pool of surviving cells, and the population having acquired the new selective marker is selected.  The selected cells are then screened for further acquisition or improvement
of the desired property.  In this way the different possible combinations of genes conferring or improving a desired phenotype are explored in a combinatorial fashion.  This process is carried out repetitively with each new cycle employing an additional
selection marker.


Alternatively, the amplified fragments from each improved cell are shuffled independently.  The shuffled libraries are then cloned back into a transposon delivery vehicle similar to the original vector but containing a different selection marker
and lacking the transposase gene.  Selection is then for acquisition of the new marker and loss of the previous marker.  Selected cells are enriched for those incorporating the shuffled variants of the amplified genes by homologous recombination.  This
process is carried out recursively, oscillating each cycle between the two selective markers.


11.  Improvement of Overexpressed Genes for a Desired Phenotype


The improvement of a cellular property or phenotype is often enhanced by increasing the copy number or expression of gene(s) participating in the expression of that property.  Genes that have such an effect on a desired property can also be
improved by DNA shuffling to have a similar effect.  A genomic DNA library is cloned into an overexpression vector and transformed into a target cell population such that the genomic fragments are highly expressed in cells selected for the presence of
the overexpression vector.  The selected cells are then screened for improvement of a desired property.  The overexpression vector from the improved cells are isolated and the cloned genomic fragments shuffled.  The genomic fragment carried in the vector
from each improved isolate is shuffled independently or with identified homologous genes (family shuffling).  The shuffled libraries are then delivered back to a population of cells and the selected transformants rescreened for further improvements in
the desired property.  This shuffling/screening process is cycled recursively until the desired property has been optimized to the desired level.


As stated above, gene dosage can greatly enhance a desired cellular property.  One method of increasing gene copy number of unknown genes is using a method of random amplification (see also, Mavingui et. al. (1997) Nature Biotech, 15, 564).  In
this method, a genomic library is cloned into a suicide vector containing a selective marker that also at higher dosage provides an enhanced phenotype.  An example of such a marker is the kanamycin resistance gene.  At successively higher copy number,
resistance to successively higher levels of kanamycin is achieved.  The genomic library is delivered to a target cell by any of a variety of methods including transformation, transduction, conjugation, etc. Cells that have incorporated the vector into
the chromosome by homologous recombination between the vector and chromosomal copies of the cloned genes can be selected by requiring expression of the selection marker under conditions where the vector does not replicate.  This recombination event
results in the duplication of the cloned DNA fragment in the host chromosome with a copy of the vector and selection marker separating the two copies.  The population of surviving cells are screened for improvement of a desired cellular property
resulting form the gene duplication event.  Further gene duplication events resulting in additional copies of the original cloned DNA fragments can be generated by further propagating the cells under successively more stringent selective conditions i.e.
increased concentrations of kanamycin.  In this case selection requires increased copies of the selective marker, but increased copies of the desired gene fragment is also concomitant.  Surviving cells are further screened for an improvement in the
desired phenotype.  The resulting population of cells likely resulted in the amplification of different genes since often many genes effect a given phenotype.  To generate a library of the possible combinations of these genes, the original selected
library showing phenotypic improvements are recombined, using the methods described herein, e.g., protoplast fusion, split pool transduction, transformation, conjugation, etc.


The recombined cells are selected for increased expression of the selective marker.  Survivors are enriched for cells having incorporated additional copies of the vector sequence by homologous recombination, and these cells will be enriched for
those having combined duplications of different genes.  In other words, the duplication from one cell of enhanced phenotype becomes combined with the duplication of another cell of enhanced phenotype.  These survivors are screened for further
improvements in the desired phenotype.  This procedure is repeated recursively until the desired level of phenotypic expression is achieved.


Alternatively, genes that have been identified or are suspected as being beneficial in increased copy number are cloned in tandem into appropriate plasmid vectors.  These vectors are then transformed and propagated in an appropriate host
organism.  Plasmid-plasmid recombination between the cloned gene fragments result in further duplication of the genes.  Resolution of the plasmid doublet can result in the uneven distribution of the gene copies, with some plasmids having additional gene
copies and others having fewer gene copies.  Cells carrying this distribution of plasmids are then screened for an improvement in the phenotype effected by the gene duplications.


In summary, a method of selecting for increased copy number of a nucleic acid sequence by the above procedure is provided.  In the method, a genomic library in a suicide vector comprising a dose-sensitive selectable marker is provided, as noted
above.  The genomic library is transduced into a population of target cells.  The target cells are selected in a population of target cells for increasing doses of the selectable marker under conditions in which the suicide vector does not replicate
episomally.  A plurality of target cells are selected for the desired phenotype, recombined and reselected.  The process is recursively repeated, if desired, until the desired phenotype is obtained.


12.  Strategies for Improving Genomic Shuffling via Transformation of Linear DNA Fragments


Wild-type members of the Enterobacteriaceae (e.g., Escherichia coli) are typically resistant to genetic exchange following transformation of linear DNA molecules.  This is due, at least in part, to the Exonuclease V (Exo V) activity of the RecBCD
holoenzyme which rapidly degrades linear DNA molecules following transformation.  Production of ExoV has been traced to the recD gene, which encodes the D subunit of the holoenzyme.  As demonstrated by Russet et al. (1989) Journal of Bacteriology
2609-2613, homologous recombination between a transformed linear donor DNA molecule and the chromosome of recipient is readily detected in a strains bearing a loss of function mutation in a recD mutant.  The use of recD strains provides a simple means
for genomic shuffling of the Enterobacteriaceae.  For example, a bacterial strain or set of related strains bearing a recD null mutation (e.g., the E. coli recD1903:mini-Tet allele) is mutagenized and screened for the desired properties.  In a split-pool
fashion, Chromosomal DNA prepared on one aliquot could be used to transform (e.g., via electroporation or chemically induced competence).  the second aliquot.  The resulting transformants are then screened for improvement.


The RecBCD holoezyme plays an important role in initiation of RecA-dependent homologous recombination.  Upon recognizing a dsDNA end, the RecBCD enzyme unwinds and degrades the DNA asymmetrically in a 5' to 3' direction until it encounters a chi
(or "X")-site (consensus 5'-GCTGGTGG-3') which attenuates the nuclease activity.  This results in the generation of a ssDNA terminating near the c site with a 3'-ssDNA tail that is preferred for RecA loading and subsequent invasion of dsDNA for
homologous recombination.  Accordingly, preprocessing of transforming fragments with a 5' to 3' specific ssDNA Exonuclease, such as Lamda (.lambda.) exonuclease (available, e.g., from Boeringer Mannheim) prior to transformation may serve to stimulate
homologous recombination in recD- strain by providing ssDNA invasive end for RecA loading and subsequent strand invasion.


The addition of DNA sequence encoding chi-sites (consensus 5'-GCTGGTGG-3') to DNA fragments can serve to both attenuate Exonuclease V activity and stimulate homologous recombination, thereby obviating the need for a recD mutation (see also,
Kowalczykowski, et al. (1994) "Biochemistry of homologous recombination in Escherichia coli," Microbiol.  Rev.  58:401-465 and Jessen, et al. (1998) "Modification of bacterial artificial chromosomes through Chi-stimulated homologous recombination and its
application in zebrafish transgenesis." Proc.  Natl.  Acad.  Sci.  95:5121-5126).


Chi-sites are optionally included in linkers ligated to the ends of transforming fragments or incorporated into the external primers used to generate DNA fragments to be transformed.  The use of recombination-stimulatory sequences such as chi is
a generally useful approach for evolution of a broad range of cell types by fragment transformation.


Methods to inhibit or mutate analogs of Exo V or other nucleases (such as, Exonucleases I (endA1), III (nth), IV (nfo), VII, and VIII of E. coli) is similarly useful.  Inhibition or elimination of nucleases, or modification of ends of
transforming DNA fragments to render them resistant to exonuclease activity has applications in evolution of a broad range of cell types.


13.  Shuffling to Optimize Unknown Interactions


Many observed traits are the result of complex interactions of multiple genes or gene products.  Most such interactions are still uncharacterized.  Accordingly, it is often unclear which genes need to be optimized to achieve a desired trait, even
if some of the genes contributing to the trait are known.


This lack of characterization is not an issue during DNA shuffling, which produces solutions that optimize whatever is selected for.  An alternative approach, which has the potential to solve not only this problem, but also anticipated future
rate limiting factors, is complementation by overexpression of unknown genomic sequences.


A library of genomic DNA is first made as described, supra.  This is transformed into the cell to be optimized and transformants are screened for increases in a desired property.  Genomic fragments which result in an improved property are evolved
by DNA shuffling to further increase their beneficial effect.  This approach requires no sequence information, nor any knowledge or assumptions about the nature of protein or pathway interactions, or even of what steps are rate limiting; it relies only
on detection of the desired phenotype.  This sort of random cloning and subsequent evolution by DNA shuffling of positively interacting genomic sequences is extremely powerful and generic.  A variety of sources of genomic DNA are used, from isogenic
strains to more distantly related species with potentially desirable properties.  In addition, the technique is applicable to any cell for which the molecular biology basics of transformation and cloning vectors are available, and for any property which
can be assayed (preferably in a high-throughput format).


14.  Homologous Recombination within the Chromosome


Homologous recombination within the chromosome is used to circumvent the limitations of plasmid based evolution and size restrictions.  The strategy is similar to that described above for shuffling genes within their chromosomal context, except
that no in vitro shuffling occurs.  Instead, the parent strain is treated with mutagens such as ultraviolet light or nitrosoguanidine, and improved mutants are selected.  The improved mutants are pooled and split.  Half of the pool is used to generate
random genomic fragments for cloning into a homologous recombination vector.  Additional genomic fragments are optionally derived from related species with desirable properties.  The cloned genomic fragments are homologously recombined into the genomes
of the remaining half of the mutant pool, and variants with improved properties are selected.  These are subjected to a further round of mutagenesis, selection and recombination.  Again this process is entirely generic for the improvement of any whole
cell biocatalyst for which a recombination vector and an assay can be developed.


V. Methods for Recursive Sequence Recombination


Some formats and examples for recursive sequence recombination, sometimes referred to as DNA shuffling or molecular breeding, have been described by the present inventors and co-workers in copending application, 09/100,856 filed Jun.  19, 1998,
PCT/US95/02126 filed Feb.  17, 1995 (published as WO 95/22625); Stemmer, Science 270, 1510 (1995).  Stemmer et al., Gene, 164, 49-53 (1995); Stemmer, Bio/Technology, 13, 549-553 (1995); Stemmer, Proc.  Natl.  Acad.  Sci.  USA 91, 10747-10751 (1994);
Stemmer, Nature 370, 389-391 (1994); Crameri et al., Nature Medicine, 2(1):1-3, (1996), and Crameri et al., Nature Biotechnology 14, 315-319 (1996) (each of which is incorporated by reference in its entirety for all purposes).


As shown in FIGS. 16 and 17, DNA Shuffling provides most rapid technology for evolution of complex new functions.  As shown in FIG. 16, panel (A), recombination in DNA shuffling achieves accumulation of multiple beneficial mutations in a few
cycles.  In contrast, because of the high frequency of deleterious mutations relative to beneficial ones, iterative point mutation must build beneficial mutations one at a time, and consequently requires many cycles to reach the same point.  As shown in
FIG. 16 panel B, rather than a simple linear sequence of mutation accumulation, DNA shuffling is a parallel process where multiple problems may be solved independently, and then combined.


(1) In Vitro Formats


One format for shuffling in vitro is illustrated in FIG. 1.  The initial substrates for recombination are a pool of related sequences.  The X's in the FIG. 1, panel A, show where the sequences diverge.  The sequences can be DNA or RNA and can be
of various lengths depending on the size of the gene or DNA fragment to be recombined or reassembled.  Preferably the sequences are from 50 bp to 50 kb.


The pool of related substrates are converted into overlapping fragments, e.g., from about 5 bp to 5 kb or more, as shown in FIG. 1, panel B. Often, the size of the fragments is from about 10 bp to 1000 bp, and sometimes the size of the DNA
fragments is from about 100 bp to 500 bp.  The conversion can be effected by a number of different methods, such as DNasel or RNase digestion, random shearing or partial restriction enzyme digestion.  Alternatively, the conversion of substrates to
fragments can be effected by incomplete PCR amplification of substrates or PCR primed from a single primer.  Alternatively, appropriate single-stranded fragments can be generated on a nucleic acid synthesizer.  The concentration of nucleic acid fragments
of a particular length and sequence is often less than 0.1% or 1% by weight of the total nucleic acid.  The number of different specific nucleic acid fragments in the mixture is usually at least about 100, 500 or 1000.


The mixed population of nucleic acid fragments are converted to at least partially single-stranded form.  Conversion can be effected by heating to about 80.degree.  C. to 100.degree.  C., more preferably from 90.degree.  C. to 96.degree.  C., to
form single-stranded nucleic acid fragments and then reannealing.  Conversion can also be effected by treatment with single-stranded DNA binding protein or recA protein.  Single-stranded nucleic acid fragments having regions of sequence identity with
other single-stranded nucleic acid fragments can then be reannealed by cooling to 20.degree.  C. to 75.degree.  C., and preferably from 40.degree.  C. to 65.degree.  C. Renaturation can be accelerated by the addition of polyethylene glycol (PEG), other
volume-excluding reagents or salt.  The salt concentration is preferably from 0 mM to 200 mM, more preferably the salt concentration is from 10 mM to 100 mM.  The salt may be KCl or NaCl.  The concentration of PEG is preferably from 0% to 20%, more
preferably from 5% to 10%.  The fragments that reanneal can be from different substrates as shown in FIG. 1, panel C. The annealed nucleic acid fragments are incubated in the presence of a nucleic acid polymerase, such as Taq or Klenow, or proofreading
polymerases, such as pfu or pwo, and dNTP's (i.e. dATP, dCTP, dGTP and dTTP).  If regions of sequence identity are large, Taq polymerase can be used with an annealing temperature of between 45-65.degree.  C. If the areas of identity are small, Klenow
polymerase can be used with an annealing temperature of between 20-30.degree.  C. (Stemmer, Proc.  Natl.  Acad.  Sci.  USA (1994), supra).  The polymerase can be added to the random nucleic acid fragments prior to annealing, simultaneously with annealing
or after annealing.


The process of denaturation, renaturation and incubation in the presence of polymerase of overlapping fragments to generate a collection of polynucleotides containing different permutations of fragments is sometimes referred to as shuffling of
the nucleic acid in vitro.  This cycle is repeated for a desired number of times.  Preferably the cycle is repeated from 2 to 100 times, more preferably the sequence is repeated from 10 to 40 times.  The resulting nucleic acids are a family of
double-stranded polynucleotides of from about 50 bp to about 100 kb, preferably from 500 bp to 50 kb, as shown in FIG. 1, panel D. The population represents variants of the starting substrates showing substantial sequence identity thereto but also
diverging at several positions.  The population has many more members than the starting substrates.  The population of fragments resulting from shuffling is used to transform host cells, optionally after cloning into a vector.


In a variation of in vitro shuffling, subsequences of recombination substrates can be generated by amplifying the full-length sequences under conditions which produce a substantial fraction, typically at least 20 percent or more, of incompletely
extended amplification products.  The amplification products, including the incompletely extended amplification products are denatured and subjected to at least one additional cycle of reannealing and amplification.  This variation, in which at least one
cycle of reannealing and amplification provides a substantial fraction of incompletely extended products, is termed "stuttering." In the subsequent amplification round, the incompletely extended products reanneal to and prime extension on different
sequence-related template species.


In a further variation, a mixture of fragments is spiked with one or more oligonucleotides.  The oligonucleotides can be designed to include precharacterized mutations of a wildtype sequence, or sites of natural variations between individuals or
species.  The oligonucleotides also include sufficient sequence or structural homology flanking such mutations or variations to allow annealing with the wildtype fragments.  Some oligonucleotides may be random sequences.  Annealing temperatures can be
adjusted depending on the length of homology.


In a further variation, recombination occurs in at least one cycle by template switching, such as when a DNA fragment derived from one template primes on the homologous position of a related but different template.  Template switching can be
induced by addition of recA, rad51, rad55, rad57 or other polymerases (e.g., viral polymerases, reverse transcriptase) to the amplification mixture.  Template switching can also be increased by increasing the DNA template concentration.


In a further variation, at least one cycle of amplification can be conducted using a collection of overlapping single-stranded DNA fragments of related sequence, and different lengths.  Fragments can be prepared using a single stranded DNA phage,
such as M13.  Each fragment can hybridize to and prime polynucleotide chain extension of a second fragment from the collection, thus forming sequence-recombined polynucleotides.  In a further variation, ssDNA fragments of variable length can be generated
from a single primer by Vent or other DNA polymerase on a first DNA template.  The single stranded DNA fragments are used as primers for a second, Kunkel-type template, consisting of a uracil-containing circular ssDNA.  This results in multiple
substitutions of the first template into the second.  See Levichkin et al., Mol. Biology 29, 572-577 (1995).


(2) In Vivo Formats


(a) Plasmid-Plasmid Recombination


The initial substrates for recombination are a collection of polynucleotides comprising variant forms of a gene.  The variant forms often show substantial sequence identity to each other sufficient to allow homologous recombination between
substrates.  The diversity between the polynucleotides can be natural (e.g., allelic or species variants), induced (e.g., error-prone PCR), or the result of in vitro recombination.  Diversity can also result from resynthesizing genes encoding natural
proteins with alternative and/or mixed codon usage.  There should be at least sufficient diversity between substrates that recombination can generate more diverse products than there are starting materials.  There must be at least two substrates
differing in at least two positions.  However, commonly a library of substrates of 10.sup.3 -10.sup.8 members is employed.  The degree of diversity depends on the length of the substrate being recombined and the extent of the functional change to be
evolved.  Diversity at between 0.1-50% of positions is typical.  The diverse substrates are incorporated into plasmids.  The plasmids are often standard cloning vectors, e.g., bacterial multicopy plasmids.  However, in some methods to be described below,
the plasmids include mobilization functions.  The substrates can be incorporated into the same or different plasmids.  Often at least two different types of plasmid having different types of selection marker are used to allow selection for cells
containing at least two types of vector.  Also, where different types of plasmid are employed, the different plasmids can come from two distinct incompatibility groups to allow stable co-existence of two different plasmids within the cell.  Nevertheless,
plasmids from the same incompatibility group can still co-exist within the same cell for sufficient time to allow homologous recombination to occur.


Plasmids containing diverse substrates are initially introduced into procaryotic or eukaryotic cells by any transfection methods (e.g., chemical transformation, natural competence, electroporation, viral transduction or biolistics).  Often, the
plasmids are present at or near saturating concentration (with respect to maximum transfection capacity) to increase the probability of more than one plasmid entering the same cell.  The plasmids containing the various substrates can be transfected
simultaneously or in multiple rounds.  For example, in the latter approach cells can be transfected with a first aliquot of plasmid, transfectants selected and propagated, and then infected with a second aliquot of plasmid.


Having introduced the plasmids into cells, recombination between substrates to generate recombinant genes occurs within cells containing multiple different plasmids merely by propagating in the cells.  However, cells that receive only one plasmid
are unable to participate in recombination and the potential contribution of substrates on such plasmids to evolution is not fully exploited (although these plasmids may contribute to some extent if they are propagated in mutator cells or otherwise
accumulate point mutations (i.e., by ultraviolet radiation treatment).  The rate of evolution can be increased by allowing all substrates to participate in recombination.  Such can be achieved by subjecting transfected cells to electroporation.  The
conditions for electroporation are the same as those conventionally used for introducing exogenous DNA into cells (e.g., 1,000-2,500 volts, 400 .mu.F and a 1-2 mM gap).  Under these conditions, plasmids are exchanged between cells allowing all substrates
to participate in recombination.  In addition the products of recombination can undergo further rounds of recombination with each other or with the original substrate.  The rate of evolution can also be increased by use of conjugative transfer. 
Conjugative transfer systems are known in many bacteria (E. coli, P. aeruginosa, S. pneumoniae, and H. influenzae) and can also be used to transfer DNA between bacteria and yeast or between bacteria and mammalian cells.


To exploit conjugative transfer, substrates are cloned into plasmids having MOB genes, and tra genes are also provided in cis or in trans to the MOB genes.  The effect of conjugative transfer is very similar to electroporation in that it allows
plasmids to move between cells and allows recombination between any substrate and the products of previous recombination to occur merely by propagating the culture.  The details of how conjugative transfer is exploited in these vectors are discussed in
more detail below.  The rate of evolution can also be increased by fusing protoplasts of cells to induce exchange of plasmids or chromosomes.  Fusion can be induced by chemical agents, such as PEG, or viruses or viral proteins, such as influenza virus
hemagglutinin, HSV-1 gB and gD.  The rate of evolution can also be increased by use of mutator host cells (e.g., Mut L, S, D, T, H and Ataxia telangiectasia human cell lines).


The time for which cells are propagated and recombination is allowed to occur, of course, varies with the cell type but is generally not critical, because even a small degree of recombination can substantially increase diversity relative to the
starting materials.  Cells bearing plasmids containing recombined genes are subject to screening or selection for a desired function.  For example, if the substrate being evolved contains a drug resistance gene, one selects for drug resistance.  Cells
surviving screening or selection can be subjected to one or more rounds of screening/selection followed by recombination or can be subjected directly to an additional round of recombination.


The next round of recombination can be achieved by several different formats independently of the previous round.  For example, a further round of recombination can be effected simply by resuming the electroporation or conjugation-mediated
intercellular transfer of plasmids described above.  Alternatively, a fresh substrate or substrates, the same or different from previous substrates, can be transfected into cells surviving selection/screening.  Optionally, the new substrates are included
in plasmid vectors bearing a different selective marker and/or from a different incompatibility group than the original plasmids.  As a further alternative, cells surviving selection/screening can be subdivided into two subpopulations, and plasmid DNA
from one subpopulation transfected into the other, where the substrates from the plasmids from the two subpopulations undergo a further round of recombination.  In either of the latter two options, the rate of evolution can be increased by employing DNA
extraction, electroporation, conjugation or mutator cells, as described above.  In a still further variation, DNA from cells surviving screening/selection can be extracted and subjected to in vitro DNA shuffling.


After the second round of recombination, a second round of screening/selection is performed, preferably under conditions of increased stringency.  If desired, further rounds of recombination and selection/screening can be performed using the same
strategy as for the second round.  With successive rounds of recombination and selection/screening, the surviving recombined substrates evolve toward acquisition of a desired phenotype.  Typically, in this and other methods of recursive recombination,
the final product of recombination that has acquired the desired phenotype differs from starting substrates at 0.1%-25% of positions and has evolved at a rate orders of magnitude in excess (e.g., by at least 10-fold, 100-fold, 1000-fold, or 10,000 fold)
of the rate of naturally acquired mutation of about 1 mutation per 10.sup.-9 positions per generation (see Anderson & Hughes, Proc.  Natl.  Acad.  Sci.  USA 93, 906-907 (1996)).


(b) Virus-Plasmid Recombination


The strategy used for plasmid-plasmid recombination can also be used for virus-plasmid recombination; usually, phage-plasmid recombination.  However, some additional comments particular to the use of viruses are appropriate.  The initial
substrates for recombination are cloned into both plasmid and viral vectors.  It is usually not critical which substrate(s) are inserted into the viral vector and which into the plasmid, although usually the viral vector should contain different
substrate(s) from the plasmid.  As before, the plasmid (and the virus) typically contains a selective marker.  The plasmid and viral vectors can both be introduced into cells by transfection as described above.  However, a more efficient procedure is to
transform the cells with plasmid, select transformants and infect the transformants with a virus.  Because the efficiency of infection of many viruses approaches 100% of cells, most cells transformed and infected by this route contain both a plasmid and
virus bearing different substrates.


Homologous recombination occurs between plasmid and virus generating both recombined plasmids and recombined virus.  For some viruses, such as filamentous phage, in which intracellular DNA exists in both double-stranded and single-stranded forms,
both can participate in recombination.  Provided that the virus is not one that rapidly kills cells, recombination can be augmented by use of electroporation or conjugation to transfer plasmids between cells.  Recombination can also be augmented for some
types of virus by allowing the progeny virus from one cell to reinfect other cells.  For some types of virus, virus infected-cells show resistance to superinfection.  However, such resistance can be overcome by infecting at high multiplicity and/or using
mutant strains of the virus in which resistance to superinfection is reduced.


The result of infecting plasmid-containing cells with virus depends on the nature of the virus.  Some viruses, such as filamentous phage, stably exist with a plasmid in the cell and also extrude progeny phage from the cell.  Other viruses, such
as lambda having a cosmid genome, stably exist in a cell like plasmids without producing progeny virions.  Other viruses, such as the T-phage and lytic lambda, undergo recombination with the plasmid but ultimately kill the host cell and destroy plasmid
DNA.  For viruses that infect cells without killing the host, cells containing recombinant plasmids and virus can be screened/selected using the same approach as for plasmid-plasmid recombination.  Progeny virus extruded by cells surviving
selection/screening can also be collected and used as substrates in subsequent rounds of recombination.  For viruses that kill their host cells, recombinant genes resulting from recombination reside only in the progeny virus.  If the screening or
selective assay requires expression of recombinant genes in a cell, the recombinant genes should be transferred from the progeny virus to another vector, e.g., a plasmid vector, and retransfected into cells before selection/screening is performed.


For filamentous phage, the products of recombination are present in both cells surviving recombination and in phage extruded from these cells.  The dual source of recombinant products provides some additional options relative to the
plasmid-plasmid recombination.  For example, DNA can be isolated from phage particles for use in a round of in vitro recombination.  Alternatively, the progeny phage can be used to transfect or infect cells surviving a previous round of
screening/selection, or fresh cells transfected with fresh substrates for recombination.


(c) Virus-Virus Recombination


The principles described for plasmid-plasmid and plasmid-viral recombination can be applied to virus-virus recombination with a few modifications.  The initial substrates for recombination are cloned into a viral vector.  Usually, the same vector
is used for all substrates.  Preferably, the virus is one that, naturally or as a result of mutation, does not kill cells.  After insertion, some viral genomes can be packaged in vitro.  The packaged viruses are used to infect cells at high multiplicity
such that there is a high probability that a cell receives multiple viruses bearing different substrates.


After the initial round of infection, subsequent steps depend on the nature of infection as discussed in the previous section.  For example, if the viruses have phagemid genomes such as lambda cosmids or M13, F1 or Fd phagemids, the phagemids
behave as plasmids within the cell and undergo recombination simply by propagating the cells.  Recombination can be augmented by electroporation of cells.  Following selection/screening, cosmids containing recombinant genes can be recovered from
surviving cells (e.g., by heat induction of a cos- lysogenic host cell), repackaged in vitro, and used to infect fresh cells at high multiplicity for a further round of recombination.


If the viruses are filamentous phage, recombination of replicating form DNA occurs by propagating the culture of infected cells.  Selection/screening identifies colonies of cells containing viral vectors having recombinant genes with improved
properties, together with phage extruded from such cells.  Subsequent options are essentially the same as for plasmid-viral recombination.


(d) Chromosome-Plasmid Recombination


This format can be used to evolve both the chromosomal and plasmid-borne substrates.  The format is particularly useful in situations in which many chromosomal genes contribute to a phenotype or one does not know the exact location of the
chromosomal gene(s) to be evolved.  The initial substrates for recombination are cloned into a plasmid vector.  If the chromosomal gene(s) to be evolved are known, the substrates constitute a family of sequences showing a high degree of sequence identity
but some divergence from the chromosomal gene.  If the chromosomal genes to be evolved have not been located, the initial substrates usually constitute a library of DNA segments of which only a small number show sequence identity to the gene or gene(s)
to be evolved.  Divergence between plasmid-borne substrate and the chromosomal gene(s) can be induced by mutagenesis or by obtaining the plasmid-borne substrates from a different species than that of the cells bearing the chromosome.


The plasmids bearing substrates for recombination are transfected into cells having chromosomal gene(s) to be evolved.  Evolution can occur simply by propagating the culture, and can be accelerated by transferring plasmids between cells by
conjugation, electroporation or protoplast fusion.  Evolution can be further accelerated by use of mutator host cells or by seeding a culture of nonmutator host cells being evolved with mutator host cells and inducing intercellular transfer of plasmids
by electroporation, conjugation or protoplast fusion.  Preferably, mutator host cells used for seeding contain a negative selection marker to facilitate isolation of a pure culture of the nonmutator cells being evolved.  Selection/screening identifies
cells bearing chromosomes and/or plasmids that have evolved toward acquisition of a desired function.


Subsequent rounds of recombination and selection/screening proceed in similar fashion to those described for plasmid-plasmid recombination.  For example, further recombination can be effected by propagating cells surviving recombination in
combination with electroporation, conjugative transfer of plasmids, or protoplast fusion.  Alternatively, plasmids bearing additional substrates for recombination can be introduced into the surviving cells.  Preferably, such plasmids are from a different
incompatibility group and bear a different selective marker than the original plasmids to allow selection for cells containing at least two different plasmids.  As a further alternative, plasmid and/or chromosomal DNA can be isolated from a subpopulation
of surviving cells and transfected into a second subpopulation., Chromosomal DNA can be cloned into a plasmid vector before transfection.


(e) Virus-Chromosome Recombination


As in the other methods described above, the virus is usually one that does not kill the cells, and is often a phage or phagemid.  The procedure is substantially the same as for plasmid-chromosome recombination.  Substrates for recombination are
cloned into the vector.  Vectors including the substrates can then be transfected into cells or in vitro packaged and introduced into cells by infection.  Viral genomes recombine with host chromosomes merely by propagating a culture.  Evolution can be
accelerated by allowing intercellular transfer of viral genomes by electroporation, or reinfection of cells by progeny virions.  Screening/selection identifies cells having chromosomes and/or viral genomes that have evolved toward acquisition of a
desired function.


There are several options for subsequent rounds of recombination.


For example, viral genomes can be transferred between cells surviving selection/recombination by electroporation.  Alternatively, viruses extruded from cells surviving selection/screening can be pooled and used to superinfect the cells at high
multiplicity.  Alternatively, fresh substrates for recombination can be introduced into the cells, either on plasmid or viral vectors.


(f) Poolwise Whole Genome Recombination


Asexual evolution is a slow and inefficient process.  Populations move as individuals rather than as a group.  A diverse population is generated by mutagenesis of a single parent, resulting in a distribution of fit and unfit individuals.  In the
absence of a sexual cycle, each piece of genetic information for the surviving population remains in the individual mutants.  Selection of the fittest results in many fit individuals being discarded, along with the genetically useful information they
carry.  Asexual evolution proceeds one genetic event at a time, and is thus limited by the intrinsic value of a single genetic event.  Sexual evolution moves more quickly and efficiently.  Mating within a population consolidates genetic information
within the population and results in useful information being combined together.  The combining of useful genetic information results in progeny that are much more fit than their parents.  Sexual evolution thus proceeds much faster by multiple genetic
events.  These differences are further illustrated in FIG. 17.  In contrast to sexual evolution, DNA shuffling is the recursive mutagenesis, recombination, and selection of DNA sequences (see also, FIG. 25.).


Sexual recombination in nature effects pairwise recombination and results in progeny that are genetic hybrids of two parents.  In contrast, DNA shuffling in vitro effects poolwise recombination, in which progeny are hybrids of multiple parental
molecules.  This is because DNA shuffling effects many individual pairwise recombination events with each thermal cycle.  After many cycles the result is a repetitively inbred population, with the "progeny" being the F.sub.X (for X cycles of reassembly)
of the original parental molecules.  These progeny are potentially descendants of many or all of the original parents.  The graph shown in FIG. 25 shows a plot of the potential number of mutations an individual can accumulate by sequential, pairwise and
poolwise recombination.


Poolwise recombination is an important feature to DNA shuffling in that it provides a means of generating a greater proportion of the possible combinations of mutations from a single "breeding" experiment.  In this way, the "genetic potential" of
a population can be readily assessed by screening the progeny of a single DNA shuffling experiment.


For example, if a population consists of 10 single mutant parents, there are 2.sup.10 =1024 possible combinations of those mutations ranging from progeny having 0-10 mutations.  Of these 1024, only 56 will result from a single pairwise cross
(FIG. 14) (i.e those having 0, 1, and 2 mutations).  In nature the multiparent combinations will eventually arise after multiple random sexual matings, assuming no selection is imparted to remove some mutations from the population.  In this way, sex
effects the consolidation and sampling of all useful mutant combinations possible within a population.  For the purposes of directed evolution, having the greatest number of mutant combinations entering a screen or selection is desirable so that the best
progeny (i.e., according to the selection criteria used in the selection screen) is identified in the shortest possible time.


One challenge to in vivo and whole genome shuffling is devising methods for effecting poolwise recombination or multiple repetitive pairwise recombination events.  In crosses with a single pairwise cross per cycle before screening, the ability to
screen the "genetic potential" of the starting population is limited.  For this reason, the rate of in vivo and whole genome shuffling mediated cellular evolution would be facilitated by effecting poolwise recombination.  Two strategies for poolwise
recombination are described below (protoplast fusion and transduction).


(i.) Protoplast Fusion--Protoplast fusion (discussed supra) mediated whole genome shuffling (WGS) is one format that can directly effect poolwise recombination.  Whole gene shuffling is the recursive recombination of whole genomes, in the form of
one or more nucleic acid molecule(s) (fragments, chromosomes, episomes, etc), from a population of organisms, resulting in the production of new organisms having distributed genetic information from at least two of the starting population of organisms. 
The process of protoplast fusion is further illustrated in FIG. 26.


Progeny resulting from the fusion of multiple parent protoplasts have been observed (Hopwood & Wright, 1978), however, these progeny are rare (10.sup.-4 -10.sup.-6).  The low frequency is attributed to the distribution of fusants arising from
two, three, four, etc parents and the likelihood of the multiple recombination events (6 crossovers for a four parent cross) that would have to occur for multiparent progeny to arise.  Thus, it is useful to enrich for the multiparent progeny.  This can
be accomplished, e.g., by repetitive fusion or enrichment for multiply fused protoplasts.  The process of poolwise fusion and recombination is further illustrated in FIG. 27.


(ii.) Repetitive Fusion: Protoplasts of identified parental cells are prepared, fused and regenerated.  Protoplasts of the regenerated progeny are then, without screening or enrichment, formed, fused and regenerated.  This can be carried out for
two, three, or more cycles before screening to increase the representation of multiparent progeny.  The number of possible mutations/progeny doubles for each cycle.  For example, if one cross produces predominantly progeny with 0, 1, and 2 mutations, a
breeding of this population with itself will produce progeny with 0, 1, 2, 3, and 4 mutations (FIG. 15), the third cross up to eight, etc. The representation of the multiparent progeny from these subsequent crosses will not be as high as the single and
double parent progeny, but it will be detectable and much higher than from a single cross.  The repetitive fusion prior to screening is analogous to many sexual crosses within a population, and the individual thermal cycles of in vitro DNA shuffling
described supra.  A factor effecting the value of this approach is the starting size of the parental population.  As the population grows, it becomes more likely that a multiparent fusion will arise from repetitive fusions.  For example, if 4 parents are
fused twice, the 4 parent progeny will make up approximately 0.2% of the total progeny.  This is sufficient to find in a population of 3000 (95% confidence), but better representation is preferable.  If ten parents are fused twice >20% of the progeny
will be four parent offspring.


(iii.) Enrichment for multiply fused protoplasts: After the fusion of a population of protoplasts, the fusants are typically diluted into hypotonic medium, to dilute out the fusing agent (e.g., 50% PEG).  The fused cells can be grown for a short
period to regenerate cell walls or separated directly and are then separated on the basis of size.  This is carried out, e.g., by cell sorting, using light dispersion as an estimate of size, to isolate the largest fusants.  Alternatively the fusants can
be sorted by FACS on the basis of DNA content.  The large fusants or those containing more DNA result from the fusion of multiple parents and are more likely to segregate to multiparent progeny.  The enriched fusants are regenerated and screened directly
or the progeny are fused recursively as above to further enrich the population for diverse mutant combinations.


(iv.) Transduction--Transduction can theoretically effect poolwise recombination, if the transducing phage particles contain predominantly host genomic DNA rather than phage DNA.  If phage DNA is overly represented, then most cells will receive
at least one undesired phage genome.  Phage particles generated from locked-in-prophage (supra) are useful for this purpose.  A population of cells is infected with an appropriate transducing phage, and the lysate is collected and used to infect the same
starting population.  A high multiplicity of infection is employed to deliver multiple genomic fragments to each infected cell, thereby increasing the chance of producing recombinants containing mutations from more than two parent genomes.  The resulting
transductants are recovered under conditions where phage can not propagate e.g., in the presence of citrate.  This population is then screened directly or infected again with phage, with the resulting transducing particles being used to transduce the
first progeny.  This would mimic recursive protoplast fusion, multiple sexual recombination, and in vitro DNA shuffling.


(g) Methods for Whole Genome Shuffling by Blind Family Shuffling of Parsed Genomes and Recursive Cycles of Forced Integration and Excision by Homologous Recombination, and Screening for Improved Phenotypes.


In vitro methods have been developed to shuffle single genes and operons, as set forth, e.g., herein.  "Family" shuffling of homologous genes within species and from different species is also an effective methods for accelerating molecular
evolution.  This section describes additional methods for extending these methods such that they can be applied to whole genomes.


In some cases, the genes that encode rate limiting steps in a biochemical process, or that contribute to a phenotype of interest are known.  This method can be used to target family shuffled libraries to such loci, generating libraries of
organisms with high quality family shuffled libraries of alleles at the locus of interest.  An example of such a gene would be the evolution of a host chaperonin to more efficiently chaperone the folding of an overexpressed protein in E. coli.


The goals of this process are to shuffle homologous genes from two or more species and to then integrate the shuffled genes into the chromosome of a target organism.  Integration of multiple shuffled genes at multiple loci can be achieved using
recursive cycles of integration (generating duplications), excision (leaving the improved allele in the chromosome) and transfer of additional evolved genes by serially applying the same procedure.


In the first step, genes to be shuffled into suitable bacterial vectors are subcloned.  These vectors can be plasmids, cosmids, BACS or the like.  Thus, fragments from 100 bp to 100 kb can be handled.  Homologous fragments are then "family
shuffled" together (i.e. homologous fragments from different species or chromosomal locations are homologously recombined).  As a simple case, homologs from two species (say, E. coli and Salmonella) are cloned, family shuffled in vitro and cloned into an
allele replacement vector (e.g., a vector with a positively selectable marker, a negatively selectable marker and conditionally active origin of replication).  The basic strategy for whole genome family shuffling of parsed (subcloned) genomes is
additionally set forth in FIG. 22.


The vectors are transduced into E. coli and selected, e.g., for drug resistance.  Most drug resistant vectors occur only by homologous recombination between a family shuffled insert and a chromosomal copy of the cloned insert.  Colonies with
improved phenotype are screened (e.g., by mass spectroscopy for enzyme activity or small molecule production, or a chromogenic screen, or the like, depending on the phenotype to be assayed).  Negative selection (i.e. sac selection) is imposed to force
excision of tandem duplication.  Roughly half of the colonies should retain the improved phenotype.  Importantly, this process regenerates a `clean` chromosome in which the wild type locus is replaced with a family shuffled fragment that encodes a
beneficial allele.  Since the chromosome is "clean" (i.e., has no vector sequences), other improved alleles can also be moved into this point on the chromosome by homologous recombination.


In subsequent rounds, independently identified improved alleles are optionally moved into the improved strain (e.g., by P1 transduction of the drug marked tandem duplication above).  Transductants are screened for further improvement in phenotype
by virtue of receiving the transduced tandem duplication, which itself contains the family shuffled genetic material.  Negative selection is again imposed and the process of shuffling the improved strain is recursively repeated as desired.


Although this process was described with reference to targeting a gene or genes of interest, it can be used "blindly," making no assumptions about which locus is to be targeted.  This procedure is set forth in FIG. 23.  For example, the whole
genome of an organism of interest is cloned into manageable fragments (e.g., 10 kb for plasmid-based methods).  Homologous fragments are then isolated from related species.


For E. coli., cloning the genome in 10 kb fragments requires about 300 clones.  The homologous fragments are isolated, e.g., from Salmonella.  This gives roughly three hundred pairs of homologous fragments.  Each pair is family shuffled and the
shuffled fragments are cloned into an allele replacement vector.  The inserts are integrated into the E. coli genome as described above.  A global screen is made to identify variants with an improved phenotype.  This serves as the basis collection of
improvements that are to be shuffled to produce a desired strain.  The shuffling of these independently identified variants into one super strain is done as described above.


(h) Methods for High Throughput Family Shuffling of Genes


Family shuffling has been shown to be an efficient method for creating high quality libraries of genetic variants.  Given a cloned gene from one species, it is of interest to quickly and rapidly isolate homologs from other species, and this
process can be rate limiting.  For example, if one wants to perform family shuffling on an entire genome, one may need to construct hundreds to thousands of individual family shuffled libraries.


In this embodiment, a gene of interest is optionally cloned into a vector in which ssDNA can be made.  An example of such a vector is a phagemid vector with an M13 origin of replication.  Genomic DNA or cDNA from a species of interest is
isolated, denatured, annealed to the phagemid, and then enzymatically manipulated to clone it.  The cloned DNA is then used to family shuffle with the original gene of-interest.  PCR based formats are also available.  These formats require no
intermediate cloning steps, and are, therefore, of particular interest for high throughput applications.


Shuffling the E. coli chaperonin gene DnaJ with other homologs is described below as an example.  The example can be generalized to any other gene, including eukaryotic genes such as plant or animal genes (including mammalian genes), by following
the format described.  FIG. 24 provides a schematic outline of the steps to high throughput family shuffling.


As a first step, the E. coli DnaJ gene is cloned into an M13 phagemid vector.  ssDNA is then produced, preferably in a dut(-) ung(-) strain so that Kunkel site directed mutagenesis protocols can be applied.  Genomic DNA is then isolated from a
non-E. coil source, such as Salmonella and Yersinia Pestis.  The bacterial genomic DNAs are denatured and reannealed to the phagemid ssDNA (e.g., about 1 microgram of ssDNA).  The reannealled product is treated with an enzyme such as Mung Bean nuclease
that degrades ssDNA as an exonuclease but not as an endonuclease (the nuclease does not degrade mismatched DNA that is embedded in a larger annealed fragment).  The standard Kunkel site directed mutagenesis protocol is used to extend the fragment and the
target cells are transformed with the resulting mutagenized DNA.


In a first variation on the above, the procedure is adapted to the situation where the target gene or genes of interest are unknown, In this variation, the whole genome of the organism of interest is cloned in fragments (e.g., of about 10 kb
each) into a phagemid.  Single stranded phagemid DNA is then produced.  Genomic DNA from the related species is denatured and annealed to the phagemids.  Mung bean nuclease is used to trim away unhybridized DNA ends.  Polymerase plus ligase is used to
fill in the resulting gapped circles.  These clones are transformed into a mismatch repair deficient strain.  When the mismatched molecules are replicated in the bacteria, most colonies contain both the E. coli and the homologous fragment.  The two
homologous genes are then isolated from the colonies (e.g., either by standard plasmid purification or colony PCR) and shuffled.


Another approach to generating chimeras that requires no in vitro shuffling is simply to clone the Salmonella genome into an allele replacement vector, transform E. coli, and select for chromosomal integrants.  Homologous recombination between
Salmonella genes and E. coli homologs generate shuffled chimeras.  A global screen is done to screen for improved phenotypes.  If colonies with improved phenotypes are obtained, it is verified that the improvement is due to allele replacement by P1
transduction into a fresh strain and counterscreening for improved phenotype.  A collection of such improved alleles can then be combined into one strain using the methods for whole genome shuffling by blind family shuffling of parsed genomes as set
forth herein.  Additionally, once these loci are identified, it is likely that further rounds of shuffling and screening will yield further improvements.  This could be done by cloning the chimeric gene and then using the methods described in this
disclosure to breed the gene with homologs from many different strains of bacteria.


In general, the transformants contain clones of the homologue of the target gene (e.g., E. coli DnaJ in the example above).  Mismatch repair in vivo results in a decrease in diversity of the gene.  There are at least two solutions to this. 
First, transduction can be performed into a mismatch repair strain.  Alternatively or in addition, the M13 template DNA can be selectively degraded, leaving the cloned homologue.  This can be done using methods similar to the standard Eckstein site
directed mutagenesis technique (General texts which describe general molecular biological techniques useful herein, including mutagenesis, include Sambrook et al., Molecular Cloning--A Laboratory Manual (2nd Ed.), Vol. 1-3, Cold Spring Harbor Laboratory,
Cold Spring Harbor, N.Y., 1989 ("Sambrook") and Current Protocols in Molecular Biology, F. M. Ausubel et al., eds., Current Protocols, a joint venture between Greene Publishing Associates, Inc.  and John Wiley & Sons, Inc., (supplemented through 1998)
("Ausubel")).


This method relies on incorporation of alpha thiol modified dNTP's during synthesis of the new strand followed by selective degradation of the template and resynthesis of the template strand.  In one embodiment, the template strand is grown in a
dut(-) ung(-) strain so that uracil is incorporated into the phagemid DNA.  After extension as noted above (and before transformation) the DNA is treated with uracil glycosylate and an apurinic site endonuclease such as Endo III or Endo IV.  The treated
DNA is then treated with a processive exonuclease that resects from the resulting gaps while leaving the other strand intact (as in Eckstein mutagenesis).  The DNA is polymerized and ligated.  Target cells are then transformed.  This process enriches for
clones encoding the homologue which is not derived from the target (i.e., in the example above, the non-E. coli.  homologue).


An analogous procedure is optionally performed in a PCR format.  As applied to the DnaJ illustration above, DnaJ DNA is amplified by PCR with primers that build 30-mer priming sites on each end.  The PCR is denatured and annealed with an excess
of Salmonella genomic DNA.  The Salmonella DnaJ gene hybribidizes with the E. coli homologue.  After treatment with Mung Bean nuclease, the resulting mismatched hybrid is PCR amplified with the flanking 30-mer primers.  This PCR product can be used
directly for family shuffling.


As genomics provides an increasing amount of sequence information, it is increasingly possible to directly PCR amplify homologs with designed primers.  For example, given the sequence of the E. coli genome and of a related genome (i.e.
Salmonella), each genome can be PCR amplified with designed primers in, e.g., 5 kb fragments.  The homologous fragments can be put together in a pairwise fashion for shuffling.  For genome shuffling, the shuffled products are cloned into the allele
replacement vector and bred into the genome as described supra.


Hyper-Recombinogenic RecA Clones


The invention further provides hyper-recombinogenic RecA proteins (see, the examples below).  Examples of such proteins are from clones 2, 4, 5, 6 and 13 shown in FIG. 13.  It is fully expected that one of skill can make a variety of related
recombinogenic proteins given the disclosed sequences.


First, clones comprising the sequences in FIGS. 12 and 13 are optionally used as the starting point for any of the shuffling methods herein, providing a starting point for mutation and recombination to improve the clones which are shown.


Second, standard molecular biological techniques can be used to make nucleic acids which comprise the given nucleic acids, e.g., by cloning the nucleic acids into any known vector.  Examples of appropriate cloning and sequencing techniques, and
instructions sufficient to direct persons of skill through many cloning exercises are found in Berger and Kimmel, Guide to Molecular Cloning Techniques, Methods in Enzymology volume 152 Academic Press, Inc., San Diego, Calif.  (Berger); Sambrook et al.
(1989) Molecular Cloning--A Laboratory Manual (2nd ed.) Vol. 1-3, Cold Spring Harbor Laboratory, Cold Spring Harbor Press, N.Y., (Sambrook); and Current Protocols in Molecular Biology, F. M. Ausubel et al., eds., Current Protocols, a joint venture
between Greene Publishing Associates, Inc.  and John Wiley & Sons, Inc., (1994 Supplement) (Ausubel).  Product information from manufacturers of biological reagents and experimental equipment also provide information useful in known biological methods. 
Such manufacturers include the SIGMA chemical company (Saint Louis, Mo.), R&D systems (Minneapolis, Minn.), Pharmacia LKB Biotechnology (Piscataway, N.J.), CLONTECH Laboratories, Inc.  (Palo Alto, Calif.), Chem Genes Corp., Aldrich Chemical Company
(Milwaukee, Wis.), Glen Research, Inc., GIBCO BRL Life Technologies, Inc.  (Gaithersberg, Md.), Fluka Chemica-Biochemika Analytika (Fluka Chemie AG, Buchs, Switzerland), Invitrogen, San Diego, Calif., and Applied Biosystems (Foster City, Calif.), as well
as many other commercial sources known to one of skill.


Third, it will be appreciated that conservative substitutions of the given sequences can be used to produce nucleic acids which encode hyperrecombinogenic clones.  "Conservatively modified variations" of a particular nucleic acid sequence refers
to those nucleic acids which encode identical or essentially identical amino acid sequences, or where the nucleic acid does not encode an amino acid sequence, to essentially identical sequences.  Because of the degeneracy of the genetic code, a large
number of functionally identical nucleic acids encode any given polypeptide.  For instance, the codons CGU, CGC, CGA, CGG, AGA, and AGG all encode the amino acid arginine.  Thus, at every position where an arginine is specified by a codon, the codon can
be altered to any of the corresponding codons described without altering the encoded polypeptide.  Such nucleic acid variations are "silent variations," which are one species of "conservatively modified variations." Every nucleic acid sequence herein
which encodes a polypeptide also describes every possible silent variation.  One of skill will recognize that each codon in a nucleic acid (except AUG, which is ordinarily the only codon for methionine) can be modified to yield a functionally identical
molecule by standard techniques.  Accordingly, each "silent variation" of a nucleic acid which encodes a polypeptide is implicit in any described sequence.  Furthermore, one of skill will recognize that individual substitutions, deletions or additions
which alter, add or delete a single amino acid or a small percentage of amino acids (typically less than 5%, more typically less than 1%) in an encoded sequence are "conservatively modified variations" where the alterations result in the substitution of
an amino acid with a chemically similar amino acid.  Conservative substitution tables providing functionally similar amino acids are well known in the art.  The following six groups each contain amino acids that are conservative substitutions for one
another: 1) Alanine (A), Serine (S), Threonine (T); 2) Aspartic acid (D), Glutamic acid (E); 3) Asparagine (N), Glutamine (Q); 4) Arginine (R), Lysine (K); 5) Isoleucine (I), Leucine (L), Methionine (M), Valine (V); and 6) Phenylalanine (F), Tyrosine
(Y), Tryptophan (W).  See also, Creighton (1984) Proteins W.H.  Freeman and Company.  Finally, the addition of sequences which do not alter the activity of a nucleic acid molecule, such as a non-functional sequence is a conservative modification of the
basic nucleic acid.


One of skill will appreciate that many conservative variations of the nucleic acid constructs disclosed yield a functionally identical construct.  For example, due to the degeneracy of the genetic code, "silent substitutions" (i.e., substitutions
of a nucleic acid sequence which do not result in an alteration in an encoded polypeptide) are an implied feature of every nucleic acid sequence which encodes an amino acid.  Similarly, "conservative amino acid substitutions," in one or a few amino acids
in an amino acid sequence of a packaging or packageable construct are substituted with different amino acids with highly similar properties, are also readily identified as being highly similar to a disclosed construct.  Such conservatively substituted
variations of each explicitly disclosed sequence are a feature of the present invention.


Fourth, nucleic acids which hybridize under stringent conditions to the nucleic acids in the figures are a feature of the invention.  "Stringent hybridization wash conditions" in the context of nucleic acid hybridization experiments such as
Southern and northern hybridizations are sequence dependent, and are different under different environmental parameters.  An extensive guide to the hybridization of nucleic acids is found in Tijssen (1993) Laboratory Techniques in Biochemistry and
Molecular Biology--Hybridization with Nucleic Acid Probes part 1 chapter 2 "overview of principles of hybridization and the strategy of nucleic acid probe assays", Elsevier, N.Y.  Generally, highly stringent hybridization and wash conditions are selected
to be about 5.degree.  C. lower than the thermal melting point (T.sub.m) for the specific sequence at a defined ionic strength and ph.  The T.sub.m is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to
a perfectly matched probe.  Very stringent conditions are selected to be equal to the T.sub.m for a particular probe.  In generai, a signal to noise ratio of 2.times.  (or higher) than that observed for an unrelated probe in the particular hybridization
assay indicates detection of a specific hybridization.


Nucleic acids which do not hybridize to each other under stringent conditions are still substantially identical if the polypeptides which they encode are substantially identical.  This occurs, e.g., when a copy of a nucleic acid is created using
the maximum codon degeneracy permitted by the genetic code.


Finally, preferred nucleic acids encode hyper-recombinogenic RecA proteins which are at least one order of magnitude (10 times) as active as a wild-type RecA protein.


EXAMPLES


The following examples are offered to illustrate, but not to limit the present invention.  Variations upon the exact procedures set forth will be apparent to one of skill upon review of the present disclosure.


Example 1


Evolving Hyper-Recombinogenic RecA


RecA protein is implicated in most E. coli homologous recombination pathways.  Most mutations in recA inhibit recombination, but some have been reported to increase recombination (Kowalczykowski et al., Microbiol.  Rev., 58, 401-465 (1994)).  The
following example describes evolution of RecA to acquire hyper-recombinogenic activity useful in in vivo shuffling formats.


Hyperrecombinogenic RecA was selected using a modification of a system developed by Shen et al., Genetics 112, 441-457 (1986); Shen et al., Mol. Gen.  Genet.  218, 358-360 (1989)) to measure the effect of substrate length and homology on
recombination frequency.  Shen & Huang's system used plasmids and bacteriophages with small (31-430 bp) regions of homology at which the two could recombine.  In a restrictive host, only phage that had incorporated the plasmid sequence were able to form
plaques.


For shuffling of recA, endogenous recA and mutS were deleted from host strain MC1061.  In this strain, no recombination was seen between plasmid and phage.  E. coli recA was then cloned into two of the recombination vectors (Bp221 and
.pi.MT631c18).  Plasmids containing cloned RecA were able to recombine with homologous phage:.kappa.V3 (430 bp identity with Bp221),.function.V13 (430 bp stretch of 89% identity with Bp221) and .kappa.link H (31bp identity with .pi.Mt631c18, except for 1
mismatch at position 18).


The cloned RecA was then shuffled in vitro using the standard DNase-treatment followed by PCR-based reassembly.  Shuffled plasmids were transformed into the nonrecombining host strain.  These cells were grown up overnight, infected with phage
.kappa.Vc, .kappa.V13 or .kappa.link H, and plated onto NZCYM plates in the presence of a 10-fold excess of MC1061 lacking plasmid.  The more efficiently a recA allele promotes recombination between plasmid and phage, the more highly the allele is
represented in the bacteriophage DNA.  Consequently, harvesting all the phage from the plates and recovering the recA genes selects for the most recombinogenic recA alleles.


Recombination frequencies for wild type and a pool of hyperrecombinogenic RecA after 3 rounds of shuffling were as follows:


 Cross Wild Type Hyper Recom  BP221 .times. V3 6.5 .times. 10.sup.-4 3.3 .times. 10.sup.-2  BP221 .times. V13 2.2 .times. 10.sup.-5 1.0 .times. 10.sup.-3  .sup..pi. MT631c18 .times. link H 8.7 .times. 10.sup.-6 4.7 .times.  10.sup.-5


These results indicate a 50-fold increase in recombination for the 430 bp substrate, and a 5-fold increase for the 31 bp substrate.


The recombination frequency between BP221 and V3 for five individual clonal isolates are shown below, and the DNA and protein sequences and alignments thereof are included in FIGS. 12 and 13.


 Wildtype: 1.6 .times. 10.sup.-4  Clone 2: 9.8 .times. 10.sup.-3 (61 .times. increase)  Clone 4: 9.9 .times. 10.sup.-3 (62 .times. increase)  Clone 5: 6.2 .times. 10.sup.-3 (39 .times. increase)  Clone 6: 8.5 .times. 10.sup.-3 (53 .times.
increase)  Clone 13: 0.019 (116 .times. increase)


Clones 2, 4, 5, 6 and 13 can be used as the substrates in subsequent rounds of shuffling, if further improvement in recA is desired.  Not all of the variations from the wildtype recA sequence necessarily contribute to the hyperrecombinogenic
phenotype.  Silent variations can be eliminated by backcrossing.  Alternatively, variants of recA incorporating individual points of variation from wildtype at codons 5, 18, 156, 190, 236, 268, 271, 283, 304, 312, 317, 345 and 353 can be tested for
activity.


Example 2


Whole Organism Evolution for Hyper-Recombination


The possibility of selection for an E. coli strain with an increased level of recombination was indicated from phenotypes of wild-type, .DELTA.recA, mutS and .DELTA.recA mutS strains following exposure to mitomycin C, an inter-strand
cross-linking agent of DNA.


Exposure of E. coli to mitomycin C causes inter-strand cross-linking of DNA thereby blocking DNA replication.  Repair of the inter-strand DNA cross links in E. coli occurs via a RecA-dependent recombinational repair pathway (Friedberg et al., in
DNA Repair and Mutagenesis (1995) pp.  191-232).  Processing of cross-links during repair results in occasional double-strand DNA breaks, which too are repaired by a RecA-dependent recombinational route.  Accordingly, recA-strains are significantly more
sensitive than wildtype strains to mitomycin C exposure.  In fact, mitomycin C is used in simple disk-sensitivity assays to differentiate between RecA.sup.+ and RecA.sup.- strains.


In addition to its recombinogenic properties, mitomycin C is a mutagen.  Exposure to DNA damaging agents, such as mitomycin C, typically results in the induction of the E. coli SOS regulon which includes products involved in error-prone repair of
DNA damage (Friedberg et al., 1995, supra, at pp.  465-522).


Following phage P1-mediated generalized transduction of the .DELTA.(recA-srl):Tn10 allele (a nonfunctional allele) into wild-type and mutS E. coli, tetracycline-resistant transductants were screened for a recA-phenotype using the mitomycin
C-sensitivity assay.  It was observed in LB overlays with a 1/4+L inch filter disk saturated with 10 .mu.g of mitomycin C following 48 hours at 37.degree.  C., growth of the wild-type and mutS strains was inhibited within a region with a radius of about
10 mm from the center of the disk.  DNA cross-linking at high levels of mitomycin C saturates recombinational repair resulting in lethal blockage of DNA replication.  Both strains gave rise to occasional colony forming units within the zone of
inhibition, although, the frequency of colonies was .about.10-20-fold higher in the mutS strain.  This is presumably due to the increased rate of spontaneous mutation of mutS backgrounds.  A side-by-side comparison demonstrated that the .DELTA.recA and
.DELTA.recA mutS strains were significantly more sensitive to mitomycin C with growth inhibited in a region extending about 15 mm from the center of the disk.  However, in contrast to the recA.sup.+ strains, no Mitt individuals were seen within the
region of growth inhibition-not even in the mutS background.  The appearance of Mit.sup.r individuals in recA.sup.+ backgrounds, but not in .DELTA.recA backgrounds indicates the Mit.sup.r is dependent upon a functional RecA protein and suggests that
Mit.sup.r may result from an increased capacity for recombinational repair of mitomycin C-induced damage.


Mutations which lead to increased capacity for RecA-mediated recombinational repair may be diverse, unexpected, unlinked, and potentially synergistic.  A recursive protocol alternating selection for Mitt and chromosomal shuffling evolves
individual cells with a dramatically increased capacity for recombination.


The recursive protocol is as follows.  Following exposure of a mutS strain to mitomycin C, Mit.sup.r individuals are pooled and cross-bread [e.g., via Hfr-mediated chromosomal shuffling or split-pool generalized transduction, or protoplast
fusion).  Alleles which result in Mit.sup.r and presumably result in an increased capacity for recombinational repair are shuffled among the population in the absence of mismatch repair.  In addition, error-prone repair following exposure to mitomycin C
can introduce new mutations for the next round of shuffling.  The process is repeated using increasingly more stringent exposures to mitomycin C. A number of parallel selections in the first round as a means of generating a variety of alleles. 
Optionally, recombinogencity of isolates can be monitored for hyper-recombination using a plasmid.times.plasmid assay or a chromosome.times.chromosome assay (e.g., that of Konrad, J. Bacteriol.  130, 167-172 (1977)).


Example 3


Whole Genome Shuffling of Streptomyces Coelicolor to Improve the Production of .gamma.-actinorhodin.


To improve the production of the secondary metabolite -y-actinorhodin from S. coelicolor, the entire genome of this organism is shuffled either alone or with its close relative S. lividans.  In the first procedure described below, genetic
diversity arises from random mutations generated by chemical or physical means.  In the second procedure, genetic diversity arises from the natural diversity existing between the genomes of S. coelicolor and S. lividans.


Spore suspensions of S. coelicolor are resuspended in sterile water and subjected to U.V.  mutagenesis such that 1% of the spores survive (.about.600 "energy" units using a Stratalinker, Stratagene), and the resulting mutants are "grown out" on
sporulation agar.  Individual spores represent uninucleate cells harboring different mutations within their genome.  Spores are collected, washed, and plated on solid medium, preferably soy agar, R5, or other rich medium that results in sporulating
colonies.  Colonies are then imaged and picked randomly using an automated colony picker, for example the Q-bot (Genetix).Alternatively colonies producing larger or darker halos of blue pigment are picked in addition or preferentially.


The colonies are inoculated into 96 well microtitre plates containing 1/3+L .times.YEME medium (170 .mu.l/well).  Two sterile 3 mm glass beads are added to each well, and the plates are shaken at 150-250 rpm at 30.degree.  C. in a humidified
incubator.  The plates are incubated up to 7 days and the cell supernatents are assayed for .gamma.-actinorhodin production.


To assay, 50 .mu.L of supernatant is added to 100 .mu.L of distilled water in a 96 well polypropylene microtitre plate, and the plate is centrifuged at 4000 rpm to pellet the mycelia.  50 .mu.L of the cleared supernatant is then removed and added
to a flat bottom polystyrene 96 well microtitre plate containing 150 .mu.L 1M KOH in each well.  The resulting plates are then read in a microtitre plate reader measuring the absorbance at 654 nm of the individual samples as a measure of the content
.gamma.-actinorhodin.


Mycelia from cultures producing .gamma.-actinorhodin at levels significantly higher than that of wildtype S. coelicolor are then isolated.  These are propagated on solid sporulation medium, and spore preparations of each improved mutant are made. From these preparations protoplasts of each of the improved mutants are generated, pooled together, and fused (as described in Genetic Manipulation of Streptomyces--A laboratory Manual, Hopwood, D. A., et al.).  The fused protoplasts are regenerated and
allowed to sporulate.  Spores are collected and either plated on solid medium for further picking and screening, or, to increase the representation of multiparent progeny, are used to generate protoplasts and fused again (or several times as described
previously for methods to effect poolwise recombination) before further picking and screening.


Further improved mutants result from the combination of two or more mutations that have additive or synergistic effects on g-actinorhodin production.  Further improved mutants can be again mated by protoplast poolwise fusion, or they can be
exposed to random mutagenesis to create a new population of cells to be screened and mated for further improvements.


As an alternative to random mutagenesis a source of genetic diversity, natural diversity can be employed.  In this case, protoplasts generated from wildtype S. coelicolor and S. lividans are fused together.  Spores from the regenerated progeny of
this mating are then either repetitively fused and regenerated to create additional diversity, or they are separated on solid medium, picked, and screened for enhanced production of g-actinorhodin.  As before, the improved subpopulation are mated
together to identify further improved family shuffled organisms.


Example 4


Whole Genome Shuffling of Rhodococcus for Two-Phase Reaction Catalysis


This example provides and example of how to apply the techniques described herein to technologies that allow the generic improvement of biotransformations catalyzed by whole cells.  Rhodococcus was selected as an initial target because it is both
representative of systems in which molecular biology is rudimentary (as is common in whole cell catalysts which are generally selected by screening environmental isolates), and because it is an organism that can catalyze two-phase reactions.


The goal of whole genome shuffling of Rhodococcus is to obtain an increase in flux through any chosen pathway.  The substrate specificity of the pathway can be altered to accept molecules which are not currently substrates.  Each of these
features can be selected for during whole genome shuffling.


During whole genome shuffling, libraries of shuffled enzymes and pathways are made and transformed into Rhodococcus and screened, preferably by high-throughput assays for improvements in the target phenotype, e.g., by mass spectroscopy for
measuring the product.


As noted above, the chromosomal context of genes can have dramatic effects on their activities.  Cloning of the target genes onto a small plasmid in Rhodococcus can dramatically reduce the overall pathway activity (by a factor of 5- to 10-fold or
more).  Thus, the starting point for DNA shuffling of a pathway (on a plasmid) can be 10-fold lower than the activity of wild-type strain.  By contrast, integration of the genes into random sites in the Rhodococcus chromosome can result in a significant
(5- to 10-fold) increase in activity.  A similar phenomenon was observed in the recent directed evolution in E coli of an arsenate resistance operon (originally from Staphylococcus aureus) by DNA shuffling.  Shuffling of this plasmid produced sequence
changes that led to efficient integration of the operon into the E coli chromosome.  Of the total 50-fold increase in arsenate resistance obtained by directed evolution of the three gene pathway, approximately 10-fold resulted from this integration into
the chromosome.  The position within the chromosome is also likely to be important: for example sequences close to the replication origin have an effectively higher gene dosage and therefore greater expression level.


In order to fully exploit unpredictable chromosomal position effects, and to incorporate them into a directed evolution strategy which utilizes multiple cycles of mutation, recombination and selection, genes are manipulated in vitro and then
transferred to an optimal chromosomal position.  Recombination between plasmid and chromosome occurs in two different ways.  Integration takes place at a position where there is significant sequence homology between plasmid and chromosome, i.e., by
homologous recombination.  Integration also takes place where there is no apparent sequence identity, i.e., by non-homologous recombination.  These two recombination mechanisms are effected by different cellular machineries and have different potential
applications in directed evolution.


To combine the increase in activity that resulted from gene duplication and chromosomal integration of the target pathway with the powerful technique of DNA shuffling, libraries of shuffled genes are made in vitro, and integrated into the
chromosome in place of the wild-type genes by homologous recombination.  Recombinants are then be screened for increased activity.  This process is optionally made recursive as discussed herein.  The best Rhodococcus variants are pooled, and the pool
divided in two.  Genes are cloned out of the pool by PCR, shuffled together and re-integrated into the chromosomes of the other half of the pool by homologous recombination.  Recombinants are once again be screened, the best taken and pooled and the
process optionally repeated.


Sometimes there are complex interactions between enzymes catalyzing successive reactions in a pathway.  Sometimes the presence of one enzyme can adversely affect the activities of others in the pathway.  This can be the result of protein-protein
interactions, or inhibition of one enzyme by the product of another, or an imbalance of primary or secondary metabolism.


This problem is overcome by DNA shuffling, which produces solutions in the target gene cluster that bring about improvements in whatever trait is screened.  An alternative approach, which can solve not only this problem, but also anticipated
future rate limiting steps such as supply of reducing power and substrate transportation, is complementation by overexpression of other as yet unknown genomic sequences.


A library of Rhodococcus genomic DNA in a multicopy Rhodococcus vector such as pRC1 is first made.  This is transformed into Rhodococcus and transformants are screened for increases in the desired phenotype.  Genomic fragments which result in
increased pathway activity are evolved by DNA shuffling to further increase their beneficial effect on a selected property.  This approach requires no sequence information, nor any knowledge or assumptions about the nature of protein or pathway
interactions, or even of the rate -limiting step; it relies only on detection of the desired phenotype.  This sort of random cloning and subsequent evolution by DNA shuffling of positively interacting genomic sequences is extremely powerful and generic. 
A variety of sources of genomic DNA are used, from isogenic strains to more distantly related species with potentially desirable properties.  In addition, the technique is, in principle, applicable to any microorganism for which the molecular biology
basics of transformation and cloning vectors are available, and for any property which can be assayed, preferably in a high-throughput format.


Homologous recombination within the chromosome is used to circumvent the limitations of plasmid-evolution and size restrictions, and is optionally used to alter central metabolism.  The strategy is similar to that described above for shuffling
genes within their chromosomal context, except that no in vitro shuffling occurs.  Instead, the parent strain is treated with mutagens such as ultraviolet light or nitrosoguanidine, and improved mutants are selected.  The improved mutants are pooled and
split.  Half of the pool is used to generate random genomic fragments for cloning into a homologous recombination vector.  Additional genomic fragments are derived from related species with desirable properties (in this case higher metabolic rates and
the ability to grow on cheaper carbon sources).  The cloned genomic fragments are homologously recombined into the genomes of the remaining half of the mutant pool, and variants with improved phenotypes are selected.  These are subjected to a further
round of mutagenesis, selection and recombination.  Again this process is entirely generic for the improvement of any whole cell biocatalyst for which a recombination vector and an assay can be developed.


Efficient homologous recombination is important for the recursivity of the chromosomal evolution strategies outlined above.  Non-homologous recombination results in a futile integration (upon selection) followed by excision (following
counterselection) of the entire plasmid.  Alternatively, if no counter-selection were used, there is integration of more and more copies of plasmid I genomic sequences which is both unstable and also requires an additional selectable marker for each
cycle.  Furthermore, additional non-homologous recombination will occur at random positions and may or may not lead to good expression of the integrated sequence.


Example 5


Increasing the rate of Homologous Recombination in Rhodococcus


A genetic approach is used to increase the rate of homologous recombination in Rhodococcus.  Both targeted and non-targeted strategies to evolve increases in homologous recombination are used.  Rhodococcus recA is evolved by DNA shuffling to
increase its ability to promote homologous recombination within the chromosome.  The recA gene was chosen because there are variants of recA known to result in increased rates of homologous recombination in E coli.  as discussed above.


The recA gene from Rhodococcus is DNA shuffled and cloned into a plasmid that carries a selectable marker and a disrupted copy of the Rhodococcus homolog of the S cerevisiae URA3 gene (a gene which also confers sensitivity to the uracil precursor
analogue 5-fluoroorotic acid).  Homologous integration of the plasmid into the chromosome disrupts the host uracil synthesis pathway leading to a strain that carries the selectable marker and is also resistant to 5-fluoroorotic acid.  The shuffled recA
genes is integrated, and can be amplified from the chromosome, shuffled again and cloned back into the integration-selection vector.  At each cycle, the recA genes promoting the greatest degree of homologous recombination are those that are the best
represented as integrants in the genome.  Thus a Rhodococcus recA with enhanced homologous recombination-promoting activity is evolved.


Many other genes are involved in several different homologous recombination pathways, and mutations in some of these proteins may also lead to cells with an increased level of homologous recombination.  For example mutations in E coli DNA
polymerase III have recently been shown to increase RecA-independent homologous recombination.  Resistance to DNA cross-linking agents such as nitrous acid, mitomycin and ultraviolet are dependent on homologous wit recombination.  Thus, increases in the
activity of this pathway result in increased resistance to these agents.  Rhodococcus cells are mutagenized and selected for increased tolerance to DNA cross-linking agents.  These mutants are tested for the rate at which a plasmid will integrate
homologously into the chromosome.  Genomic libraries are prepared from these mutants, combined as described above, and used to evolve a strain with even higher levels of homologous recombination.


The foregoing description of the preferred embodiments of the present invention has been presented for purposes of illustration and description.  They are not intended to be exhaustive or to limit the invention to the precise form disclosed, and
many modifications and variations are possible in light of the above teaching.  Such modifications and variations which may be apparent to a person skilled in the art are intended to be within the scope of this invention.  All patent documents and
publications cited above are incorporated by reference in their entirety for all purposes to the same extent as if each item were so individually denoted.


 SEQUENCE LISTING  <100> GENERAL INFORMATION:  <160> NUMBER OF SEQ ID NOS: 14  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ ID NO 1  <211> LENGTH: 1485  <212> TYPE: DNA  <213> ORGANISM: Escherichia coli 
<400> SEQUENCE: 1  gggattttgg tcatgagatt atcaaaaagc ggccgcggcc taagaggcca gagaagcctg 60  tcggcacggt ctggtttgct tttgccactg cccgcggtga aggcattacc cggcgggatg 120  cttcagcggc gaccgtgatg cggtgcgtcg tcaggctact gcgtatgcat tgcagacctt 180  gtggcaacaa
tttctacaaa acacttgata ctgtatgagc atacagtata attgcttcaa 240  cagaacatat tgactatccg gtattacccg gcatgacagg agtaaaaatg gctatcgacg 300  aaaacaaaca gaaagcgttg gcggcagcac tgggccagat tgagaaacaa tttggtaaag 360  gctccatcat gcgcctgggt gaagaccgtt ccatggatgt
ggaaaccatc tctaccggtt 420  cgctttcact ggatatcgcg cttggggcag gtggtctgcc gatgggccgt atcgtcgaaa 480  tctacggacc ggaatcttcc ggtaaaacca cgctgacgct gcaggtgatc gccgcagcgc 540  agcgtgaagg taaaacctgt gcgtttatcg atgctgaaca cgcgctggac ccaatctacg 600  cacgtaaact
gggcgtcgat atcgacaacc tgctgtgctc ccagccggac accggcgagc 660  aggcactgga aatctgtgac gccctggcgc gttctggcgc agtagacgtt atcgtcgttg 720  actccgtggc ggcactgacg ccgaaagcgg aaatcgaagg cgaaatcggc gactctcaca 780  tgggccttgc ggcacgtatg atgagccagg cgatgcgtaa
gctggcgggt aacctgaagc 840  agtccaacac gctgctgatc ttcatcaacc agatccgtat gaaaattggt gtgatgttcg 900  gtaacccgga aaccaccacc ggtggtaacg cgctgaaatt ctacgcctct gttcgtctcg 960  acatccgtcg tatcggcgcg gtgaaagagg gcgaaaacgt ggtgggtagc gaaacccgcg 1020  tgaaagtggt
gaagaacaaa atcgctgcgc cgtttaaaca ggctgaattc cagatcctct 1080  acggcgaagg tatcaacttc tacggcgaac tggttgacct gggcgtaaaa gagaagctga 1140  tcgagaaagc aggcgcgtgg tacagctaca aaggtgagaa gatcggtcag ggtaaagcga 1200  atgcgactgc ctggctgaaa gataacccgg aaaccgcgaa
agagatcgag aagaaagtac 1260  gtgagttgct gctgagcaac ccgaactcaa cgccggattt ctctgtagat gatagcgaag 1320  gcgtagcaga aactaacgaa gatttttaat cgtcttgttt gatacacaag ggtcgcatct 1380  gcggcccttt tgctttttta agttgtaagg atatgccatg acagaatcaa catcccgtcg 1440  gcctggtagg
ccattttttg gatcttcacc tagatccttt taaat 1485  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ ID NO 2  <211> LENGTH: 1382  <212> TYPE: DNA  <213> ORGANISM: Escherichia coli  <400> SEQUENCE: 2  tgttggcacg gtctggcttg
cttttgccac tgcccgcggt gaaggcatta cccggcggga 60  atgcttcaac ggcgaccgtg atgcggtgcg tcgtcaggct actgcgtatg cattgcagac 120  cttgtggcaa caatttctac gaaacacctg atactgtatg agcatacagt ataattgctt 180  caacagaaca tattgactat ccggtattac ccggcatgac aggagtgaaa
atggctattg 240  acgaaaacaa acagaaagcg ttggcgacag cactgggcca gattgagaaa caatttggta 300  aaggctccat catgcgcctg ggtgaagacc gttccatgga tgtggaaacc atctctaccg 360  gttcgctttc actggatatc gcgcttgggg caggtggtct gccgatgggc cgtatcgtcg 420  aaatctacgg accggaatct
tccggtaaaa ccacactgac gctgcaggtg atcgccgcag 480  cgcagcgtga aggtaaaacc tgtgcgttta tcgatgccga acacgcgctg gacccaatct 540  acgcacgcaa actgggcgtc gatatcgaca acctgctgtg ctcccagccg gacaccggcg 600  agcaggcact ggaaatctgt gacgccctgg cgcgttctgg cgcagtagac
gttatcgtcg 660  ttgactccgt ggcggcactg acgccgaaag cggaaatcga aggcgaaatc ggcgactctc 720  acatgggcct tgcggcacgt atgatgagcc aggcgatgcg caagctggcg ggtaacctga 780  agcagtccaa cacgctgctg atcttcatta accagatccg tatgaaaatt ggtgtgatgt 840  tcggtaaccc ggaaaccact
accggtggta acgcgctgaa attctacgcc tccgttcgtc 900  tcgacatccg tcgtatcggc gcggtgaaag agggcgaaaa cgtggtgggt agcgaaaccc 960  gcgtgaaagt ggtgaagaac aaaatcgctg cgccgtttaa acaggctgaa ttccaggtcc 1020  tctacggcga aggtatcaac ttctacggcg aactggttga cctgggcgta
aaagagaagc 1080  tgatcgagaa agcaggcgcg tggtacagct acaaaggaga gaagattggt cagggtaaag 1140  cgaacgcgac tgcctggctg aaagataatc cggaaaccgc gaaagagatt gagaagaaag 1200  tacgtgagtt gctgctgagc aacccgaact caacgccgga tttctctgga gatgatagcg 1260  aaggcgtagc agaaactaac
gaagattttt aatcgtcttg tttgatacac aagggtcgca 1320  tctgcgaccc ttttgctttt ttaagttgta aggatatgcc atgacagaat caacatcccg 1380  tc 1382  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ ID NO 3  <211> LENGTH: 1430  <212> TYPE: DNA 
<213> ORGANISM: Escherichia coli  <400> SEQUENCE: 3  agaggccaga gaagcctgtc ggcacggtct ggtttgcctt tgccactgcc cgcggtgaag 60  gcattactcg gcgggaatgc ttcagtggcg accgtgatgc ggtgcgtcgt caggctactg 120  cgtatgcatt gcagaccttg tggcaacaat ttctacaaaa
cacctgatac tgtatgagca 180  tacagtataa ttgcttcaac agaacatatt gactatccgg tattacccgg catgacagga 240  gtaaacatgg ctatcgacga aaacaaacag aaagcgttag cggcagcact gggccagatt 300  gagaaacaat ttggtaaagg ctccatcatg cgcctgggtg aagaccgttc catggatgtg 360  gaaaccatct
ccaccggttc gctttcactg gatatcgcac ttggggcagg tggtctgccg 420  atgggccgta tcgtcgaaat ctacggaccg gaatcttccg gtaaaaccac gctgacgctg 480  caggtgatcg ccgcagcgca gcgtgaaggt aaaacctgtg cgtttatcga tgctgaacac 540  gcgctggacc caatctacgc acgtaaactg ggcgtcgata
tcgacaacct gctgtgctcc 600  cagcccgaca ccggcgagca ggcactggaa atctgtgacg ccctggcgcg ttctggcgcg 660  gtagacgtta tcgtcgttga ctccgtggcg gcactgacgc cgaaagcgga aatcgaaggc 720  gaaatcggcg actctcacat gggccttgcg gcacgtatga tgagccaggc gatgcgtaag 780  ctggcgggta
acctgaagca gtccaacacg ctgctgatct tcatcaacca gatccgtatg 840  aaaattggtg tgatgttcgg taacccggaa accactaccg gtggtaacgc gctgaaattc 900  tacgcctctg ttcgtctcga catccgtcgt atcggcgcgg tgaaagaggg cgaaaacgtg 960  gtgggtagcg aaacccgcgt gaaagtggtg aagaacaaaa
tcgctgcgcc gtttaaacag 1020  gctgaattcc aaatcctcta cggcgaaggt atcaacttct acggcgaact ggttgacctg 1080  ggcgtaaaag agaagctgat cgagaaagca ggcgcgtggt acagctacaa aggtgagaag 1140  atcggtcagg gtaaagcgaa tgcgactgcc tggctgaaag ataacccgga aaccgcgaaa 1200  gagatcgaga
agaaagtacg tgagttgctg ctgagtaacc cgaactcaac gccggatttc 1260  tctgtagatg atagcgaagg cgtagcagga actaacgaag atttttaatc gtcttgtttg 1320  atacacaagg gtcgcatctg cggccctttt gcttttttaa gttgtaggga tatgccatga 1380  cagaatcaac atcccgtcgg cctggtaggc cattttttgg
atcttcacct 1430  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ ID NO 4  <211> LENGTH: 1380  <212> TYPE: DNA  <213> ORGANISM: Escherichia coli  <400> SEQUENCE: 4  cggcagggtc tggtttgctt ttgccactgc ccgcggtgaa ggcattatcc
ggcgggaatg 60  cttcagcggc ggccgtgatg cggtgcgtcg tcaggctact gcgtatgcat tgcagacctt 120  gtggcaacaa tttctacaaa acacctgata ctgtatgagc atacagtata attgcttcga 180  cagaacatat tgactatccg gtattacccg gcatgacagg agtaaaaatg gctatcgacg 240  agaacaaaca gaaagcgttg
gcggcagcac tgggccagat tgagaaacaa tttggtaaag 300  gctccatcat gcgcctgggt gaagaccgtt ccatggatgt ggaaaccatc tctaccggtt 360  cgctttcact ggatatcgcg cttggggcag gtggtctgcc gatgggccgt atcgtcgaaa 420  tctacggacc ggaatcttcc ggtaaaacca cactgacgct gcaggtgatc
gccgcagcgc 480  agcgtgaagg taaaacctgt tgcgtttatc gatgctgaac acgcgctaga cccaatctac 540  gcacgtaaac tgggcgtcga tatcgacaac ctgctgtgct cccagccgga caccggcgag 600  caggcactgg aaatctgtga cgccctggcg cgttctggcg cagtagacgt tatcgtcgtt 660  gactccgtag cggcactgac
gccgaaagcg gaaatcgaag gcgaaatcgg cgactctcac 720  atgggccttg cggcacgtat gatgagccag gcgatgcgta agctggcggg taacctgaag 780  ttgtccaaca cgctgctgat ctttatcaac cagatccgta tgaaaattgg cgtgatgttc 840  ggtaacccgg aaaccaccac cggtggtaac gcgctgaaat tctacgcctc
tgttcgtctc 900  gacatccgtc gtatcggtgc ggtgaaagag ggcgaaaacg tggtgggtag cgaaacccgc 960  gtgaaagtgg tgaagaacaa aatcgctgcg ccgtttaaac aggctgaatt ccagatcctc 1020  tacggcgaag gtatcaactt ctacggcgaa ctggttgacc tgggcgtaaa agagaagctg 1080  atcgagaaag caggcgcgtg
gtacagctac aaaggtgaga agatcggtca gggtaaagcg 1140  aatgcggctg cctggctgaa aggtaacccg gaaaccgcga aagagatcga gaagaaagta 1200  cgtgagttgc tgctgagcaa cccgaactca acgccggatt tctctagaga tgatagcgaa 1260  ggcgtagcag aaactaacga agatttttaa tcgtcttgtt taatacacga
gggtcgcatc 1320  tgcggccctt ttgctttttt aagttgtaag gatatgccat gacagaatca acatccagtc 1380  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ ID NO 5  <211> LENGTH: 1343  <212> TYPE: DNA  <213> ORGANISM: Escherichia coli  <400>
SEQUENCE: 5  agaggccaga gaagccagtt ggcacggtct ggtttgcttt tgccactgcc cggggtgagg 60  gcattacccg gcgggaatgc ttcagcggcg accgtgatgc ggtgcgtcgt caggctactg 120  cgtatgcact gcagaccttg tggcaacaat ttctacaaaa cacctgttac tgtatgagca 180  tgcagtataa ttgcttcaac
agaacatatt gactatccgg tattacccgg catgacagga 240  gtaaaaatgg ctattgacga aaacaaacag aaagcgttgg cggcagcact gggccagatt 300  gagaaacaat ttggtaaagg ctccatcatg cgcctgggtg aagaccgttc catggatgtg 360  gaaaccatct ctactggttc gctttcactg gatatcgcgc ttggggcagg
tggtctgccg 420  atgggccgta tcgtcgaaat ctatggaccg gaatcttccg gtaaaaccac actgacgctg 480  caggtgatcg ccgcagcgca gcgtgagggt aaaacctgtg cgtttatcga tgctgaacac 540  gcgctggacc caatctacgc acgtaaactg ggcgtcgata tcgacaacct gctgtgctcc 600  cagccggaca ccggcgagca
ggcactggaa atctgtgacg ccctggcgcg ttctggcgct 660  gtagacgtta tcgtcgttga ctccgtggcg gcactgtcgc cgaaagcgga aatcgaaggc 720  gaaatcggcg actctcacat gggccttgcg gcacgtatga tgagccaggc aatgcgtaag 780  ctggcgggta acctgaagca gtccaacacg ctgctgatct tcatcaacca
gatccgtatg 840  aaaattggtg tgatgttcgg taacccggaa accaccaccg gtggtaacgc gctgaaattc 900  tacgcctctg ttcgtctcga catccgtcgt atcggcgcag tgaaagaggg cgaaaacgtg 960  gtgggtagcg aaacccgcgt gaaagtggtg aagaacaaaa tcgctgcgcc gtttaaacag 1020  gctgaattcc agatcctcta
cggcgaaggt atcaacttct acggcgaact ggttgatctg 1080  ggcgtaaaag agaagctgat cgagaaagca ggcgcgtggt acagctacaa aggtgagaag 1140  gttggtcagg gtaaagcgaa tgcgactgcc tggctgaaag ataacccgga aaccgcgaaa 1200  gagatcgaga agaaagtacg tgagttgctg ctgagcaacc cgaactcaac
gccggatttc 1260  tctgtagatg atagcgaagg cgtagcagaa actaacgaag atttttaatc stcttgtttg 1320  atacacaagg gtcgcatctg cgg 1343  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ ID NO 6  <211> LENGTH: 1379  <212> TYPE: DNA  <213>
ORGANISM: Escherichia coli  <400> SEQUENCE: 6  gaggccagag aagcctgtcg gcttggtctg gtttgctttt accattgccc gcggtgaagg 60  cattacccgg cgggaatgct tcagcggcga ccgtgatgcg gtgcgtcgtc aggctactgt 120  gtatgcactg cagaccttgt ggcaacgatt tctacaaaac actcgatacc
gtatgagcac 180  acagtataat cgcttcgaca gaacttattg actatccggt attacccggc atgacaggag 240  taaaaatggc tattgacgaa aacaaacaga aagcgttggc ggcagcactg ggccagattg 300  agaaacagtt tggtaaaggc tccatcatgc gcctggggga agaccgttcc atggatgtgg 360  aaaccatctc taccggttcg
ctttcactgg atatcgcgct tggggcaggt ggtctgccga 420  tgggccgtat cgtcgaaatc tacggaccgg aatcttccgg taaaaccacg ctgacgctgc 480  aggtgatcgc cgcagcgcag cgtgaaggta aaacctgtgc gtttatcgat gctgaacacg 540  cgctggaccc gatctacgca cgtaaactgg gcgtcgatat cgacaacctg
ctgtgctccc 600  agccggacac cggcgagcag gcactggaaa tctgtgacgc cctggcgcgc tctggcgcag 660  tggacgttat cgtcgttgac tccgtggcgg cactgacgcc gaaagcggaa atcgaaggcg 720  aaatcggcga ctctcacatg ggccttgcag cacgtatgat gagccaggcg atgcgtaagc 780  tggcgggtaa cctgaagcag
tccaacacgc tgctgatctt catcaaccag atccgtatga 840  aaattggtgt gatgttcggt aacccggaaa ccactaccgg tggtaacgcg ctgaaattct 900  acgcctctgt tcgtctcgac atccgtcgta tcggcacggt gaaagagggc gaaaacgtgg 960  tgggtagcga aacccgcgtg aaagtggtga agaacaaaat cgctgcgccg
tttaaacagg 1020  ctgaattcca aatcctctac gacgaaggta tcaacttcta cggcgaactg gttgacatgg 1080  gcgtaaaaga gaagctgatc gagaaagcag gcgcgtggta cagctacaaa ggtgagaagg 1140  ccggtcaggg taaagcgaat gcgactgcct ggctgaaaga taacccggaa accgcgaaag 1200  agatcgagaa gaaagtacgt
gagttgctgc tgagcaaccc gaactcaacg ccggatttct 1260  ctgtagatga tagcgaaggc gtagcagaaa ctaacgaaga tttttaatcg tcttgtttga 1320  tacacaaggg tcgcatctgc ggcccttttg cttttttaag ttgtaaggat atgccatga 1379  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ ID NO
7  <211> LENGTH: 358  <212> TYPE: PRT  <213> ORGANISM: Escherichia coli  <400> SEQUENCE: 7  Met Thr Gly Val Lys Met Ala Ile Asp Glu Asn Lys Gln Lys Ala Leu  1 5 10 15  Ala Ala Ala Leu Gly Gln Ile Glu Lys Gln Phe Gly Lys Gly Ser
Ile  20 25 30  Met Arg Leu Gly Glu Asp Arg Ser Met Asp Val Glu Thr Ile Ser Thr  35 40 45  Gly Ser Leu Ser Leu Asp Ile Ala Leu Gly Ala Gly Gly Leu Pro Met  50 55 60  Gly Arg Ile Val Glu Ile Tyr Gly Pro Glu Ser Ser Gly Lys Thr Thr  65 70 75 80  Leu Thr Leu
Gln Val Ile Ala Ala Ala Gln Arg Glu Gly Lys Thr Cys  85 90 95  Ala Phe Ile Asp Ala Glu His Ala Leu Asp Pro Ile Tyr Ala Arg Lys  100 105 110  Leu Gly Val Asp Ile Asp Asn Leu Leu Cys Ser Gln Pro Asp Thr Gly  115 120 125  Glu Gln Ala Leu Glu Ile Cys Asp Ala
Leu Ala Arg Ser Gly Ala Val  130 135 140  Asp Val Ile Val Val Asp Ser Val Ala Ala Leu Thr Pro Lys Ala Glu  145 150 155 160  Ile Glu Gly Glu Ile Gly Asp Ser His Met Gly Leu Ala Ala Arg Met  165 170 175  Met Ser Gln Ala Met Arg Lys Leu Ala Gly Asn Leu Lys
Gln Ser Asn  180 185 190  Thr Leu Leu Ile Phe Ile Asn Gln Ile Arg Met Lys Ile Gly Val Met  195 200 205  Phe Gly Asn Pro Glu Thr Thr Thr Gly Gly Asn Ala Leu Lys Phe Tyr  210 215 220  Ala Ser Val Arg Leu Asp Ile Arg Arg Ile Gly Ala Val Lys Glu Gly  225 230
235 240  Glu Asn Val Val Gly Ser Glu Thr Arg Val Lys Val Val Lys Asn Lys  245 250 255  Ile Ala Ala Pro Phe Lys Gln Ala Glu Phe Gln Ile Leu Tyr Gly Glu  260 265 270  Gly Ile Asn Phe Tyr Gly Glu Leu Val Asp Leu Gly Val Lys Glu Lys  275 280 285  Leu Ile Glu
Lys Ala Gly Ala Trp Tyr Ser Tyr Lys Gly Glu Lys Ile  290 295 300  Gly Gln Gly Lys Ala Asn Ala Thr Ala Trp Leu Lys Asp Asn Pro Glu  305 310 315 320  Thr Ala Lys Glu Ile Glu Lys Lys Val Arg Glu Leu Leu Leu Ser Asn  325 330 335  Pro Asn Ser Thr Pro Asp Phe
Ser Val Asp Asp Ser Glu Gly Val Ala  340 345 350  Glu Thr Asn Glu Asp Phe  355  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ ID NO 8  <211> LENGTH: 358  <212> TYPE: PRT  <213> ORGANISM: Escherichia coli  <400> SEQUENCE:
8  Met Thr Gly Val Lys Met Ala Ile Asp Glu Asn Lys Gln Lys Ala Leu  1 5 10 15  Ala Thr Ala Leu Gly Gln Ile Glu Lys Gln Phe Gly Lys Gly Ser Ile  20 25 30  Met Arg Leu Gly Glu Asp Arg Ser Met Asp Val Glu Thr Ile Ser Thr  35 40 45  Gly Ser Leu Ser Leu Asp
Ile Ala Leu Gly Ala Gly Gly Leu Pro Met  50 55 60  Gly Arg Ile Val Glu Ile Tyr Gly Pro Glu Ser Ser Gly Lys Thr Thr  65 70 75 80  Leu Thr Leu Gln Val Ile Ala Ala Ala Gln Arg Glu Gly Lys Thr Cys  85 90 95


Ala Phe Ile Asp Ala Glu His Ala Leu Asp Pro Ile Tyr Ala Arg Lys  100 105 110  Leu Gly Val Asp Ile Asp Asn Leu Leu Cys Ser Gln Pro Asp Thr Gly  115 120 125  Glu Gln Ala Leu Glu Ile Cys Asp Ala Leu Ala Arg Ser Gly Ala Val  130 135 140  Asp Val Ile
Val Val Asp Ser Val Ala Ala Leu Thr Pro Lys Ala Glu  145 150 155 160  Ile Glu Gly Glu Ile Gly Asp Ser His Met Gly Leu Ala Ala Arg Met  165 170 175  Met Ser Gln Ala Met Arg Lys Leu Ala Gly Asn Leu Lys Gln Ser Asn  180 185 190  Thr Leu Leu Ile Phe Ile Asn
Gln Ile Arg Met Lys Ile Gly Val Met  195 200 205  Phe Gly Asn Pro Glu Thr Thr Thr Gly Gly Asn Ala Leu Lys Phe Tyr  210 215 220  Ala Ser Val Arg Leu Asp Ile Arg Arg Ile Gly Ala Val Lys Glu Gly  225 230 235 240  Glu Asn Val Val Gly Ser Glu Thr Arg Val Lys
Val Val Lys Asn Lys  245 250 255  Ile Ala Ala Pro Phe Lys Gln Ala Glu Phe Gln Val Leu Tyr Gly Glu  260 265 270  Gly Ile Asn Phe Tyr Gly Glu Leu Val Asp Leu Gly Val Lys Glu Lys  275 280 285  Leu Ile Glu Lys Ala Gly Ala Trp Tyr Ser Tyr Lys Gly Glu Lys Ile 
290 295 300  Gly Gln Gly Lys Ala Asn Ala Thr Ala Trp Leu Lys Asp Asn Pro Glu  305 310 315 320  Thr Ala Lys Glu Ile Glu Lys Lys Val Arg Glu Leu Leu Leu Ser Asn  325 330 335  Pro Asn Ser Thr Pro Asp Phe Ser Gly Asp Asp Ser Glu Gly Val Ala  340 345 350  Glu
Thr Asn Glu Asp Phe  355  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ ID NO 9  <211> LENGTH: 358  <212> TYPE: PRT  <213> ORGANISM: Escherichia coli  <400> SEQUENCE: 9  Met Thr Gly Val Asn Met Ala Ile Asp Glu Asn Lys Gln
Lys Ala Leu  1 5 10 15  Ala Ala Ala Leu Gly Gln Ile Glu Lys Gln Phe Gly Lys Gly Ser Ile  20 25 30  Met Arg Leu Gly Glu Asp Arg Ser Met Asp Val Glu Thr Ile Ser Thr  35 40 45  Gly Ser Leu Ser Leu Asp Ile Ala Leu Gly Ala Gly Gly Leu Pro Met  50 55 60  Gly
Arg Ile Val Glu Ile Tyr Gly Pro Glu Ser Ser Gly Lys Thr Thr  65 70 75 80  Leu Thr Leu Gln Val Ile Ala Ala Ala Gln Arg Glu Gly Lys Thr Cys  85 90 95  Ala Phe Ile Asp Ala Glu His Ala Leu Asp Pro Ile Tyr Ala Arg Lys  100 105 110  Leu Gly Val Asp Ile Asp Asn
Leu Leu Cys Ser Gln Pro Asp Thr Gly  115 120 125  Glu Gln Ala Leu Glu Ile Cys Asp Ala Leu Ala Arg Ser Gly Ala Val  130 135 140  Asp Val Ile Val Val Asp Ser Val Ala Ala Leu Thr Pro Lys Ala Glu  145 150 155 160  Ile Glu Gly Glu Ile Gly Asp Ser His Met Gly
Leu Ala Ala Arg Met  165 170 175  Met Ser Gln Ala Met Arg Lys Leu Ala Gly Asn Leu Lys Gln Ser Asn  180 185 190  Thr Leu Leu Ile Phe Ile Asn Gln Ile Arg Met Lys Ile Gly Val Met  195 200 205  Phe Gly Asn Pro Glu Thr Thr Thr Gly Gly Asn Ala Leu Lys Phe Tyr 
210 215 220  Ala Ser Val Arg Leu Asp Ile Arg Arg Ile Gly Ala Val Lys Glu Gly  225 230 235 240  Glu Asn Val Val Gly Ser Glu Thr Arg Val Lys Val Val Lys Asn Lys  245 250 255  Ile Ala Ala Pro Phe Lys Gln Ala Glu Phe Gln Ile Leu Tyr Gly Glu  260 265 270  Gly
Ile Asn Phe Tyr Gly Glu Leu Val Asp Leu Gly Val Lys Glu Lys  275 280 285  Leu Ile Glu Lys Ala Gly Ala Trp Tyr Ser Tyr Lys Gly Glu Lys Ile  290 295 300  Gly Gln Gly Lys Ala Asn Ala Thr Ala Trp Leu Lys Asp Asn Pro Glu  305 310 315 320  Thr Ala Lys Glu Ile
Glu Lys Lys Val Arg Glu Leu Leu Leu Ser Asn  325 330 335  Pro Asn Ser Thr Pro Asp Phe Ser Val Asp Asp Ser Glu Gly Val Ala  340 345 350  Gly Thr Asn Glu Asp Phe  355  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ ID NO 10  <211> LENGTH: 358 <212> TYPE: PRT  <213> ORGANISM: Escherichia coli  <400> SEQUENCE: 10  Met Thr Gly Val Lys Met Ala Ile Asp Glu Asn Lys Gln Lys Ala Leu  1 5 10 15  Ala Ala Ala Leu Gly Gln Ile Glu Lys Gln Phe Gly Lys Gly Ser Ile  20 25 30  Met Arg Leu
Gly Glu Asp Arg Ser Met Asp Val Glu Thr Ile Ser Thr  35 40 45  Gly Ser Leu Ser Leu Asp Ile Ala Leu Gly Ala Gly Gly Leu Pro Met  50 55 60  Gly Arg Ile Val Glu Ile Tyr Gly Pro Glu Ser Ser Gly Lys Thr Thr  65 70 75 80  Leu Thr Leu Gln Val Ile Ala Ala Ala
Gln Arg Glu Gly Lys Thr Cys  85 90 95  Ala Phe Ile Asp Ala Glu His Ala Leu Asp Pro Ile Tyr Ala Arg Lys  100 105 110  Leu Gly Val Asp Ile Asp Asn Leu Leu Cys Ser Gln Pro Asp Thr Gly  115 120 125  Glu Gln Ala Leu Glu Ile Cys Asp Ala Leu Ala Arg Ser Gly Ala
Val  130 135 140  Asp Val Ile Val Val Asp Ser Val Ala Ala Leu Thr Pro Lys Ala Glu  145 150 155 160  Ile Glu Gly Glu Ile Gly Asp Ser His Met Gly Leu Ala Ala Arg Met  165 170 175  Met Ser Gln Ala Met Arg Lys Leu Ala Gly Asn Leu Lys Leu Ser Asn  180 185 190 Thr Leu Leu Ile Phe Ile Asn Gln Ile Arg Met Lys Ile Gly Val Met  195 200 205  Phe Gly Asn Pro Glu Thr Thr Thr Gly Gly Asn Ala Leu Lys Phe Tyr  210 215 220  Ala Ser Val Arg Leu Asp Ile Arg Arg Ile Gly Ala Val Lys Glu Gly  225 230 235 240  Glu Asn Val Val
Gly Ser Glu Thr Arg Val Lys Val Val Lys Asn Lys  245 250 255  Ile Ala Ala Pro Phe Lys Gln Ala Glu Phe Gln Ile Leu Tyr Gly Glu  260 265 270  Gly Ile Asn Phe Tyr Gly Glu Leu Val Asp Leu Gly Val Lys Glu Lys  275 280 285  Leu Ile Glu Lys Ala Gly Ala Trp Tyr
Ser Tyr Lys Gly Glu Lys Ile  290 295 300  Gly Gln Gly Lys Ala Asn Ala Ala Ala Trp Leu Lys Gly Asn Pro Glu  305 310 315 320  Thr Ala Lys Glu Ile Glu Lys Lys Val Arg Glu Leu Leu Leu Ser Asn  325 330 335  Pro Asn Ser Thr Pro Asp Phe Ser Arg Asp Asp Ser Glu
Gly Val Ala  340 345 350  Glu Thr Asn Glu Asp Phe  355  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ ID NO 11  <211> LENGTH: 358  <212> TYPE: PRT  <213> ORGANISM: Escherichia coli  <400> SEQUENCE: 11  Met Thr Gly Val Lys
Met Ala Ile Asp Glu Asn Lys Gln Lys Ala Leu  1 5 10 15  Ala Ala Ala Leu Gly Gln Ile Glu Lys Gln Phe Gly Lys Gly Ser Ile  20 25 30  Met Arg Leu Gly Glu Asp Arg Ser Met Asp Val Glu Thr Ile Ser Thr  35 40 45  Gly Ser Leu Ser Leu Asp Ile Ala Leu Gly Ala Gly
Gly Leu Pro Met  50 55 60  Gly Arg Ile Val Glu Ile Tyr Gly Pro Glu Ser Ser Gly Lys Thr Thr  65 70 75 80  Leu Thr Leu Gln Val Ile Ala Ala Ala Gln Arg Glu Gly Lys Thr Cys  85 90 95  Ala Phe Ile Asp Ala Glu His Ala Leu Asp Pro Ile Tyr Ala Arg Lys  100 105
110  Leu Gly Val Asp Ile Asp Asn Leu Leu Cys Ser Gln Pro Asp Thr Gly  115 120 125  Glu Gln Ala Leu Glu Ile Cys Asp Ala Leu Ala Arg Ser Gly Ala Val  130 135 140  Asp Val Ile Val Val Asp Ser Val Ala Ala Leu Ser Pro Lys Ala Glu  145 150 155 160  Ile Glu Gly
Glu Ile Gly Asp Ser His Met Gly Leu Ala Ala Arg Met  165 170 175  Met Ser Gln Ala Met Arg Lys Leu Ala Gly Asn Leu Lys Gln Ser Asn  180 185 190  Thr Leu Leu Ile Phe Ile Asn Gln Ile Arg Met Lys Ile Gly Val Met  195 200 205  Phe Gly Asn Pro Glu Thr Thr Thr
Gly Gly Asn Ala Leu Lys Phe Tyr  210 215 220  Ala Ser Val Arg Leu Asp Ile Arg Arg Ile Gly Ala Val Lys Glu Gly  225 230 235 240  Glu Asn Val Val Gly Ser Glu Thr Arg Val Lys Val Val Lys Asn Lys  245 250 255  Ile Ala Ala Pro Phe Lys Gln Ala Glu Phe Gln Ile
Leu Tyr Gly Glu  260 265 270  Gly Ile Asn Phe Tyr Gly Glu Leu Val Asp Leu Gly Val Lys Glu Lys  275 280 285  Leu Ile Glu Lys Ala Gly Ala Trp Tyr Ser Tyr Lys Gly Glu Lys Val  290 295 300  Gly Gln Gly Lys Ala Asn Ala Thr Ala Trp Leu Lys Asp Asn Pro Glu  305
310 315 320  Thr Ala Lys Glu Ile Glu Lys Lys Val Arg Glu Leu Leu Leu Ser Asn  325 330 335  Pro Asn Ser Thr Pro Asp Phe Ser Val Asp Asp Ser Glu Gly Val Ala  340 345 350  Glu Thr Asn Glu Asp Phe  355  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ
ID NO 12  <211> LENGTH: 358  <212> TYPE: PRT  <213> ORGANISM: Escherichia coli  <400> SEQUENCE: 12  Met Thr Gly Val Lys Met Ala Ile Asp Glu Asn Lys Gln Lys Ala Leu  1 5 10 15  Ala Ala Ala Leu Gly Gln Ile Glu Lys Gln Phe Gly Lys
Gly Ser Ile  20 25 30  Met Arg Leu Gly Glu Asp Arg Ser Met Asp Val Glu Thr Ile Ser Thr  35 40 45  Gly Ser Leu Ser Leu Asp Ile Ala Leu Gly Ala Gly Gly Leu Pro Met  50 55 60  Gly Arg Ile Val Glu Ile Tyr Gly Pro Glu Ser Ser Gly Lys Thr Thr  65 70 75 80  Leu
Thr Leu Gln Val Ile Ala Ala Ala Gln Arg Glu Gly Lys Thr Cys  85 90 95  Ala Phe Ile Asp Ala Glu His Ala Leu Asp Pro Ile Tyr Ala Arg Lys  100 105 110  Leu Gly Val Asp Ile Asp Asn Leu Leu Cys Ser Gln Pro Asp Thr Gly  115 120 125  Glu Gln Ala Leu Glu Ile Cys
Asp Ala Leu Ala Arg Ser Gly Ala Val  130 135 140  Asp Val Ile Val Val Asp Ser Val Ala Ala Leu Thr Pro Lys Ala Glu  145 150 155 160  Ile Glu Gly Glu Ile Gly Asp Ser His Met Gly Leu Ala Ala Arg Met  165 170 175  Met Ser Gln Ala Met Arg Lys Leu Ala Gly Asn
Leu Lys Gln Ser Asn  180 185 190  Thr Leu Leu Ile Phe Ile Asn Gln Ile Arg Met Lys Ile Gly Val Met  195 200 205  Phe Gly Asn Pro Glu Thr Thr Thr Gly Gly Asn Ala Leu Lys Phe Tyr  210 215 220  Ala Ser Val Arg Leu Asp Ile Arg Arg Ile Gly Thr Val Lys Glu Gly 
225 230 235 240  Glu Asn Val Val Gly Ser Glu Thr Arg Val Lys Val Val Lys Asn Lys  245 250 255  Ile Ala Ala Pro Phe Lys Gln Ala Glu Phe Gln Ile Leu Tyr Asp Glu  260 265 270  Gly Ile Asn Phe Tyr Gly Glu Leu Val Asp Met Gly Val Lys Glu Lys  275 280 285  Leu
Ile Glu Lys Ala Gly Ala Trp Tyr Ser Tyr Lys Gly Glu Lys Ala  290 295 300  Gly Gln Gly Lys Ala Asn Ala Thr Ala Trp Leu Lys Asp Asn Pro Glu  305 310 315 320  Thr Ala Lys Glu Ile Glu Lys Lys Val Arg Glu Leu Leu Leu Ser Asn  325 330 335  Pro Asn Ser Thr Pro
Asp Phe Ser Val Asp Asp Ser Glu Gly Val Ala  340 345 350  Glu Thr Asn Glu Asp Phe  355  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ ID NO 13  <211> LENGTH: 1398  <212> TYPE: DNA  <213> ORGANISM: Artificial Sequence 
<220> FEATURE:  <223> OTHER INFORMATION: Description of Artificial Sequence consensus  e. coli sequence  <400> SEQUENCE: 13


agaggccaga gaagcctgtc ggcacggtct ggtttgcttt tgccactgcc cgcggtgaag 60  gcattacccg gcgggaatgc ttcagcggcg accgtgatgc ggtgcgtcgt caggctactg 120  cgtatgcatt gcagaccttg tggcaacaat ttctacaaaa cacctgatac tgtatgagca 180  tacagtataa ttgcttcaac agaacatatt
gactatccgg tattacccgg catgacagga 240  gtaaaaatgg ctattgacga aaacaaacag aaagcgttgg cggcagcact gggccagatt 300  gagaaacaat ttggtaaagg ctccatcatg cgcctgggtg aagaccgttc catggatgtg 360  gaaaccatct ctaccggttc gctttcactg gatatcgcgc ttggggcagg tggtctgccg 420 
atgggccgta tcgtcgaaat ctacggaccg gaatcttccg gtaaaaccac gctgacgctg 480  caggtgatcg ccgcagcgca gcgtgaaggt aaaacctgtg cgtttatcga tgctgaacac 540  gcgctggacc caatctacgc acgtaaactg ggcgtcgata tcgacaacct gctgtgctcc 600  cagccggaca ccggcgagca ggcactggaa
atctgtgacg ccctggcgcg ttctggcgca 660  gtagacgtta tcgtcgttga ctccgtggcg gcactgacgc cgaaagcgga aatcgaaggc 720  gaaatcggcg actctcacat gggccttgcg gcacgtatga tgagccaggc gatgcgtaag 780  ctggcgggta acctgaagca gtccaacacg ctgctgatct tcatcaacca gatccgtatg 840 
aaaattggtg tgatgttcgg taacccggaa accactaccg gtggtaacgc gctgaaattc 900  tacgcctctg ttcgtctcga catccgtcgt atcggcgcgg tgaaagaggg cgaaaacgtg 960  gtgggtagcg aaacccgcgt gaaagtggtg aagaacaaaa tcgctgcgcc gtttaaacag 1020  gctgaattcc agatcctcta cggcgaaggt
atcaacttct acggcgaact ggttgacctg 1080  ggcgtaaaag agaagctgat cgagaaagca ggcgcgtggt acagctacaa aggtgagaag 1140  atcggtcagg gtaaagcgaa tgcgactgcc tggctgaaag ataacccgga aaccgcgaaa 1200  gagatcgaga agaaagtacg tgagttgctg ctgagcaacc cgaactcaac gccggatttc 1260 
tctgtagatg atagcgaagg cgtagcagaa actaacgaag atttttaatc gtcttgtttg 1320  atacacaagg gtcgcatctg cggccctttt gcttttttaa gttgtaagga tatgccatga 1380  cagaatcaac atcccgtc 1398  <200> SEQUENCE CHARACTERISTICS:  <210> SEQ ID NO 14  <211> LENGTH:
358  <212> TYPE: PRT  <213> ORGANISM: Artificial Sequence  <220> FEATURE:  <223> OTHER INFORMATION: Description of Artificial Sequence consensus  e. coli sequence  <400> SEQUENCE: 14  Met Thr Gly Val Lys Met Ala Ile Asp Glu
Asn Lys Gln Lys Ala Leu  1 5 10 15  Ala Ala Ala Leu Gly Gln Ile Glu Lys Gln Phe Gly Lys Gly Ser Ile  20 25 30  Met Arg Leu Gly Glu Asp Arg Ser Met Asp Val Glu Thr Ile Ser Thr  35 40 45  Gly Ser Leu Ser Leu Asp Ile Ala Leu Gly Ala Gly Gly Leu Pro Met  50
55 60  Gly Arg Ile Val Glu Ile Tyr Gly Pro Glu Ser Ser Gly Lys Thr Thr  65 70 75 80  Leu Thr Leu Gln Val Ile Ala Ala Ala Gln Arg Glu Gly Lys Thr Cys  85 90 95  Ala Phe Ile Asp Ala Glu His Ala Leu Asp Pro Ile Tyr Ala Arg Lys  100 105 110  Leu Gly Val Asp
Ile Asp Asn Leu Leu Cys Ser Gln Pro Asp Thr Gly  115 120 125  Glu Gln Ala Leu Glu Ile Cys Asp Ala Leu Ala Arg Ser Gly Ala Val  130 135 140  Asp Val Ile Val Val Asp Ser Val Ala Ala Leu Thr Pro Lys Ala Glu  145 150 155 160  Ile Glu Gly Glu Ile Gly Asp Ser
His Met Gly Leu Ala Ala Arg Met  165 170 175  Met Ser Gln Ala Met Arg Lys Leu Ala Gly Asn Leu Lys Gln Ser Asn  180 185 190  Thr Leu Leu Ile Phe Ile Asn Gln Ile Arg Met Lys Ile Gly Val Met  195 200 205  Phe Gly Asn Pro Glu Thr Thr Thr Gly Gly Asn Ala Leu
Lys Phe Tyr  210 215 220  Ala Ser Val Arg Leu Asp Ile Arg Arg Ile Gly Ala Val Lys Glu Gly  225 230 235 240  Glu Asn Val Val Gly Ser Glu Thr Arg Val Lys Val Val Lys Asn Lys  245 250 255  Ile Ala Ala Pro Phe Lys Gln Ala Glu Phe Gln Ile Leu Tyr Gly Glu  260
265 270  Gly Ile Asn Phe Tyr Gly Glu Leu Val Asp Leu Gly Val Lys Glu Lys  275 280 285  Leu Ile Glu Lys Ala Gly Ala Trp Tyr Ser Tyr Lys Gly Glu Lys Ile  290 295 300  Gly Gln Gly Lys Ala Asn Ala Thr Ala Trp Leu Lys Asp Asn Pro Glu  305 310 315 320  Thr Ala
Lys Glu Ile Glu Lys Lys Val Arg Glu Leu Leu Leu Ser Asn  325 330 335  Pro Asn Ser Thr Pro Asp Phe Ser Val Asp Asp Ser Glu Gly Val Ala  340 345 350  Glu Thr Asn Glu Asp Phe  355


* * * * *























				
DOCUMENT INFO
Description: The invention applies the technical field of molecular genetics to evolve the genomes of cells and organisms to acquire new and improved properties.BACKGROUNDCells have a number of well-established uses in molecular biology. For example, cells are commonly used as hosts for manipulating DNA in processes such as transformation and recombination. Cells are also used for expression of recombinantproteins encoded by DNA transformed into the cells. Some types of cells are also used as progenitors for generation of transgenic animals and plants. Although all of these processes are now routine, in general, the genomes of the cells used in theseprocesses have evolved little from the genomes of natural cells, and particularly not toward acquisition of new or improved properties for use in the above processes.The traditional approach to artificial or forced molecular evolution focuses on optimization of individual genes having discrete and selectable phenotypes. The strategy is to clone a gene, identify a discrete function for the gene and an assayby which it can be selected, mutate selected positions in the gene (e.g., by error-prone PCR or cassette mutagenesis) and select variants of the gene for improvement in the known function of the gene. A variant having improved function can then beexpressed in a desired cell type. This approach has a number of limitations. First, it is only applicable to genes that have been isolated and functionally characterized. Second, the approach is usually only applicable to genes that have a discretefunction. In other words, multiple genes that cooperatively confer a single phenotype cannot usually be optimized in this manner--and many genes have cooperative functions. Finally, this approach can only explore a very limited number of the totalnumber of permutations even for a single gene. For example, varying even ten positions in a protein with every possible amino acid would generate 20.sup.10 variants, which is more than can be